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 Thesis Overview 
 
This thesis presents the work completed over the course of the author’s doctorate 
of clinical psychology, and consists of two volumes. The first volume includes three 
chapters, the first of which is a systematic literature review and meta-analysis of the 
prevalence of insomnia in clinical and non-clinical populations of children and 
adolescents. The second chapter is an empirical paper exploring the relationship 
between sleep problems and daytime challenging behaviour in children with Autism 
Spectrum Disorders. The final chapter is a document summarising chapters one 
and two for the purpose of public dissemination. 
 
The second volume constitutes each of the five clinical practice reports 
(CPR’s) completed over the course of the doctoral training. The first CPR describes 
a clinical case from an older adult placement, and compares formulations from two 
psychological perspectives that could be used to inform intervention with the client. 
The second CPR describes a single-case experimental design methodology used 
to determine the effectiveness of a therapeutic intervention with a client presenting 
with behaviour that care-staff considered challenging. The third CPR consists of a 
service evaluation conducted to appraise the effectiveness of the referral pathway 
into a secondary care psychology service, using both quantitative and qualitative 
methodology. The fourth CPR offers personal reflections on the process of providing 
a consultancy service to a care provider external to the National Health Service, and 
finally, the fifth CPR summarises a clinical case study from a placement with a child 
and adolescent mental health service. 
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CHAPTER ONE 
The prevalence of insomnia in children and adolescents: A systematic 
review and meta-analysis 
 
 
 
Abstract 
 
Background. Insomnia is characterised by difficulty initiating sleep (DIS), difficulty 
maintaining sleep (DMS) and early morning awakening (EMA), resulting in distress 
or impairment in daytime functioning. The prevalence of insomnia in childhood and 
adolescence has been estimated between 4% and 41% and is associated with 
physical and mental health conditions. The aim of this research was to synthesise 
the existing prevalence data on insomnia in childhood and adolescence, adjusting 
for methodological quality, and to compare this with prevalence estimates observed 
in clinical samples. 
Methodology.  One thousand and eighty-nine articles were identified through 
literature searches. After removal of duplicate articles, and those not meeting 
eligibility criteria, 92 articles remained and were entered into a quality framework, to 
weight articles by methodological quality. Ten articles reported data from the same 
sample as another article in the collection, and were therefore removed, leaving 82 
articles to be included in the meta-analyses. Pooled prevalence estimates of 
insomnia were generated, and compared between the varying definitions of 
insomnia, and between clinical and non-clinical populations. 
Results.   Using a quality-effects model, pooled prevalence estimates were 
generated for insomnia (19.6%), insomnia with daytime impairment (9.9%), 
insomnia without comorbidities (4.1%), and DIS (13.6%), DMS (9.4%) and EMA 
(5.6%) in children and adolescents. The prevalence of insomnia in anxiety disorders 
was 59.0% (Odds Ratio compared to non-clinical population 5.8), 58.7% in 
depression (OR 5.9), and 54.5% in chronic pain (OR 4.8). 
Discussion.  This is the first meta-analysis providing synthesised prevalence data 
for insomnia in the child and adolescent population, across definitions of insomnia. 
The findings also demonstrate that children and adolescents with comorbid 
conditions are more likely to present with insomnia. The findings indicate that the 
definition and methodology used to assess for insomnia should be considered when 
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interpreting the findings of empirical articles. A balance should be sought between 
being over-inclusive and conservative when developing criteria, particularly with 
regard to the exclusion of participants presenting with comorbidities, or who present 
with sleep problems but without daytime impairment. This limits the extent to which 
empirical findings can be generalised to clinical practice. 
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1.1 Introduction 
 
Sleep plays a crucial role in human development and functioning, with disordered 
sleep having wide-ranging negative consequences for a variety of functions 
including cognitive fatigue, emotional affect, and motor co-ordination (Banks & 
Dinges, 2007; Durmer & Dinges, 2005; Pilcher & Huffcutt, 1996; Wickens, Hutchin, 
Laux & Sebok, 2015). One category of sleep disorder is insomnia. According to the 
Diagnostic and Statistical Manual: Fifth edition (DSM-V; American Psychiatric 
Association, 2013) and the International Classification for Sleep Disorders: Third 
edition (ICSD-3; American Academy of Sleep Medicine, 2014), insomnia is 
characterised by difficulty falling to sleep, not being able to remain asleep 
throughout the night, or waking earlier than would be preferred. One or more of 
these three symptoms must occur at least three times a week, and be present for a 
minimum of 3 months for insomnia to be diagnosed. Sleep problems must also be 
present despite there being sufficient opportunity and an appropriate sleeping 
environment, as well as observable impairments to daytime functioning, in order for 
a diagnosis of insomnia to be given. 
Insomnia has commonly been subcategorised as either ‘primary’, and 
therefore idiopathic in origin, or ‘secondary’, whereby the insomnia is comorbid with 
another disorder. Recently, it has been debated whether the distinction between the 
primary and secondary subtypes of insomnia are as easily defined as the psychiatric 
taxonomy would imply (Lichstein, 2006). It can be difficult to ascertain the direction 
of causality, and whether a primary diagnosis is causing the comorbid secondary 
insomnia, whether insomnia is primary and driving the secondary diagnosis, or 
whether the two disorders are inter-related, each influencing the severity of the 
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other. As a result, both the DSM-V and ICSD-3 have combined all subtypes of 
insomnia under the single term of ‘insomnia disorders’ (Sateia, 2014), and 
distinguish this only from ‘short-term insomnia disorder’, which refers to insomnia in 
response to transient factors, such as stress or changes to the environment. This 
has implications not only within the empirical literature, in terms of whether research 
samples will now include participants with both primary and secondary forms of 
insomnia, but also the way in which insomnia is defined for clinical assessment and 
treatment, as the intervention for insomnia secondary to a comorbid disorder might 
differ to that offered for a primary insomnia. 
Irrespective of the difficulty in determining the direction of causality between 
insomnia and comorbid conditions, insomnia has been consistently reported as 
more prevalent in individuals with mental health problems, such as anxiety and 
depression (Ohayon & Roth, 2003; Taylor, Lichstein, Durrence, Reidel & Bush, 
2005). In a large cross-sectional survey of an adult Norwegian population, Sivertsen 
and colleagues reported significant associations between insomnia and mental 
health problems, with odds ratios of 1.99 and 2.42 for insomnia in depression and 
anxiety respectively (Sivertsen, Krokstad, Øverland & Mykletun, 2009). Several 
cognitive and cognitive-behavioural approaches to treatment for insomnia have 
been successfully developed as a result of these data (Harvey, 2002; Morin et al., 
2006). Furthermore, longitudinal studies have suggested that in some cases 
insomnia may occur prior to the development of some mental health problems, or 
persist after recovery, and therefore should not simply be considered  a ‘symptom’ 
of mental health problems which will cease once comorbid conditions subside 
(Baglioni et al., 2011; Breslau, Roth, Rosenthal & Andreski, 1996; Eaton, Badawi & 
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Melton, 1995; Johnson, Roth & Breslau, 2006a; Ohayon & Roth, 2003; Weissman, 
Greenwald, Niño-Murcia & Dement, 1997). 
In addition to being more prevalent in individuals experiencing mental health 
difficulties, insomnia is also observed more frequently in those with a physical health 
diagnosis than in the general population. These diagnoses range from enduring and 
highly pervasive conditions, such as cancer or chronic pain, to migraine or allergies 
(Bennett et al., 2010; Savard & Morin, 2001; Smith, Perlis, Smith, Giles & Carmody, 
2000; Sutton, Moldofsky & Badley, 2001). In these instances, the insomnia may be 
a result of physical discomfort arising from the medical condition, or a side effect of 
the medication that has been prescribed to the individual. Cognitive or emotional 
arousal has a negative impact on a person’s ability to sleep (Lichstein & Rosenthal, 
1980), thus sleep disturbance may be further heightened if an individual’s medical 
condition is causing them distress. Therefore, those with a physical health problem 
may also experience feelings of anxiety or low mood, which could further influence 
the likelihood of insomnia being present in this population. 
The association between insomnia and physical and mental health 
conditions has also been well documented in the child and adolescent populations 
(Desaulniers et al., 2015; Luc, Gupta, Birnberg, Reddick & Kohrman, 2006; 
Palermo, Wilson, Lewandowski, Toliver-Sokol & Murray, 2011). Researchers have 
emphasised the importance of identifying insomnia early, because of the likely bi- 
directional influence on the severity of physical and mental health diagnoses, as 
well as the long-term impact that sleeplessness can have on a child’s development 
(Jan et al., 2010). It is therefore important that clinicians are aware of the signs of 
insomnia, and are familiar with the treatment options available. Yet, as Meltzer and 
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Mindell (2014) highlight,  there is  no  universally-agreed  definition of  childhood 
insomnia. 
Both the DSM-V and ICSD-3 include childhood insomnia under the overall 
umbrella of insomnia disorders, rather than listing childhood sleep disorders 
separately. Other definitions that have been proposed include that by Mindell and 
colleagues (2006), who suggest that childhood insomnia is the “repeated difficulty 
with sleep initiation, duration, consolidation, or quality that occurs despite age- 
appropriate time and opportunity for sleep, and results in daytime functional 
impairment for the child and/ or family” (page 1225). Glaze, Rosen and Owens 
(2002), however, suggest that insomnia in childhood should be considered a 
descriptive term, rather than a diagnostic category. They propose that any given 
criteria must acknowledge normal changes to sleeping patterns over the course of 
development, as well as the impact that the family have on the sleep disorder, and 
that the sleep disorder has on the family. Their proposed criteria are that the child 
has significant difficulty initiating or maintaining sleep, and that this is perceived as 
problematic by the child and/ or their parent; the sleeplessness must cause daytime 
impairment; and is not borne of an alternative sleep disorder, such as narcolepsy or 
sleep apnoea, or use of substances or medication. The authors acknowledge that 
the frequency, severity and duration of the difficulty should define the significance 
of the sleeplessness, but do not suggest what recommended thresholds for these 
factors might be. 
Childhood insomnia is more difficult to define than adult insomnia due to 
several factors. Firstly, there are natural changes in a child’s sleep trajectory over 
the course of their development (Blair et al., 2012), and therefore behaviours that 
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would be considered typical for one age group, may be considered worthy of clinical 
investigation in another. For example, bedtime resistance and night-wakings are 
often observed in young children, whereas delayed sleep phase and shortened total 
sleep duration are more commonly observed in older children and adolescents (Liu, 
Liu, Owens & Kaplan, 2005; Owens, 2007; Owens, Spirito, McGuinn & Nobile, 
2000). Assessment of the sleep problem is also heavily biased by the perception of 
the parent or care-giver who is often responsible for completion of the sleep diaries 
or clinical measures. For example, a parent may perceive their child’s sleeplessness 
to be more problematic than does the child, or they may not even be aware of their 
child’s night-time behaviours if they sleep well themselves. A further consideration 
is that for children and adolescents, sleep and wake times are typically dictated by 
a parent or care-giver. Where an adult may be able to adjust their bedtime 
dependent on their level of fatigue or arousal, a child may not be able to do so. 
Children’s night-time behaviours are also heavily influenced by their parents’ 
responses. A child who is allowed to sit downstairs and watch television when they 
are unable to sleep may have little opportunity or motivation to self-soothe the next 
time they awaken during the night. All of these factors distort the threshold for when 
a sleep problem reaches clinical significance and necessitates intervention. 
In the research literature, these problems are evident in the wide variety of 
methodology used to study insomnia in childhood. Several research articles rely on 
the DSM or ICSD diagnostic criteria to define their construct of insomnia, and base 
their research items accordingly. It could be argued that these criteria are based 
upon the presentation of adult insomnia, and therefore are not necessarily 
applicable to child and adolescent populations. Yet, the definitions developed 
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specifically for the paediatric population may better capture the nature of childhood 
insomnia, but are broad and difficult to quantify. Other sleep disorders, such as 
parasomnias or sleep apnoea could also account for changes to the duration or 
quality of a child’s sleep, as well as impact on daytime functioning, and therefore 
the definitions may not distinguish childhood insomnia sufficiently from other 
disorders. Furthermore, the difficulty in identifying possible causality between 
insomnia and comorbid conditions causes problems for those seeking to conduct 
research with this group, in terms of trying to recruit a homogenous sample and 
control for possible confounding variables. 
The assessment of insomnia itself can also pose a challenge. For example, 
it is commonly observed that parent and child reports of the sleep problem differ 
(Fricke-Oerkermann et al., 2007; Short, Gradisar, Lack, Wright & Chatburn, 2013). 
As previously mentioned, this may be due to differing perceptions of the parent and 
child as to the extent of the sleep problem. Furthermore, the existing research 
literature often does not acknowledge the different components of childhood 
insomnia when assessing the presence of sleep disorders in the paediatric 
population. For example, measures do not typically enquire about bedtime routines, 
the sleeping environment, or the response of parents to the child’s sleeplessness. 
It is therefore difficult to draw conclusions from the literature as to what the clinical 
picture of childhood insomnia actually looks like. Furthermore, the main symptoms 
of insomnia are rarely studied in isolation and no synthesised prevalence data exist 
to the best of the author’s knowledge. As a result, it is not possible to determine 
what the core components of insomnia consist of in this population. 
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The challenges outlined above make it difficult to study empirically the nature 
of childhood insomnia, to ascertain the pervasiveness and trajectory of insomnia in 
the paediatric and adolescent populations, and to synthesise the findings from 
various research studies. This is problematic not only in terms of understanding the 
potential burden that insomnia has on clinical resources, but also being able to 
understand the long-term impact that sleeplessness has on a child’s functioning, 
such as learning, and physical and mental health (Curcio, Ferrara & Gennaro, 2006; 
Roberts, Roberts & Duong, 2008a). It is also not possible to conclude that 
populations of individuals with a diagnosed condition present with a higher risk of 
developing insomnia, without a robust estimate of the prevalence of insomnia in the 
general population with which to compare. A wide range of prevalence estimates 
have been reported in the child and adolescent populations, ranging between 4% 
and 41% (Archbold, Pituch, Panahi & Chervin, 2002; Camhi, Morgan, Pernisco & 
Quan, 2000). This is highly dependent on the way in which insomnia has been 
defined, the methodology employed to gauge the presence of insomnia, and the 
population from which the research sample was drawn. 
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The present review therefore has several aims: 
 
1.  To provide an estimate of the prevalence of insomnia, as well as each of the 
key symptoms of insomnia, in non-clinical populations of children and 
adolescents. 
2.  To provide an estimate of prevalence adjusted for the quality of the research 
methodology. 
3. To compare the prevalence estimates identified for the non-clinical 
population, with those identified for populations of children and adolescents 
with physical and mental health conditions. 
1.2 Methodology 
 
1.2.1 Search Strategy 
 
The meta-analysis data were gathered and evaluated through the process set out 
by the PRISMA statement (Moher, Liberati, Tetzlaff, Altman & the PRISMA Group, 
2009). This involved identifying the information through an appropriate search 
strategy, screening the resulting articles for duplicates and eligibility, and finally, 
processing the remaining articles through a qualitative framework to produce the 
overall estimates of prevalence. 
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Figure 1.1 - Preferred Reporting Items for Systematic Reviews and Meta-Analyses: 
The PRISMA Statement  (Moher, Liberati, Tetzlaff, Altman & the PRISMA Group, 
2009) 
 
The meta-analysis sought to be as inclusive as possible, and so literature 
searches were conducted across several databases (Table 1.1). The search terms 
included terms were ‘insomnia’ or ‘sleeplessness’, ‘child*,’ ‘paediatr*,’ ‘pediatr*,’ 
‘adolesc*,’  ‘school-age’  or  ‘teenage*’  and  ‘prevalence.’  The  terms  related  to 
 
insomnia and age of the population were included as a keyword search, and 
 
 
 
 
1 Inclusive of twenty-nine articles that were not available as full-text. 
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EBSCO 
 
prevalence was searched for throughout the entire article text. This was to ensure 
that studies which had reported prevalence estimates alongside other key findings 
were also included. 
 
Table 1.1 - Databases included in the search strategy 
 
Database 
Dates 
Inclusive 
 
Ovid 
1806 – 
 
 
 
Date 
Searched 
 
 
CAB Abstracts 
Embase 
Embase Classic 
HMIC Health Management Information Consortium 
 
Journals@Ovid 
 
Ovid MEDLINE® In-Process & Other Non-Indexed Citatons 
and Ovid MEDLINE® 
 
Ovid MEDLINE® 
 
Ovid MEDLINE® In-Process & Other Non-Indexed Citatons 
 
PsycARTICLES Full Text 
 
PsycINFO 
 
Social Policy and Practice 
October 2015 
16/10/2015 
 
1977 – 
October 2015 
26/10/2015
 
 
AMED 
 
Child Development and Adolescent Studies 
 
CINAHL Plus 
ERIC ProQuest 
MEDLINE 
Cochrane Library 
1898 – 
October 2015 
 
Wiley Online Library 
1975 – 
October 2015 
 
Web of Knowledge 
1975 – 
October 2015 
 
 
 
 
 
 
 
 
 
 
26/10/2015 
 
 
26/10/2015 
 
 
27/10/2015 
 
Arts and Humanities Citation Index 
 
BIOSIS Citation Index 
SciELO Citation Index 
Science Citation Index 
Social Sciences Citation Index 
13  
39 
 
1.2.2 Eligibility screening 
 
A total of 1,089 articles were identified through literature searches, and a further 43 
articles were identified through hand-searching of references. Three hundred 
articles were duplicates. These were removed, leaving 832 articles. The remaining 
articles were screened and evaluated using the strategies detailed in Tables 1.2- 
1.4. Each stage of the process comprised evaluating each article against several 
criteria, ensuring that the remaining articles were relevant to the target population 
and presented data that were relevant to the research question. 
The first stage consisted of screening all articles by title against the criteria 
listed in Table 1.2. Articles were excluded if they were not available in English, did 
not present original empirical data, or include a typically-developing sample 
between the ages of 4-18 years. Papers were also excluded if they were not relevant 
to the research question. Criteria were applied in the order listed below, such that if 
an article was a review of insomnia in adulthood, it would be excluded on the basis 
of not being an empirical study, as this criterion is applied to the article first. 
Table 1.2 - Strategy for screening articles by title. 
 
 
Criteria Articles to be excluded  
Number 
excluded 
 
English language Non-English language 46 
 
Empirical study 
Reviews, practitioner guides, conference proceedings, 
meeting abstracts, letter to editors, case studies 
 
Typically-developing 
sample 
Sample includes children with a neurodevelopmental 
disorder 
25
 
 
Sample of school-age Sample includes adult or infant populations 157 
 
 
Relevant Irrelevant articles, such as pharmacological trials 76 
 
 
Total 343 
14  
65 
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The second stage of the screening process was to review the articles by 
abstract, using the same criteria employed in the initial stage. An additional criterion 
was included at this stage, whereby the article was excluded if there was a bias in 
the recruitment strategy described in the abstract. For example, if the sample were 
recruited based on participants presenting with a related difficulty such as 
nightmares, or having a risk factor such as diagnoses of insomnia in the family, it 
was considered that the resulting prevalence estimate would likely be non- 
representative of the target population, and the article was removed from further 
analysis. 
Table 1.3 - Strategy for screening articles by abstract. 
 
 
Criteria Articles to be excluded  
Number 
excluded 
 
Empirical study 
Reviews, practitioner guides, conference proceedings, 
meeting abstracts, letter to editors, case studies 
 
Typically-developing 
sample 
Sample includes children with a neurodevelopmental 
disorder 
0
 
 
Sample of school-age Sample includes adult or infant populations 103 
 
Non-biased 
recruitment 
Sample recruited on basis of having a sleep disorder, or 
disorder related to sleep, such as snoring 
13
 
 
Relevant 
Irrelevant articles where sleep disorder is not focus of 
study, such as side effect of medication 
 
Total 203 
 
 
 
Once the articles had been screened by both title and abstract, the remaining 
papers were subject to full text screening. The criteria applied during the full text 
screening phase were similar to those in the first two stages. However, articles were 
also excluded at this stage if they did not report frequency or prevalence statistics. 
In some cases, this was because descriptive statistics were simply not reported, or 
15  
25 
 
because the data were collapsed with other variables, such as other sleep 
disorders. During this screening phase, several articles were also removed based 
on the age criterion. This was because, although the abstract detailed that data for 
the relevant age group were collected during the study, in the full text screen it was 
observed that these data could not be separated from that of other age groups. For 
example, several papers combined data for all participants under 25 years. 
Consequently, prevalence data for those aged 4-18 years could not be extracted. 
Table 1.4 - Strategy for screening articles by full text. 
 
 
Criteria 
 
Articles to be excluded 
Number 
excluded 
 
Empirical study 
Review 
meetin 
s, practitioner guides, conference proceedings, 
g abstracts, letter to editors, case studies 
 
9 
 
Sample of school-age 
Sample 
target p 
includes adult or infant populations, or include 
opulation data but within wider age bracket. 
s 
111 
 
Non-biased 
recruitment 
 
Sample recruited on basis of having a sleep disorder, or 
disorder related to sleep, such as snoring 
3
 
 
Relevant 
Irrelevant articles where sleep disorder is not focus of 
study, such as side effect of medication 
 
Frequency or 
prevalence statistics 
reported 
 
Frequency or prevalence data not reported, or insomnia 
data combined with other data, such as other sleep 17 
disorders. 
 
Total 165 
 
 
Papers that had been identified as meeting the inclusion criteria and that 
included a clinical sample, such as children and adolescents with a physical or 
mental health diagnosis, were grouped into a separate collection. This allowed for 
comparison of prevalence rates of insomnia in clinical and non-clinical samples. 
Clinical samples where it was likely that there were several comorbid physical and 
mental health problems or neurodevelopmental disorders, such as genetic 
syndromes, were not included in the analysis. This decision was made as the 
16  
 
varying influences of each condition on the presence of insomnia could not be 
ascertained. 
1.2.3 Application of the Quality Framework 
 
Following the three stages of the screening process, the remaining 92 articles were 
evaluated for their methodological quality. Where it was suspected that the same 
sample had been used as a source of data for more than one article, the article with 
the highest quality rating was retained, and the others excluded. 
The chosen quality criteria focused on sample recruitment and the extent to 
which the sample was representative of the target population, the authors’ definition 
of insomnia, and the quality and reliability of their assessment of insomnia (Table 
1.5). These criteria were based on the framework developed by Munn, Moola, Lisy 
and Riitano (2014), which is tailored specifically for the evaluation of studies 
estimating rates of prevalence. As the authors point out, prevalence data can be 
heavily biased if the sample of a study is not recruited at random or representative 
of the target population, or if the construct of interest is not accurately measured or 
well-defined. These factors therefore feature strongly in the chosen quality 
framework. 
Papers that made use of standardised measures, or of multiple forms of 
methodology to assess for insomnia, were given the highest weighting, as were 
measures that included items based on the key symptoms of insomnia, or that were 
explicitly based on diagnostic criteria. Articles in which a single item was used to 
assess for insomnia, within a measure designed to assess for a construct other than 
sleep disorders, received a lower weighting. A preferred threshold of 70% 
participant response uptake was used (Babbie, 2007), with lower rates receiving a 
17  
 
lower weighting. Quality ratings for reported reliability or validity statistics were taken 
from Landis and Koch (1977), and Streiner and Norman (2002). 
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Table 1.5 - Quality framework. 
 
 
 
 
 
Quality 
rating 
 
Sample recruitment 
Response 
rate 
 
Definition of insomnia 
 
Assessment of insomnia 
Assessment validity 
and reliability 
 
 
0 
 
 
Not specified 
 
Not specified 
<50% 
 
 
Not specified 
 
 
Not specified 
 
Not specified 
k≤ 0.2 
α or r≤ 0.2 
 
 
1 
 
Restricted or non-random 
sample, such as health clinics 
or a single school 
 
 
≥50% 
 
Sleeplessness items rated as 
present/ absent 
 
 
Parent/ professional opinion 
 
k= 0.21 - 0.4 
α or r= 0.21 – 0.4 
 
 
2 
 
Random sample, but with 
likelihood of response bias 
 
 
≥60% 
 
Sleeplessness items with 
indication of frequency or 
duration of difficulty 
 
Items not described, or measure is 
not typically used to assess for 
sleep problems 
 
k= 0.41 – 0.6 
α or r= 0.41 – 0.7 
 
Items do not include any of the 
three main symptoms and are not 
based on diagnostic criteria 
 
 
3 
 
Random or total population 
sample 
 
 
≥70% 
 
Based on diagnostic criteria, 
such as DSM-IV or V, or ICSD 
 
Items include any of the three 
main symptoms or are explicitly 
based on diagnostic criteria 
 
k≥ 0.61 
α or r≥ 0.7 
   
Sleep data collected as part 
of wider dataset, reducing 
likelihood of response bias 
 Sleeplessness items with 
indication of frequency and 
duration of difficulty or 
mention of daytime 
impairment 
 
Multiple methods e.g. 
questionnaire, diagnostic 
interview, sleep diary, 
physiological measure 
 
 
Standardised, validated or clinical 
measure 
19  
 
By evaluating the articles against the criteria of the quality framework, each 
was weighted according to its methodological quality. A rating of between zero and 
three was given for each of the criteria, and the total score was then divided by the 
maximum total score of fifteen. This gave an overall numerical quality rating for each 
article of between zero and one, with one indicating a higher quality of paper. If an 
article received a rating of zero for their recruitment of the sample, their definition of 
insomnia, or their assessment of insomnia, it was excluded from further analysis. 
1.2.4 Analysis 
 
The prevalence estimates reported in each article were identified and pooled using 
MetaXL 2.0 (Barendregt & Doi, 2011). A random effects model was applied to the 
data, due to the variability in the reported prevalence rates, the heterogeneity of the 
sampling and methodology, and the likelihood of sampling error. Use of this model 
therefore attempted to account for study level differences in addition to sampling 
error, by incorporating a parameter based on homogeneity of the study data and 
sampling variance. However, because the random effects model allocates 
weighting in a manner less dependent on sample size, this can lead to a reduction 
in the weighting of large high quality studies, and an increased impact of poor quality 
small studies. 
A quality effects model was therefore also included to ensure that pooled 
prevalence rates also accounted for methodological rigour. To generate the quality 
effects model, MetaXL uses the sample size in addition to a quality parameter to 
distribute the total weighting across the studies included in the pooled analysis, such 
that studies with a larger sample and a greater quality rating receive the highest 
proportion of available weighting. The quality parameter was generated based on 
20  
 
the method described in section 1.2.3. The inclusion of both models in the present 
meta-analysis allows the reader to observe the contribution of methodological 
quality by drawing comparison between the pooled prevalence estimates of the 
quality- and random-effects models. The meta-analysis therefore allows for 
extraction of prevalence estimates that account for both the quality of the research, 
and sources of uncontrolled variability. 
In line with the review of the prevalence of insomnia in the adult population 
published by Ohayon (2002), papers were grouped based on their definitions of 
insomnia. The first group included any article reporting a prevalence of insomnia, 
irrespective of the symptoms used to define this term. The following groups included 
papers that had reported data on a single symptom of insomnia, such as difficulty 
initiating sleep (DIS), difficulty maintaining sleep (DMS), and early morning 
awakening (EMA). If a paper reported a prevalence of overall insomnia, but only 
used a single symptom in their definition and assessment, the article was included 
under the pooled data for both estimates of the prevalence of overall insomnia, and 
the symptom alone. Articles that had then included additional criteria, such as the 
presence of daytime impairment, or insomnia in the absence of other comorbid 
conditions were grouped separately. Finally, the prevalence of insomnia in physical 
or mental health conditions were analysed, and odds ratios with 95% confidence 
intervals were calculated and compared against the overall prevalence estimate for 
insomnia. 
If comparisons were made between two groups in an article, and the two 
groups were recruited separately in order to obtain comparable sample sizes, only 
data from the control group were included in the prevalence data. If a population 
21  
 
sample was recruited and then divided according to any naturally-occurring 
differences, all sample data were included in the prevalence data, as this was 
considered to be representative of the natural variance occurring within any sample. 
For example, Zhang et al. (2015) classified a fifth of their sample as overweight, and 
drew comparisons between participants classified as overweight and the remainder 
of the sample. Because the participants who were classified as overweight were 
part of the normal variation of the sample, to only include the control group in the 
estimates of the prevalence of insomnia, would not be representative of the wider 
population. 
Where prevalence data were not reported, but frequency statistics and 
sample size were available, prevalence estimates were calculated from these data. 
In longitudinal studies, prevalence data were only extracted from the time-point with 
the largest sample, unless it could be concluded that participants could not have 
been included in the data collection at multiple time-points. The only exception to 
this was the Pallesen et al. (2008) study, from which data from the most recent time- 
point were used1. 
1.3 Results 
 
1.3.1 Types of Insomnia in the Non-Clinical Population 
 
Insomnia.   The literature search identified 55 papers that reported a 
prevalence of insomnia within typically-developing children aged 4-18 years. Of 
these, seven were excluded due to having included data from the same sample as 
another article (Amaral et al., 2014; Liu, 2004; Liu & Zhou, 2002; Roberts, Roberts 
& Chan, 2008b; Roberts, Roberts & Chen, 2000; Roberts et al., 2008a; Singareddy 
 
 
 
 
1 The most recent time-point was chosen, as the largest dataset was 10 years prior to publication. 
22  
 
et al., 2009). A further four papers were removed as they did not describe either 
their definition or assessment of insomnia, or the manner in which the sample had 
been recruited (Chen et al., 2011; Chung & Cheung, 2008; Rastogi, Tripathi & 
Ravishanker, 2010; Yang, Huh, Jeong, Lee & Choi, 2014). This resulted in a total 
of 44 papers to be included in the pooled meta-analysis. Each of these articles are 
summarised in Table 1.6. The majority of the articles were published by authors in 
North America, or countries on the Asian continent, such as Japan or South Korea. 
There were relatively few articles from Europe or Australia. 
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Table 1.6 - Summary of articles reporting the prevalence of insomnia in non-clinical samples 
 
 
 
 
 
 
Authors 
 
 
Sample 
 
 
Response 
Quality ratings  
N 
(% Male)
 
Mean age 
in years 
(SD)
 
 
 
Prev. 
 
 
 
Alvaro et al. 
recruitment rate 
Definition Assessment Reliability
 
 
α= .83 
 
 
 
318 
 
range 
 
15.0 
(2014) 
Multiple schools 2 NS 0 DSM-IV1 3 ISI2 3
 
 
Amaral et al. 
r= .793 
3  .73 (51.6%) 
 
6919 
(1.3) 
12-18 
12.5% 
(2013) 
Multiple schools 2 82.1% 3 DSM-IV 3 DSM-IV 3 NS 0  .73 (47.0%) 
12-18 21.4% 
 
Archbold et al. 
(2002)4 
 
Paediatric 
outpatient 
clinics 
 
 
1 52.0% 1 
 
2 of NRS/ DIS/ 
DMS/ EMA5 
1 PSQ6 3 “good” 2  .53
 
 
639 
(NS) 
5-14 17.1%
 
 
Barclay et al. 
(2015)7 
 
Blank et al. 
 
Longitudinal 
twin study 
1 NS 0 DSM-III-R1 3 CAPA8 3 NS 0  .47
 
 
Interviews based 
 
2789 
(46.0%) 
 
6483 
 
Mode= 8.3 
8-17 
19.5%
 
(2015) 
National survey 3 82.9% 3 DSM-IV 3 on DSM-IV 
3 NS 0  .80 (48.6%) 
13-18 33.7% 
 
Calhoun et al. 
(2014) 
 
Camhi et al. 
 
Population/ 
stratified school 
sample 
 
 
2 70.0% 3 ICSD9 3 
 
 
DIS/ DMS/ 
 
PBS10, based on 
ICSD 
3 NS 0  .73
 
 
700 
(46.0%) 
 
314 
 
8.8 
(1.8) 
5-12 
 
 
19.3% 
(2000)11 
Existing sample 3 81.6% 3 EMA 
1 Key symptoms 3 NS 0  .67 (55.1%) 
7-14 17.2% 
 
 
 
 
1 DSM= Diagnostic and Statistical Manual 
2 ISI= Insomnia Severity Index (Morin, 1993) 
3 α= Cronbach’s alpha; r= test-retest reliability/ inter-rater reliability 
4 Over 5 years only 
5 NRS= Non-restorative sleep; DIS= Difficulty initiating sleep; DMS= Difficulty maintaining sleep; EMA= Early morning awakening 
6 PSQ= Pediatric Sleep Questionnaire (Chervin et al., 2000) 
7 Wave 1 only 
8 CAPA= Child and Adolescent Psychiatric Assessment (Angold et al., 1995) 
9 ICSD= International Classification of Sleep Disorders 
10 PBS= Pediatric Behavior Scale (Lindgren & Koeppl, 1987) 
11 7-14 years only. Although authors do not use the term insomnia, they combine data on DIS and DMS, and so these symptoms cannot be analysed separately. 
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Table 1.6 - Summary of articles reporting the prevalence of insomnia in non-clinical samples 
 
 
 
 
 
 
Authors 
 
 
Sample 
 
 
Response 
Quality ratings  
N 
(% Male)
 
Mean age 
in years 
(SD)
 
 
 
Prev. 
recruitment rate 
Definition Assessment Reliability
 
 
range 
 
 
Chen et al. 
(2013)1 
National survey 3 NS 0
 
 
DIS/ DMS/ 
NRS, 
3 
often/ always, 
4week duration 
 
Insomnia self- 
assess. 
inventory2 
 
 
3 NS 0  .60 
 
 
2113 
(52.9%) 
15-17 20.9%
 
 
Choi et al. 
(2009)3 
 
Ҫifҫili et al. 
 
Random/ 
stratified school 
sample 
 
Random school 
 
 
2 86.7% 3 
 
DIS/ DMS/ 
EMA, 
3+ weekly 
 
 
2 Key symptoms 3 NS 0  .67 
 
1176 
(50.0%) 
 
302 
 
16.7 
(1.0) 
19.3%
 
 
17.3 
(2010) sample 
2 99.0% 3 DIS and DMS 1 Key symptoms 3 NS 0  .60
 (76.5%) (1.8) 
20.2%
 
 
7.8% 
 
Dohnt et al. 
(2012)4 
 
 
Fernandez- 
 
Stratified school 
sample 
2 84.0% 3
 
 
 
 
Stratified
 
 
DSM-IV and 
ICSD-III criteria 
3  Multiple methods 3 NS 0  .73
 
 
 
DIS/ DMS, 
 
384 
(59.1%) 
15.6 
(1.0) 
13-18 
 
 
9.2 
DSM-IV 
(10.9% 
ICSD- 
III) 
Mendoza et al. 
(2014) 
 
 
Gehrman et al. 
 
sample 
 
 
Longitudinal 
2 70.0% 3 often/ very 
often 
2 PBS 3 NS 0  .67  
327 
(46.2%) 
 
 
2824 
(1.8) 
5-12 
 
12.0 
19.5% 
 
 
Child = 
19.5%, 
(2011)5 twin study 
1 NS 0 DSM-III-R 3 CAPA 3 NS 0  .47
 (46.3%) 
(2.6) 
8-16 
Parent = 
6.6% 
 
 
 
 
 
1 “Poor sleep” rather than insomnia 
2 World Health Organisation, 2001 
3 Control group only 
4 DSM-IV criteria included in pooled prevalence estimates 
5 Parent and child ratings 
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Table 1.6 - Summary of articles reporting the prevalence of insomnia in non-clinical samples 
 
 
 
 
 
 
Authors 
 
 
Sample 
 
 
Response 
Quality ratings  
N 
(% Male)
 
Mean age 
in years 
(SD)
 
 
 
Prev. 
recruitment rate 
Definition Assessment Reliability
 
 
range 
 
 
Goodwin et al. 
(2003) 
School sample 2 30.6% 0
 
 
DIS/ DMS/ 
EMA/ NRS, 
frequently/ 
almost always 
 
Sleep problems 
2  screening 
questionnaire 
 
 
3 NS 0  .47 
 
 
239 
(55.2%) 
6-11 25.5%
 
 
Huang et al. 
(2012) 
 
Huang et al. 
 
Part of wider 
survey 
3 NS 0
 
 
Random school 
 
DIS/ DMS/ 
EMA during 
past 30 days 
 
DIS/ DMS/ 
 
 
2 Key symptoms 3   k= .261 1  .60 
 
33692 
(44.9%) 
13-15 31.6%
 
 
1906 
(2010) sample 
2 95.1% 3
 EMA 
1 PSQ 3 r= .64 2  .73
 
 
DIS/ DMS/ 
(37.7%) 
12-18 18.7%
 
Joo et al. 
(2005) 
 
 
 
Kaneita et al. 
Random school 
sample 
2 80.9% 3
 
 
 
 
Cluster sample 
EMA, 3+ times 
weekly, over 
past 4 weeks 
 
DIS/ DMS/ 
EMA, often/ 
 
3 Key symptoms 3 
r= 
.73-.92 
3  .93
 
3871 
(69.8%) 
 
 
 
102451 
16.8 
(0.8) 
12.7%
 
(2006) of schools 
2 64.8% 2
 always, over 
past month 
 
SOL2 >30mins/ 
3 Key symptoms 3 NS 0  .67 
(54.7%) 
12-18 23.5%
 
Kilincaslan et 
al. (2014) 
Cluster sample 
of schools 
2 92.2% 3
 
DMS, several 
nights/ every 
night 
 
2 Key symptoms 3 NS 0  .67 
3485 
(49.0%) 
16.1 
(1.0) 
14-17 
 
24.1% 
 
 
 
 
 
 
 
 
1 k= test-retest reliability/ inter-rater reliability 
2 SOL= Sleep onset latency 
  SOL 45+ mins/  
 
2 
 
NS 
 
0 
3+ night-wakings/ 
night-wakings 
 
2 
 
Key symptoms 
 
3 
 
NS 
 
0 
 
.47 
   30+ mins,       
   3+ weekly       
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Table 1.6 - Summary of articles reporting the prevalence of insomnia in non-clinical samples 
 
 
 
 
 
 
Authors 
 
 
Sample 
 
 
Response 
Quality ratings  
N 
(% Male)
 
Mean age 
in years 
(SD)
 
 
 
Prev. 
recruitment rate 
Definition Assessment Reliability
 
 
range 
 
 
Kirmil-Gray et 
al. (1984)1 
Health classes 
of three schools 
277 
(46.9%) 
15.0 
13-17 
11.0%
 
 
 
 
Lee et al. 
(2012) 
School sample 2 84.1% 3 ICD-102 3 ICD-10 3 NS 0  .73
 
 
7172 
(37.8%) 
16.8 
(1.1) 
12-17 
 
9.7% 
 
 
Liu et al. (2000) 
 
Random/ 
stratified 
sample 
 
 
2 97.0% 3 
 
DIS/ DMS/ 
EMA, often, 
past month, 
 
DIS/ DMS/ 
 
 
3 Key symptoms 3 NS 0  .73  
1365 
(60.3%) 
 
14.6 
(3.4) 
12-18 
 
 
16.9% 
Liu et al. 
(2008)3 
 
 
Mak et al. 
Representative/ 
random school 
sample 
 
Population 
 
2 97.8% 3 
EMA, 3+ 
weekly, past 
month 
 
DIS/ DMS/ 
 
3 Key symptoms 3 
α= .5 
k= .4 
2  .87
 
1066 
(58.6%) 
 
 
28839 
Median= 
14.5 
12-17 
 
16.1% 
(2010) 
 
 
Mak et al. 
(2012) 
 
 
Morioka et al. 
(2013) 
survey of 
obesity 
 
Population 
survey of 
obesity 
 
Random school 
sample. Part of 
wider survey 
3 84.5% 3 
 
 
 
3 94.8% 3 
 
 
 
3 92.2% 3 
EMA, past 30 
days 
 
DIS/ DMS/ 
EMA, past 30 
days 
 
DIS/ DMS/ 
EMA, always/ 
often, past 30 
days, 
2 Key symptoms 3 NS 0  .73 
 
 
 
2 Key symptoms 3 k= .26 2  .87 
 
 
 
3 Key symptoms 3 NS 0  .80 
(49.7%) 
12-18 35.0%
 
 
 
22678 
(41.6%) 
12-18 21.5%
 
 
 
98867 
(49.4%) 
12-18 21.5%
 
 
 
1 "Chronic poor sleepers" 
2 ICD-10= International Classification of Diseases (10th edition) 
3 7th and 10th grade 
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Table 1.6 - Summary of articles reporting the prevalence of insomnia in non-clinical samples 
 
 
 
 
 
 
Authors 
 
 
Sample 
 
 
Response 
Quality ratings  
N 
(% Male)
 
Mean age 
in years 
(SD)
 
 
 
Prev. 
 
 
 
 
Munezawa et 
recruitment 
 
 
Stratified school 
rate 
Definition Assessment Reliability
 
 
DIS/ DMS/ 
EMA, often/ 
 
 
 
 
94777 
 
range 
al. (2011) 
 
 
 
Murray et al. 
sample 
2 87.2% 3
 always, over 
past month 
 
DIS/ DMS, 
often/ 
3 Key symptoms 3 NS 0  .73 
 
 
 
Adolescent 
(50.7%) 
12-18 21.8%
 
 
 
60 
15.1 
(2012)1 
Advertisements 2 56.0% 1
 
 
 
China= 
frequently/ 
always 
2 sleep-wake 
scale2 
3 α= .81 3  .73 
(33%) 
 
 
China= 
861 
(1.8) 
12-18 
 
 
China = 
22.0% 
 
 
 
China= 
Pan et al. 
(2012) 
 
 
 
Patten et al. 
 
Random school 
sample 
2
 
 
 
 
National survey 
95.1% 
Macau= 
95.7% 
 
3 ICSD-2 3 ICSD-2 3 NS 0  .73 
 
 
 
DIS/ DMS, 
(47.6%) 
Macau= 
618 
(41.9%) 
 
7960 
15.3 (1.8) 
 
Macau = 
15.6 (1.8) 
22.9% 
 
Macau= 
16.5% 
(2000)3 
 
 
Radecki & 
of smoking 
3 65.8% 2 
 
National survey 
of office-based 
often, over 12 
months 
 
Sleeplessness/ 
can't sleep/ 
3 Key symptoms 3 NS 0  .73 
 
 
 
Physician 
(50.7%) 
12-18 14.4%
 
 
 
18325 
Brunton (1993)4 medical 
practices. 
2 NS 0 trouble falling to 
1
 
sleep 
consultation 
1 NS 0  .27
 (NS) 
<18 0.46%
 
 
Roane et al. 
(2008) 
 
Public use 
dataset 
3 NS 0
 
 
DIS/ DMS, 
almost/ every 
day 
 
 
2 Key symptoms 3 NS 0  .53 
 
4494 
(47.6%) 
 
15.8 
(1.5) 
12-18 
 
 
9.4% 
 
 
 
1 Control group only 
2 LeBourgeois et al. (2005) 
3 Baseline only. Authors use the term “sleep problems” but employ the symptoms of insomnia to define this. 
4 Under 18 years only 
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Table 1.6 - Summary of articles reporting the prevalence of insomnia in non-clinical samples 
 
 
 
 
 
 
Authors 
 
 
Sample 
 
 
Response 
Quality ratings  
N 
(% Male)
 
Mean age 
in years 
(SD)
 
 
 
Prev. 
 
 
Roberts & 
recruitment 
 
Epidemiological 
rate 
Definition Assessment Reliability
 
 
Interviews based 
 
 
4175 
 
range 
Duong (2013)1 study 
3 66.0% 2 DSM-IV 3
 
 
DMS/ DIS/ 
on DSM-IV 
3 NS 0  .73 (51.0%) 
11-17 26.8%
 
 
Roberts et al. 
(2004) 
 
 
Roberts et al. 
 
Stratified school 
sample 
2 67.0% 2
 
EMA/ NRS, 
often/ every 
day, over 4 
weeks 
 
3 DSM-IV criteria 3 NS 0  .67 
 
 
 
DSM Scale for 
 
5118 
(NS) 
 
 
5423 
Median= 
15.0 
13-18 
 
12.3% 
(2001) 
School sample 2 85.3% 3 DSM-IV 3
 
 
Stratified 
Depression2 
3 α>.9 3  .93 
 
Measure 
(50.1%) 
10-17 16.3%
 
Sharma et al. 
(2009)3 
sample based 
on groundwater 
fluoride 
1 NS 0 Lack of sleep 1 distributed by 
doctor 
1 NS 0  .20 
999 
(50.5%) 
6-18 1.6%
 
 
Siomos et al. 
(2009) 
 
Steinsbekk & 
Wichstrøm 
(2015) 
 
Cross-section 
of schools 
2 99.8% 3 ICD-10 3 AIS4 3 α= .82 3  .93
 
 
 
Weighted 
1 79.5% 3 DSM-IV 3 DSM-IV 3 k= 0.9 3  .87 
sample 
 
2195 
(49.1%) 
 
 
995 
(49.1%) 
 
15.3 
(1.7) 
13-18 
 
4.4 
(0.2) 
4 
 
 
11.4% 
 
 
 
16.6% 
 
Yen et al. 
(2008) 
 
Stratified/ 
random school 
sample 
 
 
2 72.0% 3 ICD-10 3 AIS 3 
 
α= .67 
r= .72 
3  .93
 
 
8004 
(47.8%) 
 
14.7 
(1.7) 
12-18 
 
 
11.8% 
 
 
 
 
1 Baseline only 
2 Roberts, Roberts & Chen (1997) 
3 6-18 years only 
4 AIS= Athens Insomnia Scale (Soldatos et al., 2000) 
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Table 1.6 - Summary of articles reporting the prevalence of insomnia in non-clinical samples 
 
 
 
 
 
 
Authors 
 
 
Sample 
 
 
Response 
Quality ratings  
N 
(% Male)
 
Mean age 
in years 
(SD)
 
 
 
Prev. 
recruitment rate 
Definition Assessment Reliability
 
 
range 
 
Zhang et al. 
(2009) 
Multiple schools 2 70.3% 3
 
 
DSM-IV/ 
ICSD-10 
3
 
 
DIS/ DMS/ 
 
Diagnostic 
criteria 
3 NS 0  .73
 
 
5695 
(50.3%) 
 
9.2 
(1.8) 
6-13 
 
 
4.0% 
Zhang et al. 
(2011)1 
 
 
 
Zhang et al. 
Epidemiological 
study 
2 47.2% 0
 
 
 
 
Random school 
EMA/ 3+ 
weekly, over 12 
months 
 
DIS/ DMS/ 
EMA/ 3+ 
 
3 Key symptoms 3 α= .87 3  .73 
6447 
(50.6%) 
 
 
 
3086 
9.2 
(1.8) 
4.0%
 
 
 
9.7 (1.7)/ 
(2015) sample 
2 76.4% 3
 weekly, over 12 
months 
3 Key symptoms 3 NS 0  .73 
(52.1%) 
9.0 (1.6) 
7-14 
3.7% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 Baseline data only 
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When comparing the articles described in Table 1.6, it was noted that the 
literature differed greatly across all elements of the quality framework, and the 
weightings and reported prevalence estimates varied widely as a result. Prevalence 
estimates ranged from 0.46% (Radecki & Brunton, 1993) to 35.0% (Mak et al., 
2010), which suggests great variability in the methodology employed and the 
definition of the construct of insomnia, especially when considering that all of the 
samples were from non-clinical populations of a similar age-group. 
Across the articles, the majority of the data was collected through 
questionnaire distribution at multiple schools. Although this posed a considerable 
risk for response bias, in terms of an increased interest from families for whom sleep 
was a concern, participant response rates were typically very high, with roughly half 
of the articles receiving the top weighting associated with a participant response 
rate greater than 70%. Other methods of sample recruitment that received high 
ratings included those that were conducting a wider survey on a construct other than 
sleep disorders, but had included items assessing for the presence of insomnia. 
This limited the likelihood of response bias. For example, the two articles by Mak 
and colleagues collected data on insomnia as part of a national survey of obesity. 
The authors included measures of smoking, alcohol consumption, exercise and 
health problems in addition to questions regarding sleep disorders, such as 
insomnia (Mak et al., 2010; Mak, Lee, Ho, Lo & Lam, 2012). This therefore reduced 
the likelihood of individuals with sleep problems being any more likely to return the 
questionnaire than other subgroups within the population. Other authors who 
employed similar methods of recruitment included Roberts and colleagues, who 
made use of the Teen Health 2000 dataset. This incorporated data on several 
31  
 
aspects of adolescent health and wellbeing, including sleep (Roberts & Duong, 
 
2013; Roberts et al., 2008a; 2008b). However, only the 2013 article was retained 
for the pooled prevalence estimates, because it was concluded that the same 
sample had been used across the three publications. 
Publications that had employed the use of wider datasets, designed to study 
an alternative construct of interest, sometimes only incorporated a single item to 
assess for insomnia, as part of a broader health questionnaire (such as Radecki & 
Brunton, 1993). This was in contrast to authors who had made use of standardised 
or well-validated measures specifically developed to explore the construct of sleep 
disorders, or even insomnia explicitly (such as Alvaro, Roberts & Harris, 2014). 
However, when comparing the content of the individual items themselves, they were 
often the same. As a result, articles which did not use a well-known measure 
specifically developed to assess for insomnia were able to receive the same rating 
as standardised measures, if it was evident that the items included in the chosen 
measure were a valid assessment of the construct of insomnia. Furthermore, 
articles where a single symptom had been used as the determinant of insomnia are 
included in the pooled meta-analyses for overall insomnia as well as the individual 
symptom. 
The criteria employed by the articles to define when a participant met the 
threshold for insomnia differed between authors. Although the majority of papers 
considered presence of any of the three main insomnia symptoms as being 
indicative of insomnia, others were more stringent and required two or more 
symptoms to be present (Archbold, Pituch, Panahi & Chervin, 2002; Ҫifҫili et al., 
2010).  Similarly,  whilst  several  authors  required  the  signs  of  insomnia  to  be 
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described as occurring frequently, often, or a minimum of three times a week, others 
simply required them to be present for participants to be classified as having current 
insomnia (Camhi, Morgan, Pernisco & Quan, 2000; Radecki & Brunton, 1993; 
Sharma, Sohu & Jain, 2009). Furthermore, the duration for which the symptoms 
needed to have persisted varied from 4 weeks to 12 months (Chen, Truong & Tsai, 
2013; Huang, Ho, Lo, Lai & Lam, 2012; Joo et al., 2005; Patten, Choi, Gillin & 
Pierce, 2000; Zhang et al., 2011, 2015). These variations in the definition of 
insomnia may have accounted for some of the variability observed in the reported 
prevalence estimates. Prevalence estimates for the 44 papers described above 
were calculated based on the random- and the quality-effects (Figures 1.2 and 1.3). 
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2.20 
0.21 ( 0.20. 
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• 0.34  ( 0.33, 
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Zhang et at.(2009) • 0.04  ( 0.04. 0.05) 2.31 
Zhang et al. (2011) • 
i 
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Zhang et al. (2015) • I 0.04  ( 0.03. 0.04) 2.30 
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I 
0.16 ( 0.13.  0.18) 100.00
 
Overall 
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Figure 1.2  • Pooled estimates for  the prevalence of insomnia. using a random- 
 
effects model. 
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.  
 
Study Prev (95% Cl)  o/o Weight 
Alvaro et a.l (2014) 0.13  ( 0.09. 0.16) 0.73 
Amaral et al. (2013)  • 0.21 ( 0.20. 0.22) 1.69 
Archbold et al. (2002) 0.17  ( 0.14. 0.20) 0.57 
Barclay et al. (2015) 0.20  ( 0.18. 0.21) 0.70 
Blank et a.l (2015) •· 0.34  ( 0.33. 0.35) 1.78 
Calhoun et a.l (2014) 0.19 ( 0.16. 0.22) 0.79 
Camhiet al. (2000) 0.17  ( 0.13. 0.22) 0.67 
Chen et a.l (2013) 0.21  ( 0.19. 0.23) 0.82 
Choiet al.(2009) 0.19  ( 0.17. 0.22) 0.79 
Cifciliet al.(2010) 0.20  ( 0.16, 0.25) 0.60 
Dohnt et al. (2012) 0.08  ( 0.05. 0.11) 0.74 
Femandez-Mendoza et al. (2014) 0.20  ( 0.15.  0.24) 0.67 
Gehrman et a.l (2011) • child 0.20  ( 0.18.  0.21) 0.71 
Gehrman et a.l (2011) • parent  0.07 ( 0.06.  0.08) 0.71 
Goodwtn et al. (2003) 0.26 ( 0.20. 0.31) 0.46 
Huang et al. (2010) 0.19 ( 0.17. 0.20) 0.96 
Huang et al. (2012)  • 0.32  ( 0.31. 0.32) 5.12 
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Liu et al. (2000)  • i 0.17  ( 0.15. 0.19) 0.88 
Liu et al. (2008)  -l 0.16  ( 0.14. 0.18) 1.00 
Mak et al. (2010) ! • 0.35  ( 0.34. 0.36) 4.87 
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Patten et a.l (2000)  • 0.14  ( 0.14. 0.15) 1.84 
Radecki & Brunton (1993)  0.00  ( 0.00. 0.01) 1.24 
Roane et al. (2008)  0.10  ( 0.09. 0.11) 0.97 
Roberts & Duong (2013)  0.27  ( 0.25. 0.28) 1.29 
Roberts et al. (2001) 0.16 ( 0.15. 0.17) 1.88 
Roberts et a.l (2004)  0.13  ( 0.12. 0.14) 1.31 
Sharma et a.l (2009) 0.02  ( 0.01. 0.02) 0.23 
Siomos et a.l (2009) 0.11 ( 0.10. 0.13) 1.28 
Steinsbekk & WIChstrom (2015) • 0.17  ( 0.14. 0.19) 0.99 
Yen et a.l (2008) • 0.12 ( 0.11, 0.13) 2.35 
Zhang et a.l (2009) • 0.04  ( 0.04. 0.05) 1.51 
Zhang et a.l (2011) • 0.04  ( 0.04. 0.05) 1.62 
Zhang et a.l (2015)  • 0.04  ( 0.03. 0.04) 1.13 
 
Overall  0.20  ( 0.14. 0.25) 100.00 
0=26360.26. p:O.OO,12=100o/c 
 
0 0.1  0.2  0.3 
 
 
 
Figure 1.3.Pooled estimates for the prevalence of insomnia. using a quality- 
 
effects model. 
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The results of the pooled estimates suggested that the prevalence of 
insomnia is 15.7%1  (CI= 13.1-18.5, I²= 99.8) for the random-effects model, and 
19.6% (CI= 14.5-25.3, I²= 99.8) for the quality-effects model. The difference 
between these two estimates is fairly large, and it is interesting that the random- 
effects model has generated a more conservative prevalence statistic. This 
suggests that some of the studies receiving lower scores in the quality weightings 
reported lower prevalence rates than those receiving higher quality weightings. 
These studies receiving lower quality ratings have therefore biased the random- 
effects prevalence estimate. It should be noted that the I² statistic is 100% (p< .1) 
which indicates a very high level of heterogeneity within the meta-analysis, to the 
extent that it is unlikely to have occurred by chance. This may be due to 
methodological differences, or difference in the samples employed by the different 
studies. 
It was considered that one potential cause of variance in the prevalence 
estimates may be due to differences in sleep quality over childhood and 
adolescence. As a result, articles that constituted a sample of adolescents, aged 
12-18 years, were analysed separately to articles employing participants aged 4-12 
years, to see if the heterogeneity observed in the overall pooled prevalence 
estimates would be reduced. It was found that the prevalence of insomnia in 
adolescents according to the random-effects model was 18.1 % (CI= 16.0-20.3, I²= 
99.7), and 21.3% (CI= 17.7-25.1, I²= 99.7) according to the quality-effects model. 
The pooled prevalence data for the participants under the age of 12 years was 
19.7% (CI= 16.5-23.0, I²= 70.1) in the random-effects model, and 18.6% (CI= 15.3- 
 
 
 
1 Please note that the estimates reported in the forest plots are given as decimals, whereas the 
estimates given in the text are given as percentages correct to one decimal place. 
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22.1, I²= 70.1) in the quality-effects model. This suggests that there is little effect of 
age in the variance of the data, although there is slightly less heterogeneity in the 
data for the younger age group. 
Insomnia with evidence of daytime impairment. During the application of 
the quality framework to the articles, it was noticed that a number of articles included 
an additional criterion into their definitions of insomnia; that it must occur alongside 
impairment in daytime functioning, or cause some level of distress. Despite many 
articles citing one of the editions of the DSM or ICSD publications in the 
development of their definition, and this criterion being stated in said publications, 
authors did not then assess for this in their chosen measures. Articles in which it 
was explicitly stated that this element was included in either the definition or 
assessment of insomnia are summarised in the table below (Table 1.7). For some 
of these articles, the prevalence estimate of insomnia including daytime impairment 
is equivalent to that given in Table 1.6, but for others, this prevalence statistic was 
reported separately, and so differs from any reported previously. 
Twelve articles were identified that reported a prevalence figure for insomnia 
with daytime impairment. Three were then excluded as they employed duplicate 
samples (Amaral, de Figueiredo Pereira, Silva Martins, de Serpa & Sakellarides, 
2013; Roberts et al., 2006, 2008b). The remaining nine articles are summarised in 
Table 1.7. Reported prevalence estimates ranged from 6.7-19.5% (Barclay, 
Gehrman, Gregory, Eaves & Silberg., 2015; Roberts & Duong, 2013). 
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Table 1.7 - Summary of articles reporting the prevalence of insomnia with daytime impairment in non-clinical samples 
 
 
 
 
 
 
Authors 
 
 
 
Alvaro et al. 
 
 
 
Sample recruitment 
Response 
rate 
Quality ratings 
 
Definition Assessment Reliability 
 
 
α= .83 
 
N 
% Male 
 
 
318 
Mean age 
in years 
(SD) 
range 
 
15.0 
 
 
Prev. 
(2014) 
Multiple schools 2 NS 0 DSM-IV1 3 ISI2 3
 r= .793 
3   .73 (51.6%) 
(1.3) 
12-18 
12.5% 
 
Amaral et al. 
(2014) 
Multiple schools 2 82.1% 3
 
 
EMA4, 3+ 
weekly, past 
month 
 
 
3 DSM-IV 3 NS 0   .73 
 
6919 
(47.0%) 
12-18 8.3%
 
 
Barclay et al. 
(2015)5 
 
Longitudinal twin 
study 
1 NS 0 DSM-III-R 3 CAPA6 3 NS 0   .47
 
 
2789 
(46.0%) 
 
Mode= 8.3 
8-17 
19.5%
 
 
Chung et al. 
(2014) 
 
Johnson et al. 
 
Stratified school 
sample 
2 72.0% 3 DSM-IV 3
 
 
Health insurance 
 
Insomnia 
Interview 
Schedule7 
 
DSM-IV/ ICSD- 
 
 
3 NS 0   .73 
 
290 
(43.8%) 
 
1014 
 
14.4 
(1.4) 
12-18 
 
 
9.3% 
(2006) 
Roberts & 
Duong (2013)9 
database 
3 71.2% 3 DSM-IV 3
 
 
Epidemiological 
study 
3 66.0% 2 DSM-IV 3
 
R8 
3 NS 0   .80
 
 
Interviews based 
on DSM-IV 
3 NS 0   .73
 
(49.7%) 
13-16 9.4%
 
 
4175 
(51.0%) 
11-17 6.7%
 
 
 
 
 
 
 
 
 
1 DSM= Diagnostic and Statistical Manual 
2 ISI= Insomnia Severity Index (Morin,1993) 
3 α= Cronbach’s alpha; r= test-retest reliability/ inter-rater reliability 
4 EMA= Early morning awakening 
5 Wave 1 only 
6 CAPA= Child and Adolescent Psychiatric Assessment (Angold et al., 1995) 
7 Morin (1993) 
8 ICSD-R= International Classification of Sleep Disorders (revised) 
9 Baseline only. 
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Table 1.7 - Summary of articles reporting the prevalence of insomnia with daytime impairment in non-clinical samples 
 
 
 
 
 
 
Authors 
 
 
Roberts et al. 
 
 
 
Sample recruitment 
Response 
rate 
 
Epidemiological 
Quality ratings 
 
Definition Assessment Reliability 
 
Interviews based 
 
N 
% Male 
 
 
4175 
Mean age 
in years 
(SD) 
range 
 
 
Prev. 
(2008)1 study 
3 66.0% 2 DSM-IV 3 on DSM-IV 
3 NS 0   .73 (51.1%) 
11-17 7.2% 
 
Siomos et al. 
(2009) 
 
Cross-section of 
schools 
2 99.8% 3 ICD-102 3 AIS3 3 α= .82 3   .93
 
 
2195 
(49.1%) 
 
15.3 
(1.7) 
13-18 
 
 
11.4% 
 
Yen et al. 
(2008) 
 
Stratified/ 
random school 
sample 
 
 
2 72.0% 3 ICD-10 3 AIS 3 
 
α= .67 
r= .72 
3   .93
 
 
8004 
(47.8%) 
 
14.7 
(1.7) 
12-18 
 
 
11.8% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 Wave 1 only. 
2ICD-10= International Classification of Diseases (10th edition) 
3 AIS= Athens Insomnia Scale (Soldatos et al., 2000) 
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Prevalence data and the quality weighting for each article were then entered 
into the pooled meta-analyses. The random- and quality-effects models are 
summarised in Figure 1.4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 - Pooled estimates for the prevalence of insomnia with daytime 
impairment, using random-effects (upper panel) and quality-effects (lower panel) 
models. 
 
The pooled prevalence estimates for insomnia with daytime impairment were 
 
10.4% (CI= 8.0-13.0) and 9.9% (CI= 7.1-13.0) for the random- and quality-effects 
models respectively. As expected, the added criterion of the presence of daytime 
impairment, in addition to the symptoms of insomnia, demonstrated a decrease in 
the generated pooled prevalence estimates. As discussed previously, the presence 
of some form of negative daytime consequence to the experience of insomnia is 
denoted in the criteria set out by both the most recent DSM and ICSD publications. 
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Clinically, this would seem important, as the absence of such consequences implies 
that any observed signs of sleeplessness may be artefacts of normal variation in a 
child’s sleeping pattern, and therefore not indicative of a clinical problem. Yet, this 
element of the diagnostic criteria is less commonly mentioned in the assessment 
phase of research studies. For example, the frequently-used Athens Insomnia Scale 
(AIS; Soldatos, Dikeos & Paparrigopoulos, 2000) includes items on each of the 
symptoms of insomnia, as well as items exploring daytime impairment in wellbeing 
and functioning. However, it is possible to score above the recommended cut-off, 
without scoring on the latter items, and therefore it is unclear whether researchers 
are only considering participants scoring positively on these items as experiencing 
insomnia, or whether they are using the total score across any item to define the 
disorder. 
Insomnia with the exclusion of additional comorbidities.  In addition to 
the added criterion of daytime impairment, some articles required insomnia to occur 
independently of other comorbidities, such as another sleep disorder. In the ICSD, 
this would be referred to as idiopathic insomnia, differentiated from 
psychophysiological insomnia or extrinsic sleep disorders, such as poor sleep 
hygiene or sleep-onset association. In the DSM, this would be referred to as primary 
insomnia, which differs from insomnia related to a mental or physical health 
disorder, or substance use. Two articles were excluded due to non-unique samples 
(Roberts, et al., 2006, 2008b), leaving four papers remaining (Table 1.8). 
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Table 1.8 - Summary of articles reporting the prevalence of insomnia with exclusion of comorbidities in non-clinical samples. 
 
 
 
 
 
 
Authors 
 
 
 
Ohayon & 
 
 
 
Sample recruitment 
Response 
rate 
 
Population/ 
Quality ratings 
 
 
Definition Assessment Reliability 
 
 
k= 
 
N 
(% Male) 
 
 
 
794 
Mean age 
in years 
(SD) 
range 
 
Prev. 
Roberts (2001)1 
 
Ohayon et al. 
stratified 
sample 
 
Stratified 
2 78.0% 3   DSM-IV/ ICSD2 3 Sleep-EVAL 3  
.78-.713 
 
k= 
3  .93 
(54.1%) 
 
1125 
15-18 3.3% 
(2000)4 sample 
2 80.8% 3 DSM-IV/ ICSD 3 Sleep-EVAL 3
 3  .93
 
.70-.78 (54.1%) 
15-18 2.2%
 
 
Roberts & Duong 
(2013)5 
 
Epidemiological 
study 
3 66.0% 2 DSM-IV 3
 
 
Interview based 
on DSM-IV 
3 NS 0  .73
 
 
4175 
(51.0%) 
11-17 4.7%
 
 
Robert et al. 
(2008)6 
 
Epidemiological 
study 
3 66.0% 2 DSM-IV 3
 
 
Interview based 
on DSM-IV 
3 NS 0
 
 
.73 4175 
(51.1%) 
11-17 4.7%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 15-18 years only 
2 DSM= Diagnostic and Statistical Manual; ICSD= International Classification of Sleep Disorders 
3 k= test-retest reliability/ inter-rater reliability 
4 15-18 years only 
5 Baseline only 
6 Wave 1 only 
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Prevalence data and the quality weighting for each article were entered into 
the pooled meta-analyses. The random- and quality-effects models are summarised 
in Figure 1.5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 - Pooled estimates for the prevalence of insomnia with the exclusion of 
comorbidities, using random-effects (upper panel) and quality-effects (lower panel) 
models. 
 
The pooled prevalence estimates for insomnia without comorbidities were 
 
3.8% (CI= 2.7-5.1) and 4.1% (CI= 3.0-5.5) for the random- and quality-effects 
models respectively. It can be seen that, in comparison to the prevalence rates of 
insomnia in Figure 1.4, excluding cases where symptoms of insomnia had arisen 
due to additional factors, prevalence rates decreased by approximately 80%. This 
implies that the vast majority of cases of insomnia are not idiopathic, but are related 
to a comorbid condition. This is interesting when considering that the DSM-IV does 
not allow for a diagnosis of insomnia in the presence of an additional disorder, but 
would instead suggest that any evidence of insomnia is secondary to the 
comorbidity. The exception to this would be if the insomnia appeared to be causal, 
or at least strongly contributing to the additional disorder. In terms of the existing 
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research literature, the majority of authors base their definitions of insomnia on 
DSM-IV criteria, yet do not attempt to control for additional comorbidities. Therefore, 
whilst the symptoms of insomnia reported by their participants may be clinically 
important, they do not necessarily meet the recommended thresholds. However, it 
is important for clinicians to be aware of the types of disorders in which they are 
more likely to observe insomnia, whether it primary or secondary to the comorbidity. 
Difficulty initiating sleep. Forty-nine articles were identified that reported a 
prevalence figure for difficulty initiating sleep (DIS), also referred to as onset 
insomnia or early insomnia, after three had been removed for duplicated samples 
(Liu, 2004; Liu & Zhou, 2002; Robert, Roberts & Chan, 2006) and one for failing to 
score on the three key criteria (Lazaratou, Dikeos, Anagnostopoulos, Sboukou & 
Soldatos, 2005). These are summarised in Table 1.9. Reported prevalence 
estimates for the remaining articles ranged from 2.1-62.0% (Nevéus, Läckgren, 
Stenberg, Tuvemo & Hetta, 1998; Siomos et al., 2009). 
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Table 1.9 - Summary of articles reporting the prevalence of difficulty initiating sleep in non-clinical samples. 
 
 
 
 
 
 
Authors 
 
 
 
Sample recruitment 
  
 
Response 
 Quality Ratings 
 
Definition 
 
 
 
Assessment 
  
 
 
Reliability 
   
N 
(% Male) 
Mean age 
in years 
(SD) 
 
 
Prev. 
   rate        
 
T
 
 range  
Amaral et 
al. (2013) 
 
Multiple schools 
 
2 
 
82.1% 
 
3 
 
DSM-IV1 
 
3 
 
DSM-IV 
 
3 
 
NS 
 
0 
 
.73 
6919 
(47.0%) 
 
12-18 
 
8.9% 
Barclay et 
al. (2015)2 
Longitudinal twin 
study 
 
1 
 
NS 
 
0 
 
DSM-III-R 
 
3 
 
CAPA3 
 
3 
 
NS 
 
0 
 
.47 
2789 
(46.0%) 
Mode= 8.3 
8-17 
 
14.6% 
 
Blader et 
al. (1997) 
 
Random school 
sample 
 
2 
 
60.0% 
 
2 
 
DIS4, 3+ weekly 
 
2 
 
Key symptom 
 
3 
 
NS 
 
0 
 
.60 
 
972 
(NS) 
7.5 
(1.1) 
5-12 
 
11.3% 
Blank et al. 
(2015) 
 
National survey 
 
3 
 
82.9% 
 
3 
 
DSM-IV 
 
2 
Interviews based 
on DSM-IV 
 
3 
 
NS 
 
0 
 
.73 
6483 
(48.6%) 
 
13-18 
 
24.5% 
 
Calhoun et 
al. (2014) 
Population/ 
stratified school 
sample 
 
2 
 
70.0% 
 
3 
 
ICSD5 
 
3 
 
PBS6 
 
3 
 
NS 
 
0 
 
.73 
 
700 
(46.0%) 
8.8 
(1.8) 
5-12 
 
14.3% 
 
Chen et al. 
(2013)7 
 
National survey, 
stratified sample 
 
3 
 
NS 
 
0 
DIS, often/ 
always, past 4 
weeks 
 
3 
Insomnia self- 
assess. 
inventory8 
 
3 
 
NS 
 
0 
 
.60 
 
2113 
(52.9%) 
 
15-17 
 
3.2% 
Chung & 
Cheung 
(2008)9 
 
Multiple schools 
 
2 
 
86.0% 
 
3 
 
DIS, 3+ weekly, 
past 3 months 
 
3 
 
Sleep Quality 
Index10 
 
3 
 
r= .5511 
 
2 
 
.87 
 
1335 
(NS) 
 
12-16 
 
5.4% 
 
 
1 DSM= Diagnostic and Statistical Manual 
2 Wave 1 only 
3 CAPA= Child and Adolescent Psychiatric Assessment (Angold et al., 1995) 
4 DIS= Difficulty initiating sleep 
5 ICSD= International Classification of Sleep Disorders 
6 PBS= Pediatric Behavior Scale (Lindgren & Koeppl, 1987) 
7 “Poor sleep” rather than insomnia 
8 World Health Organisation, 2001 
9 12-16 years only 
10 Urponen et al., 1991 
11 r= test-retest reliability/ inter-rater reliability 
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Table 1.9 - Summary of articles reporting the prevalence of difficulty initiating sleep in non-clinical samples. 
 
 
 
 
 
 
Authors 
 
 
Ҫifҫili et al. 
 
 
 
Sample recruitment 
Response 
rate 
 
Random school 
Quality Ratings 
 
Definition Assessment Reliability 
 
N 
(% Male) 
 
 
302 
Mean age 
in years 
(SD) 
range 
 
17.3 
 
 
Prev. 
(2010) sample 
2 99.0% 3 DIS 1 Key symptoms 3 NS 0  .60 (76.5%) (1.8) 
32.8% 
 
Choi et al. 
(2009)1 
 
 
Chung et 
 
Random/ 
stratified school 
sample 
 
Stratified school 
 
 
2 86.7% 3 
 
DIS 
3+ weekly 
2 Key symptoms 3 NS 0  .67
 
 
Insomnia 
 
1176 
(50.0%) 
 
 
290 
 
16.7 
(1.0) 
12.0%
 
 
14.4 
al. (2014) 
 
 
Gehrman et 
sample 
2 72.0% 3 DSM-IV2 3
 
 
 
Longitudinal twin 
Interview 
Schedule3 
3 NS 0  .73 
(43.8%) 
 
 
2824 
(1.4) 
12-18 
 
12.0 
35.9% 
 
 
Child = 
14.5%, 
al. (2011) study 
1 NS 0 DSM-III-R 3 CAPA 3 NS 0  .47
 (46.3%) 
(2.6) 
8-16 
Parent = 
4.9% 
 
Huang et 
al. (2012) 
 
Huang et 
 
Stratified school 
sample. Part of 
wider survey 
 
Random school 
 
 
3 NS 0 
 
DIS, past 30 
days 
2 Key symptoms 3 k= .264 1  .60
 
 
33692 
(44.9%) 
13-15 17.2%
 
 
1906 
al. (2010) sample 
2 95.1% 3 DIS 1 PSQ5 3 r= .64 2  .73 (37.7%) 
12-18 24.7% 
 
Johnson et 
al. (2004)6 
 
Existing dataset 
from random 
sample 
 
 
3 NS 0 
 
Does not fall 
asleep easily 
1 DISC-17 3 r= .24 1  .53
 
 
749 
(NS) 
 
14.0 
(3.0) 
34.3%
 
 
 
 
 
1 Control group only 
2 DSM= Diagnostic and Statistical Manual (4th edition; 3rd edition – revised) 
3 Morin (1993) 
4 k= test-retest reliability/ inter-rater reliability 
5 PSQ= Pediatric Sleep Questionnaire (Chervin et al., 2000) 
6 14 years only 
7 DISC= Diagnostic Interview Schedule for Children 
  
3 71.2% 
 
3 
 
DSM-IV 
 
3 
Interviews based 
on DSM-IV and 
ICSD-R 
 
3 
 
NS 
 
0 
 
101 
.80 
(49.7 
 
4 
%) 
13-16
 
 
11.6% 
 
 
 
3 88.0% 
 
 
 
3 
 
DIS, often/ 
almost every 
night, past 
 
 
 
3 
 
 
 
Key symptoms 
 
 
 
3 
 
 
 
NS 
 
 
 
0 
 
 
432 
.73 
(N 
 
 
5 
S) 
13-16 
 
 
 
8.0% 
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Table 1.9 - Summary of articles reporting the prevalence of difficulty initiating sleep in non-clinical samples. 
 
 
 
 
 
 
Authors 
 
 
 
Sample recruitment 
Response 
rate 
Quality Ratings 
 
Definition Assessment Reliability 
 
N 
(% Male) 
Mean age 
in years 
(SD) 
range 
 
 
Prev. 
 
Johnson et 
al. (2006) 
Health insurance 
database 
 
 
 
Junker et 
al. (2014)1 
 
 
Kaneita et 
al. (2006) 
Population 
sample for non- 
sleep study 
 
 
Cluster sample of 
schools 
2 64.8% 2
 
 
 
 
month 
 
DIS, often/ 
always, past 
month 
 
 
 
 
 
 
3 Key symptoms 3 NS 0  .67 
 
 
 
 
 
102451 
(54.7%) 
12-18 14.8%
 
 
Kilincaslan 
et al. 
(2014) 
 
Kirmil-Gray 
 
Cluster sample of 
schools 
 
 
Health classes of 
 
 
2 92.2% 3  SOL2 > 30mins 2 Key symptoms 3 NS 0  .67 
 
3485 
(49.0%) 
 
 
277 
 
16.1 
(1.0) 
14-17 
 
15.0 
 
 
12.4% 
et al. 
(1984) 
 
Lee et al. 
three schools 
2 NS 0  DIS, 3+ weekly 2 Key symptoms 3 NS 0  .47
 (46.9%) 
 
 
7172 
13-17 
13.8% 
 
16.8 
(2012) 
School sample 2 84.1% 3 ICD-103 3 ICD-10 3 NS 0  .73
 
 
DIS, every 
(37.8%) 
(1.1) 
12-17 
6.5% 
Leger et al. 
(2012) 
National survey 3 93.5% 3
 
night/ several 
times weekly, 
past 6 months 
 
3 Key symptom 3 NS 0  .80 
9251 
(50.2%) 
11-15 19.2%
 
 
 
 
 
1 Under 16 years only 
2 SOL= sleep onset latency 
3 ICD-10= International Classification of Diseases (10th edition) 
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Table 1.9 - Summary of articles reporting the prevalence of difficulty initiating sleep in non-clinical samples. 
 
 
 
 
 
 
Authors 
 
 
 
Sample recruitment 
Response 
rate 
Quality Ratings 
 
Definition Assessment Reliability 
 
N 
(% Male) 
Mean age 
in years 
(SD) 
range 
 
 
Prev. 
 
Lehmkuhl 
et al. 
(2008) 
 
Random school 
sample of new- 
starters 
 
 
2 29.0% 0 DIS, often 2 Key symptom 3 NS 0  .47  
1388 
(51.3%) 
 
 
5.5 5.1% 
 
Liu et al. 
(2000) 
 
Representative/ 
random sample 
2 97.0% 3
 
 
DIS, often, past 
month 
3 Key symptoms 3 NS 0  .73
 
 
1365 
(60.3%) 
 
14.6 
(3.4) 
12-18 
 
 
10.8% 
 
Liu et al. 
(2008)1 
 
Mak et al. 
 
Representative/ 
random sample 
2 97.8% 3
 
 
Population 
 
DIS, 3+ weekly, 
past month 
3 Key symptoms 3
 
 
DIS, past 30 
 
α= .52 
k= .4 
2  .87
 
 
1066 
(58.6%) 
 
28839 
 
Median= 
14.5 
12-17 
 
 
7.4% 
(2010) 
Mak et al. 
(2012) 
 
Morioka et 
survey of obesity 
3 84.5% 3 
 
Population 
survey of obesity 
3 94.8% 3
 
 
Random school 
days 
2 Key symptoms 3 NS 0  .73
 
 
DIS, past 30 
days 
2 Key symptoms 3 k= .26 2  .87
 
 
DIS, always/ 
(49.7%) 
12-18 19.0%
 
 
22678 
(41.6%) 
12-18 12.3%
 
 
98867 
al. (2013) 
 
Munezawa 
sample. Part of 
wider survey 
3 92.2% 3 often, past 30 
days 
 
SOL > 30 mins, 
3 Key symptoms 3 NS 0  .80 
(49.4%) 
12-18 13.3% 
et al. 
(2009) 
Multiple schools 2 78.7% 3 weekly+, past 
month 
3 PSQI3 3 NS 0  .73  
916 
(62.0%) 
12 6.8% 
 
Murray et 
al. (2012)4 
Advertisements 2 56.0% 1
 
 
DIS often/ 
frequently/ 
always 
 
Adolescent 
2 sleep-wake 
scale5 
 
 
3 α= .81 3  .73 
 
60 
(33%) 
 
15.1 
(1.8) 
12-18 
 
 
18.6% 
 
 
 
1 7th and 10th grades only 
2 α= Cronbach’s 
3 PSQI= Pittsburgh Sleep Quality Index 
4 Control group only 
5 LeBourgeois et al. (2005) 
 3 87.0% 3 
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Table 1.9 - Summary of articles reporting the prevalence of difficulty initiating sleep in non-clinical samples. 
 
 
 
 
 
 
Authors 
 
 
Nevéus et 
 
 
 
Sample recruitment 
Response 
rate 
 
Representative 
Quality Ratings 
 
Definition Assessment Reliability 
 
DIS, nightly/ 
 
N 
(% Male) 
 
 
1413 
Mean age 
in years 
(SD) 
range 
 
7.9 
 
 
Prev. 
al. (2001) school sample 
2 74.0% 3 weekly 
2 Key symptom 3 NS 0  .67 (49.3%) 6-11 
13.9% 
 
 
Nevéus et 
al. (1999)1 
Multiple schools 2 74.0% 3
 
 
 
 
Nevéus et 
 
“Onset 
insomnia”, 
nightly/ weekly/ 
2
 
monthly 
 
“Onset 
insomnia”, 
 
Measure 
designed to 
study sleep 
problems 
 
Measure 
designed to 
 
 
2 NS 0  .60 
 
 
1293 
(53.0%) 
 
 
 
100 
 
 
7.9 
6-10 
51.0%
 
 
 
8.7 
al. (1998)1 
Single school 1 91.0% 3
 nightly/ weekly/ 
2
 
monthly 
study sleep 
problems 
2 NS 0  .53 
(49.0%) 
(1.0) 
7-10 
62.0% 
 
Ohayon & 
Roberts 
(2001)2 
 
Population/ 
stratified sample 
 
Stratified school 
 
 
2 78.0% 3 
 
DSM-IV or 
ICSD 
 
 
3 Sleep-EVAL 3 
 
k= 
.71-.78 
 
 
3  .93 
 
794 
(54.1%) 
 
 
15-18y 14.1% 
Ohida et al. 
(2004) 
sample. Part of 
wider data 
collection. 
DIS, always/ 
often 
2 Key symptom 3 NS 0  .73
 
106295 
(51.3%) 
12-18 15.6%
 
 
Pagel et al. 
(2007) 
Two schools 2 47.6% 0
 
 
 
 
Pallesen et 
 
DIS, always/ 
every night 
2 PSQ 3 NS 0  .47
 
 
Sleep-onset 
difficulties, 
 
165 
(49.1%) 
 
 
 
4711 
 
14.2 
(1.5) 
11-17 
 
 
21.2% 
al. (2008) 
National survey 3 58.0% 1
 
daily/ 1+ 
weekly, over 6 
months 
3 Key symptom 3 NS 0  .67 
(51.8%) 
11-15 20.4%
 
 
 
 
1 Control group only 
2 15-18 years only 
 3 66.0% 2 DSM-IV 
Intervie 
3 
on DS 
w based 
M-IV 
3
 
NS 0 
417 
.73 
(51.1 
5 
%) 
11-17
 
7.1% 
 
 
3 
 
 
NS 
 
 
0 
 
DIS, almost 
every day, past 
 
 
3 DS 
 
 
M-IV 3 
 
 
α>.9 
 
 
3 
 
417 
.80 
(50.8
 
 
5 
%) 
11-17 
 
 
6.5% 
   4 weeks        
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Table 1.9 - Summary of articles reporting the prevalence of difficulty initiating sleep in non-clinical samples. 
 
 
 
 
 
 
Authors 
 
 
 
Sample recruitment 
Response 
rate 
 
 
China= 
Quality Ratings 
 
Definition Assessment Reliability 
 
N 
(% Male) 
 
 
China= 
861 
Mean age 
in years 
(SD) 
range 
 
 
China = 
 
 
Prev. 
 
 
 
China= 
Pan et al. 
(2012) 
 
 
 
Roberts et 
 
Random school 
sample 
2
 
 
 
 
 
Stratified school 
95.1% 
Macau= 
95.7% 
 
3 ICSD-2 3 ICSD-2 3 NS 0  .73 
 
 
 
DIS, often/ 
(47.6%) 
Macau= 
618 
(41.9%) 
 
5118 
15.3 (1.8) 
Macau = 
15.6 (1.8) 
 
 
Median= 
17.2% 
Macau= 
10.2% 
al. (2004) 
 
Roberts et 
al. (2008)1 
 
Roberts et 
al. (2002) 
 
 
Shang et 
sample 
2 67.0% 2
 
 
Epidemiological 
study 
 
Epidemiological 
study 
 
 
Stratified school 
every day, past 
4 weeks 
 
 
 
 
 
 
 
DIS, 3+ weekly, 
3 DSM-IV 3 NS 0  .67 
 
 
 
 
 
 
 
 
 
k= 
(NS) 
 
 
 
 
 
 
 
 
 
1391 
15.0 
13-18 
 
 
 
 
 
 
 
7.4 
16.7% 
al. (2005) 
 
 
Shur-Fen 
sample 
2 91.6% 3
 
 
 
Random school 
over past 
month 
 
DIS, 30+ mins, 
3 SHQ2 3 
.54-.85 
3  .90 (52.4%) 
 
 
2463 
(1.5) 
4-9 
 
11.6 
18.5% 
(2006) 
 
Singareddy 
sample 
2 95.3% 3
 
 
Population/ 
3+ weekly, past 
6 months 
3 SHQ 3 NS 0  .73 
(52.4%) 
(2.6) 
6-16 
 
8.8 
4.6% 
et al. 
(2013)3 
stratified school 
sample 
2 70.0% 3  
DIS, very often, 
past 2 months 
3 Key symptoms 3 NS 0  .73  
666 
(48.0%) 
(1.7) 
5-12 
13.3% 
 
 
 
 
1 Wave 1 only 
2 SHQ= Sleep Habits Questionnaire (Gau, 2000) 
3 Non-self-harming group only 
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Table 1.9 - Summary of articles reporting the prevalence of difficulty initiating sleep in non-clinical samples. 
 
 
 
 
 
 
Authors 
 
 
 
Siomos et 
 
 
 
Sample recruitment 
Response 
rate 
 
Cross-section of 
Quality Ratings 
 
Definition Assessment Reliability 
 
N 
(% Male) 
 
 
2195 
Mean age 
in years 
(SD) 
range 
 
15.3 
 
 
Prev. 
al. (2009) 
 
Stein et al. 
schools 
2 99.8% 3 ICD-10 3 AIS1 3 α .82 3  .93
 
 
DIS >30 mins, 
(49.1%) 
 
472 
(1.7) 
13-18 
2.1% 
(2001) 
Paediatric clinics 1 NS 0 7x weekly 
2 Key symptoms 3 NS 0  .40 (53.6%) 
4-12 8.3% 
 
Yang et al. 
(1987) 
Multiple schools 2 NS 0
 
 
 
Zhang et al. 
 
SOL >1hr, 4+ 
monthly, past 6 
months 
 
DSM-IV and 
 
 
3 Key symptoms 3 NS 0  .53 
 
 
DSM-IV and 
 
846 
(49.2%) 
 
 
5695 
 
14.7 
(1.4) 
12-18 
 
9.2 
 
 
14.9% 
(2009) 
Multiple schools 2 70.3% 3
 ICSD-1 
3 ICSD-1 
3 NS 0  .73
 (50.3%) 
(1.8) 
6-13 
2.5% 
 
Zhang et al. 
(2011)2 
 
 
Zhang et al. 
 
Epidemiological 
study 
2 47.2% 0
 
 
 
Random school 
 
DIS, 3+ weekly, 
past 12 months 3 Key symptoms 3 α= .87 3  .73 
 
 
DIS, 3+ weekly, 
 
6447 
(50.6%) 
 
 
3086 
 
9.2 
(1.8) 
2.5%
 
 
9.7 (1.7)/ 
(2015) sample 
2 76.4% 3
 
past 12 months 3 Key symptoms 3 NS 0  .73 
(52.1%) 
9.0 (1.6) 
7-14 
2.9% 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 AIS= Athens Insomnia Scale (Soldatos et al., 2000) 
2 Baseline data only 
51  
 
Many of the methodological observations made for the group of articles 
describing the prevalence of insomnia, are also relevant for the articles describing 
the prevalence of DIS. Sample recruitment primarily took place through schools, 
with efforts made to ensure a randomised, representative or stratified sample 
(Examples are Calhoun, Fernandez-Mendoza, Vgontzas, Liao & Bixler, 2014; Choi 
et al., 2009; Liu, Uchiyama, Okawa & Kurita, 2000; Singareddy et al., 2013). For 
example, Calhoun et al. (2014) distributed questionnaires through schools, and then 
selected a sample of 700 families, stratified by age, gender and risk of sleep- 
disordered breathing. Similarly, Choi and colleagues (2009) randomly selected 
schools stratified across nine geographical areas, to ensure the sample was 
representative of the population. Articles that received lower scores for sample 
recruitment included Barclay et al., (2015), and Gehrman et al. (2011), due to the 
samples consisting of twin pairs. Similarly, Stein, Mendelsohn, Obermeyer, 
Amromin and Benca (2001), and Nevéus et al. (1998) recruited from a restricted 
and non-random population, of a single school or paediatric clinic, therefore it is 
possible that the prevalence estimates gained from these samples may be less 
representative of the wider population. 
The variety of definitions of DIS also reflect those discussed previously in the 
insomnia prevalence analysis, in terms of frequency and chronicity of symptoms. 
One difference, however, is that sleep onset latency (SOL) was also included here. 
Several articles suggested that a SOL of 30 minutes signified a difficulty in falling 
asleep (Kilincaslan, Yilmaz, Oflaz & Aydin, 2014; Munezawa, Kaneita, Yokoyama, 
Suzuki & Ohida, 2009; Shur-Fen, 2006; Stein et al., 2001), whereas Yang, Zuo and 
Eaton (1987) recommended that SOL was over an hour long.  Other authors used 
52  
 
items questioning whether the child ‘falls asleep easily’ (Johnson, Cohen, Kasen, 
First & Brook, 2004). The presence of DIS was also more frequently assessed using 
a single item, whereas insomnia was often assessed over numerous items. As a 
result, one would expect the prevalence of insomnia to be greater than that of DIS, 
when considering that insomnia was frequently defined as the presence of any one 
symptom, one of which could include DIS. The reported prevalence estimates and 
quality ratings were entered into random-effects and quality-effects models to 
estimate the pooled prevalence statistics (Figures 1.6 and 1.7). 
53  
- 
 
Study  Prev (95% Cl) %Weight 
Amaral et al. (2013) • 0. 09  ( 0.08. 0.10) 2.05 
Barclay et al. (2015) 0.15  ( 0.13, 0.16) 2.03 
Blader et al. (1997) • 0. 11  ( 0.09, 0.13) 1.97 
Blank et al. (2015) 0.24  ( 0.23. 0.26) 2.05 
Calhoun et al. (2014) 0. 14  ( 0.12, 0.17) 1.94 
Chen et al. (2013) • 0. 03  ( 0.03. 0.04) 2.02 
Chung & Cheung (2008) 0.05  ( 0.04, 0.07)  1.99 
Cifcili et al. (2010) • 0. 33  ( 0.28. 0.38) 1.79 
Choi et al. (2009)  0.12  ( 0.10, 0.14) 1.99 
Chung et al. (2014) 0.36  ( 0.30, 0.41) 1.78 
Gehrman et al. (2011) - chlid • 0.14  ( 0.13, 0.16) 2.03 
Gehrman et al. (2011) - parent  0.05  ( 0.04, 0.06) 2.03 
Huang et al. (2010) • 0. 25  ( 0.23. 0.27) 2.01 
Huang et al. (2012) 0.17  ( 0.17, 0.18) 2.06 
Johnson et al. (2004) 0. 34  ( 0.31, 0.38) 1.94 
Johnson et al. (2006)  • 0.12  ( 0.10. 0.14) 1.97 
Junker et al. (2014) 0.08  ( 0.07, 0.09) 2.04 
Kaneita et al. (2006) 0.15  ( 0.15. 0.15) 2.06 
Kilni caslan et al. (2014) • 0.12  ( 0.11, 0.14) 2.04 
Kirmii-Gray et al. (1984)  • 0. 14  ( 0.10. 0.18) 1.77 
Lee et al. (2012) • 0.06  ( 0.06, 0.07) 2.05 
Leger et al. (2012) 0.19  ( 0.18, 0.20) 2.05 
Lehmkuhl et al. (2008) • 0.05  ( 0.04. 0.06) 2.00 
liu et al. (2000) 0.11   ( 0.09, 0.12) 2.00 
liu et al. (2008) • 0. 07  ( 0.06, 0.09) 1.98 
Mak et al. (2010) 0.19  ( 0.19, 0.19) 2.06 
Mak et aL (2012) • 0. 12  ( 0.12, 0.13) 2.06 
Morioka et al. (2013) 0.13  ( 0.13. 0.14) 2.06 
Munezawa et aL (2009) 0.07  ( 0.05, 0.08) 1.97 
Murray et al. (2012)  • 0. 18  ( 0.09. 0.29) 1.18 
Neveus et aL (1998)  0.62  ( 0.52, 0.71) 1.42 
Neveus et al. (1999)  0.51  ( 0.48, 0.54) 1.99 
Neveus et aL (2001) 0.14  ( 0.12. 0.16) 2.00 
Ohayon & Roberts (2001) 0.14  ( 0.12, 0.17) 1.95 
Ohida et al. (2004) 0. 16  ( 0.15. 0.16) 2.06 
Page et aL(2007) 0.21   ( 0.15, 0.28)  1.62 
Pallesen et al. (2008) • 0. 20  ( 0.19, 0.22) 2.04 
Pan et aL (2012) - China • 0.17  ( 0.15. 0.20) 1.96 
Pan et al. (2012) - Macau  0.10  ( 0.08, 0.13) 1.92 
Roberts et al. (2002)  • 0. 06  ( 0.06. 0.07) 2.04 
Roberts et aL (2004) • 0.17  ( 0.16, 0.18) 2.04 
Roberts et al. (2008}  • 0. 07  ( 0.06. 0.08) 2.04 
Shang et aL (2005) 0.18  ( 0.16, 0.21) 2.00 
Shur-Fen (2006) 0.05  ( 0.04, 0.05) 2.03 
Siomos et al. (2009)   .
 
 
2 ( 0.02, 0.03) 2.02 
Singareddy et aL (2013}  • 0.13  ( 0.11. 0.16) 1.93 
0.0 
Stein et al. (2001} · 0.08  ( 0.06, 0.11) 1.88 
Yang et al. (1987) 0.15  ( 0.13, 0.17) 1.96 
Zhang et al. (2009)  • 0.02  ( 0.02, 0.03) 2.05 
Zhang et aL (2011}  • 0. 02  ( 0.02. 0.03) 2.05 
Zhang et al. (2015) 0.03  ( 0.02, 0.04) 2.03 
 
Overall • 0.13  ( 0.12, 0.15) 100.00 
0=9552.68. p=O.OO. 12=99% 
. . 
0  0.2 0.4  0.6 
Figure 1.6- Pooled estimates for the prevalence of difficulty initiating sleep using a 
random-effects model. 
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Study Prev (95% Cl) %Weight 
Amaral et al. (2013)  • 0. 09  (  0.08. 0.10) 1.57 
Barclay et al. (2015) 0.15  ( 0.13, 0.16) 0.63 
Blader et al. (1997) 0. 11  ( 0.09. 0.13) 0.58 
Blank et al. (2015)  0.24  (  0.23. 0 26) 1.51 
Calhoun et al. (2014) 0. 14  ( 0.12, 0.17) 0.67 
Chen et al. (2013)  0.03  (  0.03. 0.04) 0.72 
Chung & Cheung (2008)  0.05  ( 0.04, 0.07) 0.90 
Cifcili et al. (2010)  0. 33  (  0.28. 0.38) 0.50 
Choi et al. (2009)  0.12  ( 0.10, 0.14) 0.68 
Chung et al. (2014) 0.36  ( 0.30, 0.41) 0.61 
Gehrman et al. (2011) - chlid 0.14  ( 0.13, 0.16) 0.63 
Gehrman et al. (2011) - parent  0.05  ( 0.04, 0.06) 0.63 
Huang et al. (2010)  • 0. 25  (  0.23. 0.27) 0.84 
Huang et al. (2012) • 0.17  ( 0.17, 0.18) 5.02 
Johnson et al. (2004)  0. 34  ( 0.31, 0.38) 0.49 
Johnson et al. (2006)  0.12  (  0.10, 0.14) 0.78 
Junker et al. (2014) 0. 08  ( 0.07, 0.09) 1.19 
Kaneita et al. (2006)  • 0.15  (  0.15. 0.15) 14.21 
Kilni caslan et al. (2014) 0.12  ( 0.11, 0.14) 0.98 
Kirmi -Gray et al. (1984)  0. 14  (  0.10. 0.18) 0.39 
Lee et al. (2012) • 0.06  ( 0.06, 0.07) 1.61 
Leger et al. (2012)  0.19  ( 0.18, 0.20)  2.10 
Lehmkuhl et al. (2008)  0.05  (  0.04, 0.06) 0.49 
Liu et al. (2000) 0.11   ( 0.09, 0.12) 0.76 
Liu et al. (2008)  • 0. 07  (  0.06. 0.09) 0.86 
Mak et al. (2010) • 0.19  ( 0.19, 0.19) 4.76 
Mak et al. (2012) • 0. 12  ( 0.12, 0.13) 4.61 
Morioka et al. (2013)  • 0.13  (  0.13, 0.14) 16.40 
Munezawa et al. (2009) 0.07  ( 0.05, 0.08) 0.70 
Murray et al. (2012)  0. 18  (  0.09. 0.29) 0.57 
Neveus et al. (1998)  0.62  ( 0.52, 0.71) 0.42 
Neveus et al. (1999)  0.51  ( 0.48, 0.54) 0.62 
Neveus et al. (2001) 0.14  (  0.12, 0.16) 0.71 
Ohayon & Roberts (2001) 0.14  ( 0.12, 0.17) 0.87 
Ohida et al. (2004)  • 0. 16  (  0.15. 0.16) 16.05 
Page et al.(2007) 0.21  ( 0.15, 0.28)  0.38 
Pallesen et al. (2008)  • 0. 20  (  0.19, 0.22) 1.15 
Pan et al. (2012) - China  0.17  ( 0.15, 0.20) 0.69 
Pan et al. (2012) - Macau  0. 10  ( 0.08, 0.13) 0.65 
Roberts et al. (2002)  • 0.06  (  0.06. 0.07) 1.29 
Roberts et al. (2004) 0.17  ( 0.16, 0.18) 1.20 
Roberts et al. (2008)  • 0. 07  (  0.06. 0.08) 1.17 
Shang et al. (2005)  · 0.18  ( 0.16, 0.21) 0.95 
Shur-Fen (2006) • 0.05  ( 0.04, 0.05) 0.92 
Siomos et al. (2009)  .  2 ( 0.02, 0.03) 1.13 
Singareddy et al. (2013) 0.13  (  0.11, 0.16) 0.66 
0.0 
Stein et al. (2001) 0. 08  (  0.06. 0.11) 0.35 
Yang et al. (1987)  0.15  ( 0.13, 0.17)  0.50 
Zhang et al. (2009)    • 0.02  ( 0.02, 0.03) 1.39 
Zhang et al. (2011)  • 0.02  (  0.02. 0.03) 1.50 
Zhang et al. (2015)  0.03  ( 0.02, 0.04) 1.01 
 
Overall 0.14  ( 0.11, 0.17) 100.00 
0=9552.68, p=O.OO. 12=99% 
 
0  0.2 0.4  0.6 
 
Figure 1.7- Pooled estimates for the prevalence of difficulty initiating sleep using a 
quality-effects model. 
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The results of the pooled prevalence analyses suggested that the prevalence 
of DIS is 13.2% (CI= 11.8-14.7) for the random-effects model, and 13.6% (CI= 10.9- 
16.7) for the quality-effects model. Visual inspection of the forest plot in both Figures 
 
1.6 and 1.7 suggests that the articles by Nevéus et al. (1998, 1999) may be 
anomalous in comparison to the remainder of the articles. When looking in detail at 
these two articles, it can be seen that the authors defined DIS as being present 
when occurring at a minimum of once a month. This definition is considerably less 
conservative than the remaining articles. With these articles removed from the 
analysis, the prevalence estimate taken from the random-effects model was 12.1% 
(CI= 10.8-13.4), and 13.3% (CI= 10.7-16.2) in the quality-effects model. The 
considerable overlap between the confidence intervals for the original meta- 
analyses, and the meta-analyses with the Nevéus et al. articles removed suggests 
that there is no significant difference in the pooled prevalence estimates, and 
therefore the original estimates were retained. 
Difficulty maintaining sleep. Forty-five articles were identified that reported 
a prevalence figure for difficulty maintaining sleep (DMS), also referred to in the 
literature as middle insomnia or night-waking, after three had been removed for non- 
unique samples (Liu, 2004; Liu & Zhou, 2002; Roberts et al., 2006), and one for 
failing to score on the three key criteria (Lazaratou et al., 2005). These are 
summarised in Table 1.10. Reported prevalence estimates for the remaining articles 
ranged from 1.3-64.2% (Johnson et al., 2004; Zhang et al., 2009, 2011, 2015). 
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Table 1.10 – Summary of articles reporting the prevalence of difficulty maintaining sleep in non-clinical samples. 
 
 
 
 
 
 
Authors 
 
 
 
Sample recruitment 
  
 
 
Response 
 Quality ratings 
 
 
Definition 
 
 
 
Assessment 
  
 
 
Reliability 
   
N 
(% Male) 
Mean age 
in years 
(SD) 
 
 
Prev. 
   rate        T
  range  
Amaral et al. 
(2013) 
 
Multiple schools 
 
2 
 
82.1% 
 
3 
 
DSM-IV1 
 
3 
 
DSM-IV 
 
3 
 
NS 
 
0 
 
.73 
6919 
(47.0%) 
 
12-18 
 
6.1% 
Barclay et al. 
(2015)2 
Longitudinal twin 
study 
 
1 
 
NS 
 
0 
 
DSM-III-R 
 
3 
 
CAPA3 
 
3 
 
NS 
 
0 
 
.47 
2789 
(46.0%) 
Mode= 8.3 
8-17 
 
19.6% 
 
Blader et al. 
(1997) 
 
Random school 
sample 
 
 
2 
 
 
60.0% 
 
 
2 
 
DMS4, 3+ 
weekly 
 
 
2 
 
 
Key symptom 
 
 
3 
 
 
NS 
 
 
0 
 
 
.60 
 
972 
(NS) 
7.5 
(1.1) 
5-12 
 
 
6.5% 
Blank et al. 
(2015) 
 
National survey 
 
3 
 
82.9% 
 
3 
 
DSM-IV 
 
3 
Interviews based 
on DSM-IV 
 
3 
 
NS 
 
0 
 
.73 
6483 
(48.6%) 
 
13-18 
 
14.2% 
 
Calhoun et al. 
(2014) 
 
Population/ 
stratified school 
sample 
 
 
2 
 
 
70.0% 
 
 
3 
 
 
ICSD5 
 
 
3 
 
PBS6, based on 
ICSD 
 
 
3 
 
 
NS 
 
 
0 
 
 
.73 
 
700 
(46.0%) 
8.8 
(1.8) 
5-12 
 
 
10.7% 
 
Chen et al. 
(2013) 
 
National survey, 
stratified sample 
 
3 
 
NS 
 
0 
DMS, often/ 
always, past 4 
weeks 
 
3 
Insomnia self- 
assess. 
inventory7 
 
3 
 
NS 
 
0 
 
.6 
 
2113 
(52.9%) 
 
15-17 
 
1.4% 
 
Choi et al. 
(2009)8 
Random/ 
stratified school 
sample 
 
2 
 
86.7% 
 
3 
 
DMS 3+ weekly 
 
2 
 
Key symptoms 
 
3 
 
NS 
 
0 
 
.67 
 
1176 
(50.0%) 
 
16.7 
(1.0) 
 
7.6% 
 
1 DSM= Diagnostic and Statistical Manual 
2 Wave 1 only 
3 CAPA= Child and Adolescent Psychiatric Assessment (Angold et al., 1995) 
4 DMS= Difficulty maintaining sleep 
5 ICSD= International Classification of Sleep Disorders 
6 PBS= Pediatric Behavior Scale (Lindgren & Koeppl, 1987) 
7 World Health Organisation, 2001 
8 Control group only 
 2 99.0% 3 DMS 1 Key symptoms 3 NS 0 
302 
.60 
(76.5%) 
17.3 
(1.8) 
45.0%
 
 
 
1 
 
 
NS 
 
 
0 
 
 
DSM-III-R3 
 
 
3 
 
 
CAPA 
 
 
3 
 
 
NS 
 
 
0 
 
 
2824 
.47 
(46.3%) 
 
12.0 Child = 
19.6%, 
(2.6) 
parent = 
 
5
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Table 1.10 – Summary of articles reporting the prevalence of difficulty maintaining sleep in non-clinical samples. 
 
 
 
 
 
 
Authors 
 
 
 
Sample recruitment 
Response 
rate 
Quality ratings 
 
 
Definition Assessment Reliability 
 
N 
(% Male) 
Mean age 
in years 
(SD) 
range 
 
 
Prev. 
 
Chung & 
Cheung 
(2008)1 
 
 
Chung et al. 
 
Multiple schools 2 86.0% 3 
 
 
 
Stratified schools 
DMS 3+ 
weekly, past 3 
months 
 
3 
Sleep Quality 
Index2 
 
 
Insomnia 
 
3 r= .523 2  .87 
1335 
(NS) 
 
 
290 
 
12-16 6.8% 
 
 
14.4 
(2014) 
 
 
Ҫifҫili et al. 
(2010) 
sample 
2 72.0% 3 DSM-IV 3
 
 
 
Random school 
sample 
Interview 
Schedule4 
3 NS 0  .73 
(43.8%) 
(1.4) 
12-18 
9.3% 
 
 
Gehrman et al. 
(2011) 
 
 
Huang et al. 
Longitudinal twin 
study 
 
 
Stratified school 
 
 
 
 
 
DMS, past 30 
 
 
 
 
 
33692 
 
 
8-16 
 
 
6.3% 
(2012) 
 
Huang et al. 
sample. Part of 
wider survey 
 
Random school 
3 NS 0 
days. 
2 Key symptoms 3   k= .263 1  .60
 (44.9%) 
13-15 12.2%
 
 
1906 
(2010) sample 
2 95.1% 3 DMS 1 PSQ5 3 r= .64 2  .73 (37.7%) 
12-18 7.4% 
 
 
 
 
 
 
 
1 12-16 years only 
2 Urponen et al., 1991 
3 k or r= test-retest reliability/ inter-rater reliability 
4 Morin (1993) 
5 PSQ= Pediatric Sleep Questionnaire (Chervin et al., 2000) 
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Table 1.10 – Summary of articles reporting the prevalence of difficulty maintaining sleep in non-clinical samples. 
 
 
 
 
 
 
Authors 
 
 
 
 
Johnson et al. 
 
 
 
Sample recruitment 
Response 
rate 
 
Existing dataset 
Quality ratings 
 
 
Definition Assessment Reliability 
 
 
Wakes in night/ 
 
N 
(% Male) 
 
 
 
749 
Mean age 
in years 
(SD) 
range 
 
 
Prev. 
(2004)1 
 
 
Johnson et al. 
from random 
sample 
 
Health insurance 
3 NS 0 wakes early in 
morning 
 
DSM-IV 
1 DISC-12 3 r= .24 1  .53 
 
 
Interviews based 
 
(NS) 
 
 
1014 
14.0 (3.0) 64.2% 
(2006) 
 
 
Kaneita et al. 
database 
3 71.2% 3 
 
 
Cluster sample 
 
 
 
DMS, often/ 
3   on DSM-IV and 
ICSD-R 
3 NS 0  .80 
(49.7%) 
13-16 4.5%
 
 
 
102451 
(2006) of schools 
2 64.8% 2 always, past 
month 
3 Key symptoms 3 NS 0  .67 
(54.7%) 
12-18 11.3% 
 
 
Kilincaslan et 
al. (2014) 
 
 
Kirmil-Gray et 
 
 
Cluster sample 
of schools 
2 92.2% 3
 
 
 
Health classes of 
 
DMS, several 
nights/ every 
night 
 
DMS, 3+ 
 
 
2 Key symptoms 3 NS 0  .67 
 
 
3485 
(49.0%) 
 
 
277 
 
16.1 
(1.0) 
14-17 
 
15.0 
 
 
10.7% 
al. (1984) 
 
 
Lee et al. 
three schools 
2 NS 0 weekly 
2 Key symptoms 3 NS 0  .47
 (46.9%) 
 
 
7172 
13-17 
13.1%
 
 
16.8 
(2012) 
School sample 2 84.1% 3 ICD-103 3 ICD-10 3 NS 0  .73
 (37.8%) 
(1.1) 
12-17 
4.5% 
 
Lehmkuhl et 
al. (2008) 
 
Random school 
sample of new- 
starters 
 
 
2 29.0% 0 DMS, often 2 Key symptoms 3 NS 3  .47 
 
1388 
(51.3%) 
5.5 5.2%
 
 
 
 
 
1 14 years only 
2 DISC-1= Diagnostic Interview Schedule for Children 
3 ICD-10= International Classification of Diseases (10th edition) 
  Mean age 
N in years 
 
2 97.0% 
DMS, 
3 
past 
often, 
month 
3 Key symptoms 3 NS 0 .73 
 
2 92.5% 3 
5
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Table 1.10 – Summary of articles reporting the prevalence of difficulty maintaining sleep in non-clinical samples. 
 
 
 
 
 
 
Authors 
 
 
 
Sample recruitment 
Response 
rate 
Quality ratings 
 
 
Definition Assessment Reliability 
 
 
 
(% Male) 
 
 
(SD) 
range 
 
 
Prev. 
 
 
 
Li et al. (2014) 
Cluster/ stratified 
school sample 
Waking 2+ 
nightly, 2+ 
weekly, past 
week 
 
CSHQ1 with 
3 additional DMS 
items 
 
 
3  ‘excellent’ 3  .93  
20505 
(49.5%) 
 
9.0 
(1.6) 
5-12 
 
 
9.8% 
 
 
Liu et al. 
(2000) 
 
 
Liu et al. 
(2008)2 
 
Mak et al. 
 
Representative/ 
stratified school 
sample 
 
Representative/ 
random school 
sample 
 
Population 
 
 
 
 
 
 
 
2 97.8% 3 
 
 
 
 
 
DMS, 
3+weekly, past 
month 
 
DMS, past 30 
 
 
 
 
 
 
 
3 Key symptoms 3 
 
 
 
 
 
 
α= .53 
2  .87 
k= .4 
 
 
1365 
(60.3%) 
 
 
1066 
(58.6%) 
 
28839 
 
14.6 
(3.4) 
12-18 
 
Median= 
14.5 
12-17 
 
 
6.3% 
 
 
 
7.1% 
(2010) 
 
Mak et al. 
(2012) 
 
Morioka et al. 
survey of obesity 
3 84.5% 3 
 
Population 
survey of obesity 
3 94.8% 3
 
 
Random school 
days 
2 Key symptoms 3 NS 0  .73
 
 
DMS, past 30 
days 
2 Key symptoms 3 k= .26 2  .87
 
 
DMS, always/ 
(49.7%) 
12-18 14.2%
 
 
22678 
(41.6%) 
12-18 8.8%
 
 
98867 
(2013) 
sample. Part of 
wider survey 
3 92.2% 3 often, past 30 
days 
3 Key symptoms 3 NS 0  .80 
(49.4%) 
12-18 10.5%
 
 
 
Murray et al. 
(2012)4 
Advertisements 2 56.0% 1
 
 
DMS, often/ 
frequently/ 
always 
 
Adolescent 
2 sleep-wake 
scale5 
 
 
3 α= .81 3  .73 
 
60 
(33%) 
 
15.1 
(1.8) 
12-18 
 
 
8.5% 
 
 
 
1 CSHQ= Child Sleep Habits Questionnaire (Owens, Spirito & McGuinn, 2000) 
2 7th and 10th grades only 
3 α = Cronbach’s 
4 Control group only 
5 LeBourgeois et al. (2005) 
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Table 1.10 – Summary of articles reporting the prevalence of difficulty maintaining sleep in non-clinical samples. 
 
 
 
 
 
 
Authors 
 
 
 
Sample recruitment 
Response 
rate 
Quality ratings 
 
 
Definition Assessment Reliability 
 
N 
(% Male) 
Mean age 
in years 
(SD) 
range 
 
 
Prev. 
 
 
Nevéus et al. 
(1998)1 
Single school 1 91.0% 3
 
“Night-time 
awakenings”, 
2 
monthly/ 
nightly/ weekly 
Measure 
designed to 
study sleep 
problems 
 
 
2 NS 0  .53 
 
100 
(49.0%) 
 
8.7 
(1.0) 
7-10 
 
 
48.0% 
 
Ohayon & 
Roberts 
(2001)2 
 
 
Pagel et al. 
 
Population/ 
stratified sample 
 
 
2 78.0% 3   DSM-IV/ ICSD 3 Sleep-EVAL. 3 
 
 
 
DMS, always/ 
 
k= 
.71-.78 
 
 
3  .93 
 
794 
(54.1%) 
 
 
165 
 
 
15-18y 8.4% 
 
 
14.2 
(2007) 
Two schools 2 47.6% 0
 
 
 
 
China= 
every night 
2 PSQ 3 NS 0  .47
 (49.1%) 
 
 
China= 
861 
(1.5) 
11-17 
 
 
China = 
10.3% 
 
 
 
China = 
Pan et al. 
(2012) 
 
 
 
 
Roberts et al. 
 
Random school 
sample 
2
 
 
 
 
 
Stratified school 
95.1% 
Macau 
= 95.7% 
 
3 ICSD-2 3 ICSD-2 3 NS 0  .73 
 
 
 
 
DMS, often/ 
(47.6%) 
Macau= 
618 
(41.9%) 
 
5118 
15.3 (1.8) 
Macau = 
15.6 (1.8) 
 
 
Median= 
3.7% 
Macau = 
2.8% 
 
(2004) 
 
Roberts et al. 
sample 
2 67.0% 2 
 
Epidemiological 
every day, past 
4 weeks 
3 DSM-IV 3 NS 0  .67 
 
 
Interview based 
 
(NS) 
 
4175 
15.0 
13-18 
14.9% 
(2008)3 study 
3 66.0% 2 DSM-IV 3 on DSM-IV 
3 NS 0  .73 (51.1%) 
11-17 3.1% 
 
 
 
 
1 Control group only 
2 15-18 years only 
3 Wave 1 only 
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Table 1.10 – Summary of articles reporting the prevalence of difficulty maintaining sleep in non-clinical samples. 
 
 
 
 
 
 
Authors 
 
 
 
 
Roberts et al. 
 
 
 
Sample recruitment 
Response 
rate 
 
 
Epidemiological 
Quality ratings 
 
 
Definition Assessment Reliability 
 
 
DMS, almost 
 
N 
(% Male) 
 
 
 
4175 
Mean age 
in years 
(SD) 
range 
 
 
Prev. 
(2002) 
 
 
 
Shang et al. 
study 
3 NS 0 
 
 
 
Stratified school 
every day, past 
4 weeks 
 
Waking 30+ 
mins, 3+ 
3 DSM-IV 3 α >.91 3 .8 
 
 
 
k= 
(50.8%) 
11-17 8.7%
 
 
 
7.4 
1391 
(2005) 
 
 
 
Shur-Fen 
sample 
2 91.6% 3
 
 
 
 
Random school 
weekly, past 
month 
 
DMS, 30+ mins 
3+ weekly, for 
3 SHQ2 3  
.54-.85 
3  .90 
(52.4%) 
 
 
 
2463 
(1.5) 
4-9 
 
 
11.6 
1.5% 
(2006) 
 
 
 
Singareddy et 
sample 
2 95.3% 3
 
 
 
Population/ 
1+ month over 
past 6 months 
 
DMS, very 
3 SHQ 3 NS 0  .73 
(52.4%) 
 
 
 
666 
(2.6) 
6-16 
 
8.8 
1.4% 
al. (2013)3 
 
 
Siomos et al. 
stratified school 
sample 
 
 
Cross-section of 
2 70.0% 3 often, past 2 
months. 
3 Key symptoms 3 NS 0  .73  
(48.0%) 
 
 
2195 
(1.7) 
5-12 
 
15.3 
21.3% 
(2009) 
 
 
Stein et al. 
schools 
2 99.8% 3 ICD-10 3 AIS4 3 α= .82 3  .93 
 
 
DMS, 30+ mins 
(49.1%) 
 
 
472 
(1.7) 
13-18 
1.8% 
(2001) 
Paediatric clinics 1 NS 0 7x weekly 
2 Key symptoms 3 NS 0  .40 (53.6%) 
4-12 4.0% 
 
 
 
 
 
 
1 α= Cronbach’s 
2 SHQ= Sleep Habits Questionnaire (Gau, 2000) 
3 Non-self-harming group only 
4 AIS= Athens Insomnia Scale (Soldatos et al., 2000) 
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Table 1.10 – Summary of articles reporting the prevalence of difficulty maintaining sleep in non-clinical samples. 
 
 
 
 
 
 
Authors 
 
 
 
Sample recruitment 
Response 
rate 
Quality ratings 
 
 
Definition Assessment Reliability 
 
N 
(% Male) 
Mean age 
in years 
(SD) 
range 
 
 
Prev. 
 
 
Zhang et al. 
(2009) 
Multiple schools 2 70.3% 3   DSM-IV/ ICSD 3 DSM-IV/ ICSD 3 NS 0  .73
 
 
5695 
(50.3%) 
9.2 
(1.8) 
6-13 
 
 
1.3% 
 
Zhang et al. 
(2011)1 
 
 
Zhang et al. 
 
Epidemiological 
study 
2 47.2% 0
 
 
 
Random school 
 
DMS, 3+ 
weekly, past 12 
months 
 
DMS, 3+ 
 
 
3 Key symptoms 3 α= .87 3  .73 
 
6447 
(50.6%) 
 
 
3086 
 
9.2 
1.3% 
(1.8) 
 
9.7 (1.7)/ 
 
(2015) sample 
2 76.4% 3 
weekly, past 12 
months 
3 Key symptoms 3 NS 0  .73  
(52.1%) 
9.0 (1.6) 
7-14 
1.3% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 Baseline data only 
63  
 
There was substantial overlap between articles reporting prevalence 
estimates for DMS and those reporting DIS. Therefore, the methods of recruitment 
and assessment were very similar. In terms of the definition of DMS, some authors 
required a minimum frequency or duration of night-wakings, in order for DMS to be 
considered as present (Huang, Wang & Guilleminault, 2010; Kirmil-Gray, 
Eagleston, Gibson & Thoresen, 1984; Shur-Fen, 2006), whereas others described 
DMS as being restless sleep, or difficulty in returning to sleep once awake, without 
using operationalised terms of how this might present clinically (Amaral et al., 2013; 
Liu, Zhao, Jia & Buysse, 2008; Roberts et al., 2008b; Roberts, Roberts & Chen, 
2002; Singareddy et al., 2013). 
 
The article by Li and colleagues (2014) was the only publication to focus 
solely on DMS. The aim of the study was to investigate the impact of psychosocial 
factors, such as demographic variables, health and the sleeping environment, on 
whether a child experienced frequent night-time awakenings, which was the term 
employed by the authors. The authors’ definition was therefore more detailed, and 
required participants to wake more than twice each night, or awaken once during 
the night for a duration of longer than 30 minutes, for a minimum of two nights per 
week during the past four weeks, to be classified as experiencing DMS. A 
prevalence rate of 9.8% was observed in their sample of over 20,000 children under 
the age of 12 years, and this was found to be influenced by health problems, poor 
psychological and emotional functioning, and poor sleep hygiene. This article was 
given high scores on the quality framework due to the clear definition of the 
construct, high participant uptake rate, and valid assessment of DMS. Articles which 
received lower scores on the quality framework were predominantly those that 
64  
 
either did not report a participant uptake rate, or whose uptake rate was relatively 
low in comparison to the other papers (Barclay et al., 2015; Gehrman et al., 2011; 
Kirmil-Gray et al., 1984; Lehmkuhl, Wiater, Mitschke & Fricke-Oerkermann, 2008; 
Pagel, Forister & Kwiatkowki, 2007; Stein et al., 2001). The articles were entered 
into the pooled meta-analysis to give overall prevalence estimates (Figures 1.8 and 
1.9). 
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; 
- 
• 
. 
 
 
Study Prev (95% Cl) %Weight 
Amaralet al. (2013) • 0.06  ( 0.06, 0. 07) 2.27 
Barclay et al. (2015) .I
' • 0.20  ( 0.18, 0.21)  2.25 
Blader et al. (1997) 0.06  ( 0.05,  0. 08)  2.19 
.
 
Blanket al. (2015) 
Calhoun et al. (2014) 
; 0.14  ( 0.13. 0. 15)  2.27 
0.11 ( 0.09, 0. 13)  2.16 
• 0.17  ( 0.13, 0. 22)  2.03 
Chen et al. (2011)  • 0.00  ( 0.00. 0. 01) 2.23 
Chen et al. (2013)  • 0.01  ( 0.01, 0. 02)  2.24 
Choiet al. (2009) · 0.08  ( 0.06. 0. 09)  2.21 
Chung & Cheung (2008) •i 0.07  ( 0.06. 0. 08)  2.22 
Chung et al. (2014) !- 0.09  ( 0.06. 0. 13)  2.01 
Cifcili et al. (2010) 
j 
0.45  ( 0.39. 0. 51)  2.02 
Gehrman et al. (2011) - child 
Gehrman et al. (2011) - parent 
• 0.20  ( 0.18, 0. 21)  2.25 
·I 0.06  ( 0.05, 0. 07)  2.25 
Huang et al. (2010) oi 0.07  ( 0.06, 0. 09)  2.24 
Huang et al. (2012) l • 0.12  ( 0.12. 0.13) 2.28
 
 
Johnson et al. (2004) ; -·- 0.64  ( 0.61, 0.68) 2.17 
Johnson et al. (2006) • ! 0.05  ( 0.03, 0. 06) 2.20 
Kaneita et al. (2006) !· 0.11  ( 0.11, 0.11) 2.28 
Kilincaslan et al. (2014) 1• 0.11  ( 0.10, 0.12) 2.26 
Kirmii-Gray et al. (1984) 1   • 0.13  ( 0.09, 0. 17)  2.00 
Lee et al. (2012) • ! 0.05  ( 0.04, 0. 05)  2.27 
Lehmkuhlet al. (2008) •i'
 
0.05  ( 0.04. 0. 06)  2.22
 
Li et al. (2014) 
' 
 
0.10  ( 0.09. 0. 10)  2.28 
Liu et al. (2000) • 0.06 ( 0.05, 0. 08) 2.22 
Liu et al. (2008) •l' 0.07  ( 0.06, 0. 09)  2.20 
Mak et al. (2010) l • 0.14  ( 0.14, 0. 15)  2.28 
Mak et al. (2012)  • 0.09  ( 0.08. 0. 09)  2.28 
Morioka et al. (2013) 1- 0.10 ( 0.10. 0. 11)  2.28 
Murray et al. (2012) 0.08  ( 0.02. 0. 17)  1.38 
Neveus et al. (1998) 0.48  ( 0.38. 0. 58)  1.64 
t
 
Ohayon & Roberts (2001) 0.08  ( 0.07. 0.10) 2.18 
Pagelet al. (2007) -i· 0.10  ( 0.06, 0.15) 1.84 
Pan et al. (2012) - China • ' 
Pan et al. (2012) - Macau  • j 
0.04  ( 0.03, 0. 05) 2.18 
0.03 ( 0.02,  0. 04)  2.15
 
Roberts et al. (2002) • 0.09  ( 0 08. 0.10) 2.26 
Roberts et al. (2004) 
Roberts et al. (2008) • 
• 0.15  ( 0.14, 0.16) 2.27 
I 0.03  ( 0.03,  0. 04)  2.26 
Shang et al. (2005) • 0.02  ( 0.01,  0. 02)  2.22 
Shur-Fen (2006) • 0.01 ( 0.01,  0. 02)  2.25 
Singareddy et al. (2013) ; • 0.21  ( 0.18, 0.25) 2.16 
Siomos et al. (2009) •  ! 0.02  ( 0.01, 0. 02) 2.24 
Stein et al. (2001) .• . ! 0.04  ( 0.02, 0. 06)  2.11 
Zhang et al. (2009) •  ' 
 
0.01  ( 0.01. 0. 02)  2.27 
Zhang et al. (2011J • 0.01 ( 0.01, 0. 02)  2.27 
Zhang et al. (2015) • 0.01  ( 0.01. 0. 02)  2.25 
 
Overall 0.09  ( 0.08. 0. 10) 100.00 
0=8538. 52. p=O.OO, 12=99% 
 
0 0.2 0.4  0.6 
 
 
Figure 1.8- Pooled estimates for the prevalence of difficulty maintaining sleep, 
using a random-effects model. 
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Study  Prev (95% Cl) %Weight 
Amaral et al. (2013) • 0.06  ( 0. 06. 0. 07) 1. 89 
Barclay et al. (2015) 0.20  ( 0. 18. 0. 21) 0.72 
Blader et al. 1997) 0.06  ( 0.05. 0.08)  0.65 
Blank et al. 2015)  • 0.14  ( 0.13. 0.15) 1. 81 
Calhoun et al. (2014)  0.11  ( 0. 09. 0.13) 0.74 
Camhi et al. (2000)  0.17  ( 0.13. 0. 22)  0.61 
Chen et al. (2011) 0.00  ( 0. 00. 0.01) 0.40 
Chen et al. (2013) O.Gl  ( 0.01. 0.02) 0.82 
Choiet al. (2009) 0.08  ( 0.06. 0.09) 0.76 
Chung & Cheung (2008)  • 0.07  ( 0.06. 0.08) 1.02 
Chung et al. (2014) 0.09  ( 0.06. 0.13) 0.66 
Cifelli et al. (2010) 0.45  ( 0.39. 0.51) 0.55 
Gehrman et al. (2011) - child  0. 20  ( 0.18.  0.21) 0.73 
Gehrman et a.l (2011) - parent  0.06  ( 0.05.  0.07) 0.73 
Huang  et al. (2010) • 0.07  ( 0.06. 0.09) 0.96 
Huang  et al. 2012) • 0.12  ( 0.12. 0.13) 6.28 
Johnson et al. 2004)  0.64  ( 0.61. 0.68) 0.54 
Johnson et al. (2006)  0.05  ( 0.03. 0.06) 0.87 
Kaneita et al. (2006)  • 0.11 ( 0.11. 0.11) 17. 96 
Kilincaslan et al. (2014) • 0.11 ( 0.10. 0.12) 1.15 
Kirmii-Gray et al. (1984) 0.13  ( 0.09. 0.17) 0.42 
Lee et al. (2012)  • 0.05 ( 0.04. 0.05) 1.93 
Lietal. 2014) ,
 
 
.10  ( 0.09. 0.10) 5.61 
Lehmkuhl et al.  2008)  0.05  ( 0.04. 0.06) 0.56 
0 
Liu et al. 2000)  ..i 0.06  ( 0.05, 0.08) 0.86 
Liu et al.  2008)  0.07 ( 0.06. 0.09) 0.96 
Mak et al. (2010) 0.14 ( 0. 14. 0.15) 5.94 
Mak et a.l (2012) •
 
0.09  ( 0.08. 0.09) 5.73 
Morioka et al. (2013) II  0.10 ( 0. 10.  0.11) 20.71 
Murray et a.l 2012) • 0.08  ( 0.02, 0. 17) 0.62 
Neveus et al.  1998)  0.48  ( 0.38. 0. 58)  0.45 
Ohayon & Roberts (2001)  0.08  ( 0. 07. 0. 10)  0.96 
Pagel et al. (2007)  0.10 ( 0. 06. 0. 15)  0.41 
Pan et al. (2012) - Chni  a  0.04  ( 0. 03. 0. 05)  0.77 
Pan et al. (2012)- Macau 0.03  ( 0. 02, 0.04)  0.72 
Roberts et al. (2002)  • 0.09  ( 0.08. 0.10)  1.51 
Roberts et al. (2004) • 0.15  ( 0.14. 0.16)  1.43 
Roberts et al. (2008)  0.03  ( 0.03. 0. 04)  1. 38 
Shang et al. (2005)  0.02  ( 0,01. 0. 02)  1. 07 
Shur-Fen (2006)  0.01  ( 0.01'  0. 02)  1. 06 
Singareddy et al. (2013)  0.21  ( 0.18. 0.25) 0.73 
Stein et al. (2001)  -
 
 
4  ( 0. 02. 0.06) 0. 38 
Siomos et al. (2009)  0.02  ( 0.01. 0.02) 1.29 
0.0 
Zhang et al. (2009) 0.01 ( O.D1. 0.02) 1.66 
Zhang et al. (2011) 0.01  ( 0.01. 0.02) 1.80 
Zhang et at (2015) 0.01 ( 0.01. 0.02) 1.18 
Overall • 0.09  ( 0.07.  0.12) 100.00 
0=8538. 52,p=O.OO. 12=99° 
 
0  0. 2 0.4  0.6 
 
 
Figure 1.9- Pooled estimates for the prevalence of difficulty maintaining sleep, 
using a quality-effects model. 
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The results of the pooled estimates suggested that the prevalence of DMS is 
 
8.8% (CI= 7.5-10.2) for the random-effects model, and 9.4% (CI= 6.8-12.4) for the 
quality-effects model. These are summarised in Figures 1.8 and 1.9. 
As with the DIS analysis, the Nevéus et al. (1998) article reported a 
prevalence that appeared to be anomalous, and again it is likely that because the 
authors chose a more liberal frequency of monthly occurrences of DMS, a greater 
number of children in their sample met the criteria. Other articles that stood out as 
being inconsistent with the other prevalence estimates, were those of Ҫifҫili et al. 
(2010) and Johnson et al. (2004). These authors also used slightly different 
definitions of DMS, in that Ҫifҫili and colleagues enquired about the presence of 
DMS and did not stipulate a frequency of symptoms, or duration of chronicity. 
Johnson and colleagues (2004) combined DMS with early morning awakening 
(EMA), and so this most likely inflated the number of participants who responded 
positively to that item. Removal of these three articles from the pooled prevalence 
estimates, yielded new estimates of 7.1% (CI= 6.0-8.3) and 8.9% (CI= 6.6-11.6) 
from the random- and quality-effects models respectively. This is a more 
conservative estimate of DMS, and is likely more in keeping with what would be 
considered a problem worthy of clinical investigation; however, the overlap between 
the confidence intervals suggests that removal of the three papers does not 
significantly change the prevalence estimates, and the original estimates were 
therefore retained. 
Early morning awakening. Twenty-six articles were identified that reported 
a prevalence figure for early morning wakening (EMA), after three had been 
removed for including non-unique samples (Liu, 2004; Liu & Zhou, 2002; Roberts et 
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al., 2006) and one for failing to score on the three key criteria (Lazaratou et al., 
 
2005). These are summarised in Table 1.11. Reported prevalence estimates for the 
remaining articles ranged from 0.2-17.3% (Blanket  al., 2015; Gehrman et al., 2011). 
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Table 1.11 – Summary of articles reporting the prevalence of early morning awakening in non-clinical samples. 
 
 
 
 
 
 
Authors 
 
 
Amaral et al. 
 
 
 
Sample recruitment 
Response 
rate 
Quality ratings 
 
Definition Assessment Reliability 
 
N 
(% Male) 
 
 
6919 
Mean age 
in years 
(SD) 
range 
 
Prev. 
(2013) 
Multiple schools 2 82.1% 3 DSM-IV1 3 DSM-IV 3 NS 0 .73 (47.0%) 
12-18 8.2% 
 
Barclay et al. 
(2015)2 
 
Blank et al. 
 
Longitudinal twin 
study 
1 NS 0 DSM-III-R 3 CAPA3 3 NS 0 .47
 
 
2789 
(46.0%) 
 
6483 
 
Mode= 8.3 
8-17 
4.9%
 
(2015) 
National survey 3 82.9% 3 DSM-IV 2 DSM-IV 3 NS 0 .73 (48.6%) 
13-18 17.3% 
 
Choi et al. 
(2009)4 
 
Chung & 
 
Random/ 
stratified school 
sample 
 
 
2 86.7% 3 
 
EMA5, 3+ 
weekly 
2 Key symptom 3 NS 0 .67
 
 
EMA, 3+ 
 
1176 
(50.0%) 
 
16.7 
(1.0) 
6.3%
 
Cheung 
(2008)6 
 
Chung et al. 
Multiple schools 2 86.0% 3 
 
 
Stratified school 
weekly, past 3 
months 
3 
Sleep Quality 
Index7 
 
Insomnia 
3 r= .618 2 .87 
1335 
(NS) 
 
 
290 
12-16 10.4% 
 
 
14.4 
(2014) 
 
 
Gehrman et 
sample 
2 72.0% 3 DSM-IV 3
 
 
 
Longitudinal twin 
Interview 
Schedule9 
3 NS 0 .73 
(43.8%) 
 
 
2824 
(1.4) 
12-18 
 
12.0 
6.6% 
 
 
Child = 
4.9%, 
al. (2011) study 
1 NS 0 DSM-III-R 3 CAPA 3 NS 0 .47
 (46.3%) 
(2.6) 
8-16 
Parent 
= 0.2% 
 
 
 
1 DSM= Diagnostic and Statistical Manual 
2 Wave 1 only 
3 CAPA= Child and Adolescent Psychiatric Assessment (Angold et al., 1995) 
4 Control group only 
5 EMA= Early morning awakening 
6 12-16 years only 
7 Urponen et al., 1991 
8 r= test-retest reliability/ inter-rater reliability 
9 Morin (1993) 
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Table 1.11 – Summary of articles reporting the prevalence of early morning awakening in non-clinical samples. 
 
 
 
 
 
 
Authors 
 
 
 
Huang et al. 
 
 
 
Sample recruitment 
Response 
rate 
 
Stratified school 
Quality ratings 
 
Definition Assessment Reliability 
 
 
EMA, past 30 
 
N 
(% Male) 
 
 
33692 
Mean age 
in years 
(SD) 
range 
 
Prev. 
(2012) 
 
Huang et al. 
sample, part of 
wider survey 
 
Random school 
3 NS 0 
days 
2 Key symptoms 3   k= .261 1 .60
 (44.9%) 
13-15 9.3%
 
 
1906 
(2010) sample 
2 95.1% 3 EMA 1 PSQ 3   r= .641 2 .73
 
 
EMA, often/ 
(37.7%) 
12-18 15.1%
 
Junker et al. 
(2014)2 
 
 
Kaneita et al. 
Population 
sample for non- 
sleep study 
 
3 88.0% 3 
almost every 
night, past 
month 
 
EMA, often/ 
 
3 Key symptom 3 NS 0 .73 
4325 
(NS) 
13-16 4.0%
 
 
 
102451 
(2006) 
Multiple schools 2 64.8% 2
 
always, past 
month 
3 Key symptom 3 NS 0 .67 
(54.7%) 
12-18 5.5%
 
 
Lee et al. 
(2012) 
School sample 2 84.1% 3 ICD-103 3 ICD-10 3 NS 0 .73
 
 
7172 
(37.8%) 
 
16.8 
(1.1) 
12-17 
 
 
1.4% 
 
Liu et al. 
(2000) 
 
Stratified school 
sample 
2 97.0% 3
 
 
EMA, often, 
past month 
3 Key symptom 3 NS 0 .73
 
 
1365 
(60.3%) 
 
14.6 
(3.4) 
12-18 
 
 
2.1% 
 
Liu et al. 
(2008)4 
 
Mak et al. 
 
Representative/ 
random school 
samples 
 
Total population 
 
 
2 97.8% 3 
 
EMA, 3+ 
weekly, past 
month 
 
EMA, past 30 
 
 
3 Key symptom 3 
 
α= .5 
k= .4 
2 .87
 
 
1066 
(58.6%) 
 
28839 
 
Median= 
14.5 
12-17 
 
 
3.4% 
(2010) survey of obesity 
3 84.5% 3 days 
2 Key symptom 3 NS 0 .73 (49.7%) 
12-18 10.3% 
 
 
 
1 k or α= test-retest reliability/ inter-rater reliability 
2 Under 16 years only 
3 ICD-10= International Classification of Diseases (10th edition) 
4 7th and 10th grades only 
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Table 1.11 – Summary of articles reporting the prevalence of early morning awakening in non-clinical samples. 
 
 
 
 
 
 
Authors 
 
 
Mak et al. 
 
 
 
Sample recruitment 
Response 
rate 
 
Total population 
Quality ratings 
 
Definition Assessment Reliability 
 
EMA, past 30 
 
N 
(% Male) 
 
 
22678 
Mean age 
in years 
(SD) 
range 
 
Prev. 
(2012) 
 
Morioka et al. 
survey of obesity 
3 94.8% 3 
 
Random school 
days 
2 Key symptom 3 k= .26 2 .87
 
 
EMA, always/ 
(41.6%) 
12-18 7.2%
 
 
98867 
(2013) 
 
Ohayon & 
sample, part of 
wider survey 
3 92.2% 3 often, past 30 
days 
3 Key symptom 3 NS 0 .80 
(49.4%) 
12-18 5.1%
 
Roberts 
(2001)1 
Population/ 
stratified sample 
2 78.0% 3  DSM-IV/ ICSD2 3 Sleep-EVAL 3 
k= 
.78-.71 3 .93  
794 
(54.1%) 
 
China= 
15-18 10.5% 
 
Pan et al. 
(2012) 
 
 
 
Roberts et al. 
 
 
Random school 
sample 
2
 
 
 
 
 
Stratified school 
China= 
95.1% 
Macau 
=95.7% 
 
 
3 ICSD-2 3 ICSD-2 3 NS 0 .73 
 
 
 
EMA, often/ 
861 
(47.6%) 
Macau= 
618 
(41.9%) 
 
5118 
China = 
15.3 (1.8) 
Macau = 
15.6 (1.8) 
 
 
Median= 
China= 
10.5% 
Macau 
= 5.8% 
(2004) 
 
 
Roberts et al. 
sample 
2 67.0% 2
 
 
 
Epidemiological 
daily, past 4 
weeks 
3 DSM-IV 3 NS 0 .67 
 
 
Interviews 
(NS) 
 
 
4175 
15.0 
13-18 
15.1% 
(2008)3 study 
3 66.0% 2 DSM-IV 3
 
based on DSM- 
IV 
3 NS 0 .73 
(51.1%) 
11-17 3.2%
 
 
Roberts et al. 
(2002) 
 
Epidemiological 
study 
3 NS 0
 
 
EMA, almost/ 
daily, past 4 
weeks 
 
 
3 DSM-IV 3 α >.9 3 .8 
 
4175 
(50.8%) 
11-17 3.3%
 
 
 
 
 
1 15-18 years only 
2 ICSD= International Classification of Sleep Disorders 
3 Wave 1 only 
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Table 1.11 – Summary of articles reporting the prevalence of early morning awakening in non-clinical samples. 
 
 
 
 
 
 
Authors 
 
 
 
Siomos et al. 
 
 
 
Sample recruitment 
Response 
rate 
 
Cross-section of 
Quality ratings 
 
Definition Assessment Reliability 
 
N 
(% Male) 
 
 
2195 
Mean age 
in years 
(SD) 
range 
 
15.3 
 
Prev. 
(2009) schools 
2 99.8% 3 ICD-10 3 AIS1 3 α= .82 3 .93
 (49.1%) 
(1.7) 
13-18 
2.2% 
 
Zhang et al. 
(2009) 
Multiple schools 2 70.3% 3
 
 
DSM IV/ 
ICSD-1 
3
 
 
DSM IV/ 
ICSD-1 
3 NS 0 .73
 
 
5695 
(50.3%) 
 
9.2 
(1.8) 
6-13 
 
 
1.2% 
 
Zhang et al. 
(2011)2 
 
 
Zhang et al. 
 
Epidemiological 
study of sleep 
problems 
 
Random school 
 
 
2 47.2% 0 
 
EMA, 3+ 
weekly, past 12 
months 
 
EMA, 3+ 
 
 
3 Key symptom 3 α= .87 3 .73 
 
6447 
(50.6%) 
 
 
3086 
 
9.2 
(1.8) 
1.2%
 
 
9.7 (1.7)/ 
(2015) sample 
2 76.4% 3
 
weekly, past 12 
months 
3 Key symptoms 3 NS 0 .73 
(52.1%) 
9.0 (1.6) 
7-14 
1.4% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 AIS= Athens Insomnia Scale (Soldatos et al., 2000) 
2 Baseline data only 
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It was surprising to observe that authors did not typically give a cut-off for the 
time at which an awakening would be considered early in the articles describing 
prevalence rates of EMA. This allows for some interpretation on the respondent’s 
behalf, as to how early their child would have to wake for it to be perceived as 
problematic. However, a frequency of three times a week was given more 
consistently in the present collection of articles than it had been in the articles 
describing the prevalence of insomnia, DIS or DMS. EMA was never reported in the 
absence of the other forms of insomnia, and was typically the lowest prevalence of 
the three symptoms. 
As with the DIS and DMS comparisons, articles that received the highest 
ratings for quality, had representative sample recruitment strategies and high 
participant response rates (Ohayon & Roberts, 2001; Siomos et al., 2009), in 
comparison to those who employed non-representative samples or had not reported 
an adequate uptake rate (Barclay et al., 2015; Gehrman et al., 2011). All of the 
articles listed in Table 1.11 were then combined in the pooled prevalence analyses 
(Figures 1.10 and 1.11). 
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Figure 1.10 - Pooled estimates for the prevalence of early morning awakening, using 
a random-effects model. 
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Figure 1.11 - Pooled estimates for the prevalence of early morning awakening, using 
a quality-effects model. 
 
The pooled estimates for the prevalence of EMA were 5.5% (CI= 4.4-6.7) 
and 5.6% (CI= 3.8-8.1) for the random- and quality-effects models respectively. 
These results suggest that, of the three symptoms of insomnia, EMA is the least 
common. Alternatively, it may be that parents perceive their child waking early in 
the morning to be less problematic, than when they awake during the night or have 
difficulty falling asleep at bedtime. They therefore may not consider this to be worthy 
of report in a questionnaire enquiring about sleep problems.  Furthermore, parents 
76  
 
may not be aware of their child waking early in the morning if the child remains in 
their room, and does not alert them to the fact that they are awake. 
It should also be noted that of the three symptoms, EMA was reported by the 
fewest number of articles. Furthermore, papers reporting the prevalence of 
insomnia overall would not always include EMA in their criteria, but would more 
frequently include DIS and DMS (Ҫifҫili et al., 2010; Fernandez-Mendoza et al., 
2014; Kilincaslan et al., 2014; Murray, Murphy, Palermo & Clarke, 2012; Patten et 
al., 2000; Roane & Taylor, 2008). It may be that EMA is therefore overlooked both 
empirically and clinically, or it could be that, due to its reduced prevalence in 
comparison to DIS and DMS, it is not given as much attention in the applied or 
empirical arenas. 
1.3.2 Prevalence of Insomnia in Mental Health Conditions 
 
Anxiety disorders. Three articles which included a sample of children and/ 
or adolescents with a diagnosis of anxiety or generalised anxiety disorder were 
grouped together, and have been summarised in Table 1.12. Reported prevalence 
rates ranged from 30.4-76.5% (Johnson et al., 2006a; Ohayon, Roberts, Zulley, 
Smirne & Priest, 2000). 
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Table 1.12 – Summary of articles reporting the prevalence of insomnia in anxiety disorders. 
 
 
 
 
 
 
Authors 
 
 
Sample 
 
 
Response 
Quality ratings  
N 
(% Male)
 
Mean age 
in years 
(SD)
 
 
 
Prev. 
 
 
Alfano et al. 
recruitment rate 
Definition Assessment Reliability
 
 
 
128 
 
range 
 
10.7 
(2007)1 
Medical trial 1 NS 0 DIS/ DMS2 1 Key symptoms 3 NS 0   .33 
 
DIS/ DMS/ 
NRS3, 4+ 
(50.8%) 6-17 
56.9% 
Johnson et al. 
(2006) 
 
 
 
Ohayon et al. 
Health 
insurance 
database 
 
 
Stratified/ 
 
2 71.2% 3 
weekly, w. 
daytime impact, 
1 month in 
lifetime 
 
3 DSM/ ICSD4 3 NS 0   .73 
 
 
 
 
k= 
1014 
(49.7%) 
 
 
 
1125 
14.4 
13-16 
30.4%
 
(2000) 
probability 
sample 
2 80.8% 3   DSM-IV/ ICSD 3 DSM-IV/ ICSD 3 
.70-.785 
3   .93 (54.1%) 
15-18 76.5%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 Baseline only 
2 DIS= Difficulty initiating sleep; DMS= Difficulty maintaining sleep 
3 NRS= Non-restorative sleep 
4 DSM= Diagnostic and Statistical Manual; ICSD= International Classification of Sleep Disorders 
5 k= inter-rater reliability 
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Each article was entered into a random- and quality-effects model to determine the 
pooled prevalence statistics. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.12 - Pooled estimates for the prevalence on insomnia in anxiety disorders, 
using random-effects (upper panel) and quality-effects (lower panel) models. 
 
The pooled prevalence statistics for the rates of insomnia in children with a 
comorbid anxiety disorder were 55.5% (CI= 17.7-90.5) for the random-effects 
model, and 59.0% (CI= 13.4-97.6) for the quality-effects model. As with the rates of 
insomnia in the wider population, there was an extensive level of heterogeneity 
within the data. This is reflected in the very large confidence intervals for both 
models. As with previous analyses, this is most likely down to the authors varying 
definitions of insomnia. For example, Alfano, Ginsburg and Newman Kingery (2007) 
required only the presence of DIS or DMS for participants to score positively for 
insomnia, whereas Johnson et al. (2006a) applied more stringent criteria, and only 
included participants who were also experiencing daytime distress or impairment. 
Furthermore, the article by Ohayon et al. (2000) reported “insomnia symptoms” in 
76.5% of their adolescent sample who met criteria for an anxiety disorder, however 
it is unclear whether these insomnia symptoms equated to meeting diagnostic 
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criteria, and whether several types of anxiety were included under the term ‘anxiety 
disorder'. 
Depression. Several articles identified within the initial search also included 
samples of children and adolescents with a diagnosis of depression. For the 
purpose of the present analysis, those with a diagnosis of major depressive disorder 
and those with depression have been combined. Six articles were identified, yet two 
were removed due to failing to score on one of the key items of definition, 
recruitment or assessment (Strober, Green & Carlson, 1981; Yorbik, Birmaher, 
Axelson, Williamson & Ryan, 2004). The remaining articles are summarised in 
Table 1.13. Prevalence estimates ranged from 54.5-72.7% (Murray et al., 2012; 
Roberts, Lewinsohn, & Seeley, 1995). 
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Table 1.13 – Summary of articles reporting the prevalence of insomnia in depression. 
 
 
 
 
 
 
Authors 
 
 
 
Sample recruitment 
  
 
Response 
 Quality ratings 
 
Definition 
 
 
 
Assessment 
  
 
 
Reliability 
   
N 
(% Male) 
Mean age 
in years 
(SD) 
 
 
Prev. 
   rate        
 
T
 
 range  
 
 
 
 
Liu et al. 
(2007) 
 
 
 
Multiple 
psychiatric 
facilities 
 
 
 
 
2 
 
 
 
 
NS 
 
 
 
 
0 
DIS/ DMS/ 
EMA1/ poor 
sleep quality/ 
sleeping less, 
nearly every 
day, 2+ weeks 
during past 
month 
 
 
 
 
3 
 
 
 
 
ISCA2, based on 
DSM3 
 
 
 
 
3 
 
 
 
 
NS 
 
 
 
 
0 
 
 
 
 
.53 
 
 
 
 
553 
(55.0%) 
 
 
 
11.7 
(2.0) 
7.0-14.9 
 
 
 
 
64.0% 
 
Murray et al. 
(2012) 
Sample from 
ongoing study, or 
prescription 
database 
 
 
2 
 
 
21.0% 
 
 
0 
DIS/ DMS, 
often/ 
frequently/ 
always 
 
 
2 
 
 
Key symptoms 
 
 
3 
 
 
α= .814 
 
 
3 
 
 
.83 
 
46 
(33.0%) 
 
15.1 
(1.8) 
12-18 
 
 
72.7% 
 
Roberts & 
Duong 
(2013)5 
 
 
Health insurance 
databases 
 
 
 
2 
 
 
 
66.0% 
 
 
 
2 
 
DIS/ DMS/ 
EMA/ NRS6, 
past 4 weeks 
 
 
 
3 
 
 
 
DSM/ ICSD7 
 
 
 
3 
 
 
 
NS 
 
 
 
0 
 
 
 
.67 
Total incl. 
dep. 
group= 
4175 
(51.0%) 
 
11.7 
(2.0) 
7-14.9 
 
 
 
56.0% 
 
Roberts et al. 
(1995)8 
 
Random school 
sample 
 
3 
 
61.0% 
 
2 
 
DIS 
 
1 
 
K-SADS9 
 
3 
 
k >.810 
 
3 
 
.73 
 
44 
(46.3%) 
 
16.6 
(1.2) 
54.5% 
(DIS 
only) 
 
 
1 DIS= Difficulty initiating sleep; DMS= Difficulty maintaining sleep; EMA= Early morning awakening 
2 ISCA= Interview schedule for children and adolescents (Sherrill & Kovacs, 2000) 
3 DSM= Diagnostic and Statistical Manual 
4 α= internal consistency 
5 Baseline only 
6 NRS= Non-restorative sleep 
7 ICSD= International Classification of Sleep Disorders 
8 Time 1 only 
9 K-SADS= Schedule for affective disorder and schizophrenia for school-age children: Kiddie-SADS (Chambers et al., 1985) 
10 k= Cohen's k 
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Articles were then entered into the random- and quality effects models, to 
give overall prevalence estimates. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.13 - Pooled estimates for the prevalence of insomnia in depression, using 
random-effects (upper panel) and quality-effects (lower panel) models. 
 
The  pooled  estimates  for  the  prevalence  of  insomnia  in  children  with 
comorbid experiences of depression were 60.8% (CI= 54.0-67.4) and 58.7% (CI= 
50.7-66.5) for the random- and quality-effects models respectively. Although the 
collection of papers was slightly more homogenous than in previous analyses, the 
observed heterogeneity was still significant. One explanation for this could be that 
the Roberts et al. (1995) paper reported individual symptoms of insomnia, rather 
than an overall prevalence, and so the prevalence estimate for DIS was chosen to 
enter into the meta-analysis. The remaining articles all reported a prevalence 
estimate for insomnia, defined as being frequent symptoms of insomnia, with the 
additional criterion of added daytime impairment in the Roberts & Duong (2013) 
article, and ‘clinical significance’ in the paper by Liu et al. (2007; pg. 85). 
Another key difference between the articles is the recruitment strategy. 
Whilst the two papers published by Roberts and colleagues (1995; 2013) recruited 
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a typically-developing sample, and identified participants experiencing symptoms of 
depression within that group, Liu et al. (2007) and Murray et al. (2012) recruited 
participants through existing populations of psychiatric patients. Unfortunately, the 
Liu et al. (2007) article did not report a participant uptake rate, and the participant 
uptake rate reported in the Murray et al. (2012) sample was very low. Thus, it may 
be that a response bias has occurred in these two samples, and that individuals 
experiencing sleep problems alongside a mood disorder were more likely to 
participate. This may be especially pertinent when considering the clinical 
characteristics of depression, and the heightened risk of apathy in this group. This 
may provide some explanation for the higher prevalence of insomnia reported in 
these two articles, in comparison to those by Roberts and colleagues (1995; 2013). 
1.3.3 Prevalence of Insomnia in Physical Health Conditions 
 
As described previously, insomnia has been suggested as being more prevalent in 
physical health conditions in addition to mental health diagnoses. The articles that 
had been identified as including participants with physical health conditions, were 
grouped according to their diagnosis, for meta-analysis of the reported prevalence 
rates for each condition. However, after exclusion of articles failing to score 
positively on the three key criteria of definition and assessment of insomnia, and 
adequate sample recruitment, the only diagnosis to retain a collection of more than 
one article was that of chronic pain. 
Chronic pain. Of the articles including a sample of participants with physical 
health conditions, chronic pain featured in four articles. These are summarised in 
Table 1.14. 
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Table 1.14 – Summary of articles reporting the prevalence of insomnia in chronic pain. 
 
 
 
 
 
 
Authors 
 
 
 
Sample recruitment 
  
 
Response 
 Quality ratings 
 
Definition 
 
 
 
Assessment 
  
 
 
Reliability 
   
N 
(% Male) 
Mean age in 
years (SD) 
 
 
Prev. 
   rate        
 
T
 
 range  
 
Kanstrup et 
al. (2014) 
 
Specialist centre 
 
1 
 
NS 
 
0 
 
DSM-IV1 
 
3 
 
ISI2 
 
3 
 
α= .883 
 
3 
 
.67 
 
154 
(24.7%) 
14.6 
(2.0) 
10-18 
 
51.7% 
 
Meltzer et al. 
(2005) 
 
 
Outpatient clinic 
 
 
1 
 
 
96.0% 
 
 
3 
 
DMS4 of 2+ 
wakings, over 
past fortnight 
 
 
3 
Sleep Habits 
Survey5 and 
telephone 
interview 
 
 
3 
 
α= 
.7-.75 
 
 
3 
 
 
.87 
 
26 
(0%) 
 
15.5 
12-17 
 
 
62.5% 
 
 
Palermo et 
al. (2007) 
 
 
 
Pain clinic 
 
 
 
1 
 
 
 
86.0% 
 
 
 
3 
DIS of 30+ 
mins/ 3+ 
nightly 
wakings, 60%+ 
of time 
 
 
 
2 
 
Actigraphy, 
Adolescent 
Sleep Wake 
Scale6 
 
 
 
3 
 
 
 
NS 
 
 
 
0 
 
 
 
.60 
 
 
20 
(25.0%) 
 
15.1 
(1.4) 
12-17 
 
 
 
55.0% 
 
Palermo et 
al. (2011) 
 
 
Pain clinic 
 
 
1 
 
 
62.1% 
 
 
2 
DIS/ DMS, 
frequently/ 
quite often/ 
always 
 
 
2 
 
 
Key symptoms 
 
 
3 
 
 
α= .70 
 
 
3 
 
 
.73 
 
59 
(29.0%) 
 
15.0 
(1.7) 
12-18 
 
 
54.2% 
 
 
 
 
 
 
 
 
 
 
 
1 DSM= Diagnostic and Statistical Manual 
2 ISI= Insomnia Severity Index (Morin, 1993) 
3 α= internal consistency/ reliability 
4 DIS= Difficulty initiating sleep; DMS= Difficulty maintaining sleep 
5 Wolfson and Carskadon (1998) 
6 LeBourgeois et al. (2005) 
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The reported prevalence rates were between 51.7-62.5% (Kanstrup, Holmström, 
Ringström & Wicksell, 2014; Meltzer, Logan & Mindell, 2005). The four articles were 
then entered into the pooled prevalence analyses (Figure 1.14). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.14 - Pooled estimates for the prevalence of insomnia in chronic pain, using 
random-effects (upper panel) and quality-effects (lower panel) models. 
 
The pooled estimate for the prevalence of insomnia in children experiencing 
chronic pain was 53.6% in the random-effects model (CI= 47.5-59.7), and 54.5% in 
the quality-effects model (CI= 48.1-60.8). No significant heterogeneity was 
observed between the articles, which is likely attributable to the similarities in the 
source from which the samples were recruited, and the recommended chronicity of 
3 months of experienced chronic pain. Furthermore, both articles authored by 
Palermo and colleagues (Palermo, Toliver-Sokol, Fonareva & Koh, 2007; Palermo 
et al., 2011) included the frequent occurrence of DIS or DMS as being indicative of 
insomnia. Kanstrup et al. (2014) used a cut-off of nine on the Insomnia Severity 
Index (ISI: Morin, 1993) which is comparable to a moderate level of clinical 
insomnia. Each of these definitions are of a similar level of stringency. Meltzer and 
colleagues (2005) stipulated that DMS needed to be present during two nights of a 
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fortnight, which is a less conservative definition, reflected in the slightly higher 
reported prevalence rates. 
1.3.4 Summary 
 
The final aim of the meta-analysis was to compare the prevalence of 
insomnia, in clinical and non-clinical populations. Figure 1.15 summarises the 
prevalence estimates according to the random- and quality-effects models, with 
95% confidence intervals, and demonstrates the increased prevalence of insomnia 
in the three clinical populations. Odds ratios for the quality effects data ranged from 
4.8 to 5.9 in the three clinical groups (Table 1.15), again, suggesting that children 
and adolescents with a physical or mental health problem have a higher chance of 
presenting with insomnia. 
Table 1.15 - Odds ratios for presence of insomnia in each clinical sample in 
comparison to the non-clinical estimates 
 
Odds Ratio (95% Confidence Intervals) 
 
 Random Effects Quality Effects 
Anxiety 
 
Depression 
 
Chronic Pain 
5.11 (2.72-9.60) 
 
6.88 (3.64-13.00) 
 
4.62 (2.47-8.67) 
5.77 (3.07-10.84) 
 
5.86 (3.11-11.02) 
 
4.79 (2.56-8.99) 
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100.00 
 
90.00 
 
80.00 
N= 3 
Q= .66 
N= 4 
Q= .69 
N= 4 
Q= .70 
 
70.00 
 
60.00 
 
50.00 
 
40.00 
 
 
N= 44 
Q= .68 
 
 
N= 9 
Q= .75 
 
 
N= 4 
Q= .83 
 
 
N= 51 
Q= .69 
 
 
N= 46 
Q= .69 
 
 
N= 28 
Q= .73 
 
 
20.00 
 
10.00 
 
0.00 
 
 
 
 
Figure 1.15 - Pooled prevalence estimates and 95% confidence intervals for each definition of insomnia in the non-clinical sample, 
and for each clinical sample. N= Number of articles in analysis; Q= Mean quality weighting; = Random effects; = Quality effects. 
87  
 
1.4 Discussion 
 
The aim of the current systematic review and meta-analysis was to delineate the 
prevalence of insomnia and its components in non-clinical child and adolescent 
populations, and compare this to the prevalence of insomnia in physical and mental 
health conditions commonly associated with insomnia. This is the first study to 
undertake an extensive search of the empirical literature, in order to synthesise the 
range of reported prevalence rates in this age-group. In addition, careful evaluation 
of the varying definitions of the construct of insomnia, and the methodology 
employed to assess its presence has been undertaken. 
The overall findings of the meta-analyses suggest that the prevalence of 
insomnia in children and adolescents is between 16 and 20%. The prevalence was 
comparable between adolescents and children, with the prevalence of insomnia 
estimated at 18-21% in adolescent samples and 19-20% in child samples under 12 
years of age. With regards to the prevalence of each symptom of insomnia, DIS was 
the most frequently reported with a prevalence of 13-14%, followed by DMS which 
had a reported prevalence of 9%. EMA was the least common symptom of insomnia 
and occurred in 6% the participants included here. The observation that DIS was 
the most prevalent of the symptoms of insomnia suggests that this would be the 
most effective focus of intervention. This is consistent with the most common current 
treatment options available, which are typically designed to encourage night-time 
settling. These include behavioural therapies to develop helpful bedtime routines 
and reduce unhelpful bedtime associations, and pharmacological treatments, either 
prescribed by a medical professional or purchased by parents over the counter 
(Taylor & Roane, 2010). 
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Despite the occurrence of daytime impairment being one of the key criteria 
in recent DSM and ICSD publications, this was reported infrequently in the research 
literature. Those that did include this element in their definition of insomnia 
contributed to an overall prevalence of 10%. This prevalence estimate is 
considerably lower than when insomnia is based on the presence of symptoms 
alone, and implies that there are a number of children and adolescents who 
experience the sleeplessness symptoms of insomnia, but do not present with 
subsequent daytime consequences. This raises the question of whether this 
element of the insomnia diagnosis is clinically relevant. If a child experiences 
features of sleeplessness, is this less worthy of intervention when there is no impact 
on their functioning the following day? If we consider sleeplessness without any 
negative consequences to be natural variability in children’s sleep patterns, rather 
than indicative of a clinical problem, then a great deal of the empirical literature may 
not be based on insomnia at all, but on typical variance within the population. 
Alternatively, it may be that these children present with sleep problems at a sub- 
clinical level that do not cause short-term impairment to daytime functioning, and 
are therefore overlooked by parents and care-givers, yet they may still have 
significant longitudinal consequences on long-term development (Jan et al., 2010). 
Another important aspect to consider is the person for whom the 
sleeplessness is problematic. Often, sleep measures or diaries are completed by 
the parent or care-giver, and their perception of their child’s sleep may differ to the 
child’s own (Fricke-Oerkermann et al., 2007; Short et al., 2013). Although several 
studies made use of physiological measures, such as polysomnography or 
actigraphy, these were typically not employed to determine whether the participant 
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was displaying signs of insomnia. Instead insomnia was assessed using 
questionnaire items based on the three key symptoms stipulated in the diagnostic 
criteria. Another feature of the criteria which was infrequently considered was the 
opportunity and environment for adequate sleep to be achieved, and in the DSM, 
the exclusion of alternative diagnoses that may better explain the presence of 
sleeplessness. There are therefore considerable improvements that need to be 
made in the empirical fields, when considering what is actually meant by the 
construct of insomnia. Without clear and agreed definitions of the disorder, empirical 
findings cannot be reliably generalised to clinical practice. 
The series of articles by Roberts and colleagues included some of the few 
studies that reported multiple prevalence data, dependent on the rigour of the 
definition (Roberts & Duong, 2013; Roberts et al., 2008a). For example, the authors 
reported a prevalence for the presence of any symptom of insomnia, another for 
insomnia with daytime impairment, and finally, insomnia with daytime impairment in 
the absence of any other comorbidities, such as substance use or mental health 
diagnoses. These were the most thorough definitions of insomnia of the retrieved 
articles, and demonstrate clearly how the definition of insomnia contributes heavily 
to the observed prevalence. Yet, it was interesting to note that none of the articles 
used definitions specific to insomnia in childhood, as suggested by Mindell et al., 
(2006) and Glaze et al., (2002), nor was it commonplace to explore the importance 
of bedtime routines and associations, fears around bedtime, or the presence of 
appropriate sleep hygiene and sleeping environment, in order to discount other 
possible explanations for poor sleep in this population. 
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One strength of the literature is the extent to which authors attempted to gain 
large, representative participant samples. Although the focus of the vast majority of 
papers was beyond identifying prevalence rates, the manner in which participants 
were recruited and the high response rates were valuable when extracting 
meaningful prevalence data. However, this often led to a trade-off in terms of the 
assessment of insomnia. Many of the studies measured rates of insomnia as part 
of a wider screening of child and adolescent wellbeing. Whilst this reduced 
considerably the likelihood of a response bias distorting the prevalence data, it also 
meant that insomnia was a very small part of the dataset of interest, and so was 
often poorly operationalised or assessed with a single item. As a result, larger 
epidemiological studies tended to overinflate prevalence estimates, in comparison 
to smaller studies that had been more conservative in what they considered to meet 
diagnostic criteria. 
When considering the prevalence estimates for children in the clinical 
groups, it could be seen that there was a higher proportion of participants 
experiencing insomnia across the mental and physical health conditions. Of the 
mental health diagnoses, those with signs of depressive disorder reported a 
prevalence of insomnia of 59-63% (OR= 5.9-6.9). In comparison, 56-59% of those 
with anxiety also had signs of insomnia (OR= 5.1-5.8). Both of these prevalence 
estimates are considerably higher than that observed in the non-clinical population. 
Children who were included in papers reporting the prevalence of insomnia in 
chronic pain conditions demonstrated a prevalence of 54-55% (OR= 4.6-4.8). It can 
be seen that across the clinical groups, the prevalence of insomnia was much 
greater than in the non-clinical samples. 
91  
 
These findings should be interpreted with some caution, as the number of papers 
from which to derive prevalence estimates was relatively small, and the level of 
heterogeneity was high. In particular, the confidence intervals for the anxiety group 
would imply that the prevalence estimate could be anywhere between 13% and 
97%. This may be due to variations in the authors’ definition or assessment of 
insomnia, or the types of anxiety disorder included within the sample. For example, 
Ohayon et al. (2000) reported the prevalence of insomnia symptoms in children and 
adolescents with anxiety disorders, compared to Alfano et al. (2007), and Johnson 
et al. (2006a) who reported prevalence rates in participants with a generalised 
anxiety disorder only. This would suggest that the Ohayon et al. paper may be more 
inclusive, and therefore the higher prevalence estimate is to be expected. Synthesis 
of the prevalence estimates in clinical samples therefore adds an additional source 
of variability, as differences can occur not only in the definition and assessment of 
insomnia, but also the clinical disorder of interest. Future research should look to 
clarify the multiple factors surrounding mental and physical health problems that 
could contribute to the development of insomnia, or the elements of insomnia that 
influence the manifestation of physical and mental health problems. 
In summary, the findings of the meta-analyses suggest that insomnia is 
prevalent in 4-20% of the non-clinical child and adolescent population, dependent 
on the rigour of the chosen criteria. Furthermore, children and adolescents who 
have comorbid mental or physical health problems are considerably more likely to 
present with insomnia, whatever the direction of causality. Authors of future 
research should seek to define their construct of insomnia clearly, and ensure that 
if they are basing their definition on diagnostic criteria, they include these elements 
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in their assessment. Attention should also be given to the features of insomnia that 
are particular to this age group, and the methodological flaws associated with such. 
For example, including items on factors, such as use of technology before bed, a 
noisy or bright sleeping environment, or unhelpful bedtime routines or associations, 
may influence whether a participant is incorrectly classified as experiencing 
insomnia, therefore reducing the validity of any conclusions drawn. In addition, 
efforts should be made to ascertain whether any symptoms of insomnia are 
problematic for the child or for the parent, and if it is the latter, whether this is 
attributed the same clinical relevance. 
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CHAPTER TWO 
 
The relationship between sleep and daytime behaviour in children with 
 
Autism Spectrum Disorder 
 
 
 
Abstract 
 
Background.  Sleep problems have been reported frequently in children with 
autism spectrum disorder (ASD), with some evidence of an association between 
sleep problems and daytime challenging behaviour, although the direction of this 
association is unclear. The aim of this research was to explore the putative temporal 
association between sleep and daytime presentation. 
Methodology.  Seventeen children with ASD, aged 5-13 years (mean= 10.1, SD= 
 
2.2), and their families completed questionnaire assessments of both sleep 
problems and challenging behaviour, as well as participating in a seven-day sleep 
study. During the sleep study, actigraphy data were collected alongside sleep 
diaries and twice-daily ratings of challenging behaviour. 
Results.   Participants who had the highest sleep problem scores scored 
significantly higher on measures of challenging behaviour. A significant association 
was observed between night-wakings and overall challenging behaviour score. 
Linear mixed effects regression analyses identified that time spent awake after 
sleep onset the previous night, interacted with irritability to significantly predict 
severity of daytime challenging behaviour during the subsequent day. Sleep 
parameters did not predict subsequent daytime irritability, and neither irritability nor 
challenging behaviour predicted sleep the following night. 
Discussion.  The findings support the existing empirical literature, as well as 
providing novel evidence for a unidirectional temporal association between poor 
sleep and subsequent daytime challenging behaviour. Future research should aim 
to replicate these findings and explore the nature of the relationship between 
irritability, sleep and behaviour. 
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2.1 Introduction 
 
Autism Spectrum Disorder (ASD) is a pervasive developmental disorder 
characterised by impairments in social interaction and communication, and 
restricted or repetitive behaviours or interests (Diagnostic and Statistical Manual: 5th 
edition; American Psychiatric Association, 2013). Many individuals with ASD are 
reported to experience sleep problems, although these difficulties may be 
overshadowed by other issues perceived as more pressing, such as challenging 
behaviour (Reynolds & Malow, 2011). Prevalence estimates of sleep disorders in 
people with ASD vary from 50% to 80% (For a review, see Elrod & Hood, 2015; 
Richdale & Schreck, 2009) depending on the age and ability of the sample, definition 
and measurement of the sleep problem, and whether participants have a current or 
lifetime history of sleep problems. Although there is no definitive explanation for why 
people with ASD are more likely to experience sleep problems, hypotheses include 
an altered melatonin response, a genetic basis for a shift in circadian rhythm and 
atypical levels of arousal (Chamberlain & Herman, 1990; Hu et al., 2009; Melke et 
al., 2008; Nicholas et al., 2007; Richdale & Prior, 1995; Rossignol & Frye, 2011). 
Furthermore, some of the other characteristics commonly observed in people with 
ASD, such as heightened anxiety or arousal, difficulty in interpreting social cues, or 
preference for routine may also exacerbate sleep problems (Henderson, Barry, 
Bader & Jordan, 2011; Patzold, Richdale & Tonge, 1998; Richdale & Prior, 1995). 
Several types of sleep problem have been observed in people with ASD, 
including difficulties with sleep onset and maintenance, early waking, and irregular 
or poor quality sleep, particularly in young children. Other common problems include 
waking during the night for longer periods of time than is observed in comparison 
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groups, or having an overall decrease in the total time spent asleep (Honomichl, 
Goodlin-Jones, Burnham, Gaylor & Anders, 2002; Hoshino, Watanabe, Yashima, 
Kaneko, & Kumashiro, 1984; Patzold et al., 1998; Richdale & Prior, 1995). These 
difficulties have been reported as being more prevalent, frequent, and severe than 
those observed in typically-developing children or other clinical comparison groups, 
such as individuals with developmental delay (Couturier et al., 2005; Krakowiak, 
Goodlin-Jones, Hertz-Picciotto, Croen & Hansen, 2008; Richdale & Prior, 1995; 
Schreck & Mulik, 2000). A recent meta-analysis by Elrod and Hood (2015) 
concluded that children with ASD sleep for, on average, 32 minutes less than 
typically-developing children, take 10.9 minutes longer to fall asleep, and have 1.9% 
less efficient sleep. 
Several reviews have emphasised the importance of identifying not only the 
topography of the sleep problem but also the possibility of an underlying sleep 
disorder (Reynolds & Malow, 2011). Cohen, Conduit, Lockley, Rajaratnam and 
Cornish (2014) posit that the vast range of cognitive abilities and behavioural 
presentations that are encompassed within the spectrum of ASD is also reflected in 
the wide variety of sleep problems and disorders. They suggest that the majority of 
these fall under the classification of insomnia, parasomnia or circadian rhythm 
sleep-wake disorders, in the International Classification of Sleep Disorders (ICSD- 
3; American Academy of Sleep Medicine, 2014). Richdale and Schreck (2009) 
reported that although diagnostic criteria do not always translate well to sleep 
problems experienced by those with ASD, the most frequently reported difficulties 
can be best explained by a diagnosis of behavioural insomnia of childhood, in the 
ICSD-2 (American Academy of Sleep Medicine, 2005). They suggest that this may 
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be due to younger, or lower-functioning children having developed unhelpful and 
inflexible bedtime associations, or older and high-functioning children experiencing 
anxiety, resulting in settling difficulties. 
It has been suggested that poor sleep in people with ASD is associated with 
problematic daytime presentations, such as hyperactivity, social and emotional 
problems, communication impairments, and increased strength of autistic 
symptomatology (Allik, Larsson & Smedje, 2006; Hoshino et al., 1984; Malow et al., 
2006; Patzold et al., 1998; Schreck, Mulick & Smith, 2004). Furthermore, poor sleep 
has also been associated with an increase in challenging daytime behaviours, such 
as aggressive or disruptive behaviour, self-injury and stereotypy (Goldman et al., 
2011; Malow et al., 2006; Matson, Ancona & Wilkins, 2008; Schreck et al., 2004). 
Patzold et al. (1998) found that daytime behaviour problems significantly correlated 
with night-waking and poor sleep quality, as well as past and current sleep 
problems. This was replicated by Henderson et al. (2011) who observed that 
externalising behaviours were negatively correlated with sleep quality, and Tudor, 
Hoffman and Sweeney (2012), who reported associations between sleep onset 
delay and sleep duration and stereotypy, as well as between social interaction and 
the sleep problems of sleep onset delay, sleep duration, night-wakings, 
parasomnias, and sleep-disordered breathing. Rzepecka, McKenzie, McClure & 
Murphy (2011) also observed that sleep problems accounted for a large amount of 
the variance of challenging behaviour, with slightly less accounted for by anxiety. 
Interventions for sleep problems have demonstrated a positive impact on rates of 
daytime challenging behaviour in children with and without ASD (Minde, Faucon & 
Falkner, 1994; Mindell, Kuhn, Lewin, Meltzer & Sadeh, 2006; Wiggs & Stores, 
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1999). Similarly, Wiggs and Stores (1996) compared daytime behaviour of children 
with a diagnosis of ASD with and without sleep disturbance, and reported that 
children with sleep problems were more likely to present with several forms of 
challenging daytime behaviours, including, stereotypy and hyperactivity, as well as 
irritability. Heightened irritability or hostility has also been reported as being 
correlated with sleep duration, night-waking and parasomnia, as well as with sleep 
anxiety and daytime sleepiness by Mazurek and Sohl (2016). 
In combination, these findings imply that a relationship exists between sleep 
problems and increased daytime challenging behaviour and irritability in people with 
ASD. However, the majority of existing studies employ a cross-sectional design, 
and compare behaviour between those above and below a sleep disorder cut-off, 
or explore associations between measures of sleep and behaviour. Thus, the 
findings could be interpreted as daytime behaviour and irritability having an impact 
on sleep, or that an underlying factor exists which influences both of these variables. 
The lack of longitudinal data is a key limitation of existing literature, as the direction 
of any temporal association between sleep and daytime presentation cannot be 
identified. Longitudinal data are necessary in order to design targeted and effective 
interventions, in that if sleep problems are influencing levels of challenging 
behaviour and irritability, focusing the intervention on the sleep problems would 
have positive outcomes for both sleep quality and daytime challenging presentation. 
By contrast, implementing an intervention for challenging behaviour or irritability 
alone, would have limited effectiveness in improving sleep, and may not be 
efficacious in reducing mood or behaviour if the association with sleep problems is 
particularly strong. 
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The majority of sleep data for children with ASD are collected via parent- or 
carer-reports. Whilst parent- or carer-completed measures are an effective method 
for collecting data from larger samples, and with children who may not be able to 
tolerate physiological measures, such as polysomnography1, some research has 
suggested that parent- and carer-reports may not be accurate. For example, 
parents may over- or underestimate their child’s sleep problems, or be unaware of 
their child’s night-time behaviours, especially if they sleep well themselves (Hering, 
Epstein, Elroy, Iancu & Zelnik, 1999; Short, Gradisar, Lack, Wright & Chatburn, 
2013; Werner, Molinari, Guyer & Jenni, 2008). Actigraphy has been used as an 
acceptable alternative to polysomnography in the ASD population, as it is an 
unobtrusive method of estimating the child’s sleep behaviour in their home 
environment. Whilst it is less sensitive than polysomnography, and uses white light 
and movement as a proxy measure of sleep, it provides a more objective and 
accurate estimation of a child’s sleep than parent-report alone (Sadeh, 2011; Sadeh 
& Acebo, 2002). 
 
The present study uses a combination of sleep diaries and actigraphy over 
the course of a seven-night data collection period, in order to generate objective 
measures of sleep alongside concurrent parental ratings of daytime challenging 
behaviour and irritability. The aim of the study was to elucidate the temporal 
relationship between sleep parameters of quality and duration, and daytime 
challenging behaviour in children with ASD. The first hypothesis was that those 
reporting  greater  sleep  problems  would  also  present  with  more  challenging 
 
 
 
 
1 Polysomnography involves the measurement of multiple physiological parameters related to 
sleep, such as air flow, blood pressure, eye movement, and heart rhythm (Vaughn & Giallanza, 
2008). 
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behaviour. The second hypothesis was that associations would exist between the 
cross-sectional sleep parameters and ratings of challenging behaviour, as 
measured using questionnaire data. Finally, it was hypothesised that nights during 
which children experienced more troubled sleep, as measured using actigraphy, 
would be associated with more severe daytime ratings for challenging behaviour 
and irritability. However, it is unclear whether this increase in daytime behaviour and 
irritability would be observed during the preceding or subsequent day and therefore 
the direction of the association cannot be predicted. 
2.2 Methodology 
 
2.2.1 Participants 
 
Families who had participated in past research projects and who had consented to 
be contacted for the purposes of future research were sent postal information about 
the present project. This was then followed up with a telephone call, to determine 
eligibility and willingness to participate. The project was also advertised at local 
family conferences dedicated to sleep in individuals with ASD, as well as on the 
research team’s website and social media page. Children aged 4-15 years with any 
professional diagnosis on the autism spectrum and with any level of intellectual 
ability were eligible to participate. The child’s parents had to consider their child to 
have a sleep problem to take part, but a formal diagnosis of a sleep disorder was 
not required. 
Twenty families expressed an interest and consented to participate. It was 
not possible to calculate an accurate participant response rate, as the number of 
eligible families who had received details of the project was unclear. One family 
retired from the study partway through data collection, and two children were 
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excluded due to a high level of missing data. Seventeen children and their families 
therefore constituted the sample. Children were aged between 5 and 13 years 
(mean= 10.1, SD= 2.2), and 65% were male. Diagnoses of ASD had been received 
from paediatricians, local mental health services and Child Development Centres. 
None of the children had a diagnosis of epilepsy. Five children were currently 
receiving medication for sleep problems, one child was taking a psychostimulant 
and two children were taking antihistamines. All children lived at home with their 
biological mother, and either their biological father or step-father. Participant 
characteristics are summarised in Table 2.1 and Appendix 6. 
Table 2.1 – Participant characteristics 
 
Participant Age (Years) Gender Performance IQ1 Adaptive Behaviour2 
1 9 Male NA 56 
2 12 Female 112 68 
3 7 Female 95 89 
4 8 Male 131 75 
5 13 Male 89 76 
6 13 Male 94 79 
7 11 Female 111 78 
8 8 Male 110 80 
9 12 Male 110 74 
10 10 Male 112 62 
11 9 Male 70 68 
12 10 Male 76 66 
13 7 Female 77 126 
14 11 Female 112 68 
15 10 Male 127 97 
16 5 Male >103 65 
17 10 Female 84 67 
 
 
1 As measured on the Wechsler Abbreviated Scale of Intelligence 
2 As measured on the Vineland Adaptive Behavior Scales 
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Descriptive statistics for adaptive functioning as measured on the Vineland 
Adaptive Behavior Scale (VABS), are given in Table 2.2. The majority of children 
fell within the ‘low’ or ‘low to moderate’ ranges across all subscales, except for motor 
skills in which most children scored within the ‘adequate’ range. Of the seventeen 
participants, eleven met the threshold for autism on the Autism Diagnostic 
Observation Schedule (ADOS), and the remaining six met criteria for autism 
spectrum disorder. One child was classed as having an intellectual disability based 
on performance on the Mullen Scales for Early Learning (MSEL; Age equivalent 
scores 23-36 months). Another child scored at ceiling on the MSEL, yet was below 
the recommended age range on the Wechsler Abbreviated Scales of Intelligence 
(WASI), and so standardised IQ data were not available. Estimation of intellectual 
ability for the remainder of the sample was based on performance IQ due to a 
significant discrepancy observed between verbal and performance subscales for a 
number of participants, and the likelihood of overall IQ being underestimated as a 
result (Happé, 1994; Siegel, Minshew & Goldstein, 1996). The performance IQ 
mean for the remainder of the sample was therefore 100.6 (SD= 18.6). 
  moderate  moderate  
Communication 17 85.1 (16.9) 23.5 (4) 35.3 (6) 29.4 (5) 11.7 (2) 0 (0) 
Daily Living Skills 17 78.5 (22.1) 41.2 (7) 35.3 (6) 17.6 (3) 0 (0) 5.9 (1) 
Socialisation 17 71.7 (17.5) 58.8 (10) 29.4 (5) 5.9 (1) 5.9 (1) 0 (0) 
Motor Skills 17 89.6 (20.2) 23.5 (4) 23.5 (4) 47.1 (8) 5.9 (1) 0 (0) 
Overall Adaptive Behaviour 17 76.1 (16.3) 47.1 (8) 41.2 (7) 5.9 (1) 5.9 (1) 0 (0) 
 
1
2
4
 
 
 
 
Table 2.2 - Mean scores for each subscale of the Vineland Adaptive Behavior Scales and overall adaptive behaviour score, 
 
and percentage of sample falling within each category denoting level of functioning. 
 
 
 
 
N Mean (SD) Low 
 
 
Low - 
% (n) 
Adequate 
 
 
High - 
 
 
 
High 
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2.2.2 Measures 
 
Measures were completed either over the telephone, in person with the child 
or parent, or as part of a questionnaire pack. 
Vineland Adaptive Behavior Scales (VABS: Sparrow, Balla & Cicchetti, 
 
1984). The VABS was used to assess the child’s functional ability across domains 
of communication, daily living, socialisation and motor skills, and provides a 
standardised score for overall adaptive behaviour. This was completed two weeks 
prior to the family attending the university. The VABS has been demonstrated as 
having sufficient internal consistency, test-retest reliability and inter-rater reliability 
with typically-developing samples as well as those with developmental delay (De 
Bildt, Kraijer, Sytema & Minderaa, 2005; Sparrow et al., 1984). 
Modified Simonds and Parraga Sleep Questionnaire (MSPSQ; Simonds 
 
& Parraga, 1982; Wiggs & Stores, 2004. Appendix 2).  The original measure, 
published in 1982, is completed by the parent, and is used to assess sleep quality 
and identify sleep disturbances in children. The modified version has been adapted 
for use with children with developmental disorders, and can be used to derive 
subscale scores for bedtime resistance, sleep onset delay, sleep anxiety, night- 
waking, parasomnia, sleep-disordered breathing and daytime sleepiness, as well 
as an overall score. The scoring methods suggested by Johnson, Turner, Foldes, 
Malow and Wiggs (2012), and Wiggs and Stores (2004) have been used. 
Autism Diagnostic Observation Schedule (ADOS: Lord, Rutter, 
DiLavore & Risi, 2001).   The ADOS is a commonly-used standardised 
observational instrument, which makes use of activities designed to engage the 
individual in social interaction, in order to assess for common features of ASD. The 
126  
 
ADOS has good inter-rater reliability and predictive validity, and specificity and 
sensitivity rates above 87% (Lord et al., 2001). The measure was included to 
confirm the child’s existing diagnosis of ASD. 
Mullen Scales of Early Learning (MSEL; Mullen, 1995).  The MSEL is a 
measure of cognitive ability for children aged 0-68 months, and is also commonly 
used with individuals with developmental disabilities. The measure includes 
subscales assessing gross and fine motor skills, expressive and receptive language 
ability and visual reception, and has been reported to have adequate reliability and 
validity (Bishop, Guthrie, Coffing & Lord, 2011) 
Wechsler Abbreviated Scale of Intelligence (WASI; Wechsler, 1999). 
The WASI is a brief measure of intellectual functioning designed for typically- 
developing individuals aged 6-89.9 years, consisting of four subscales; vocabulary, 
similarities, block design and matrix reasoning. The WASI was only administered if 
the child scored at ceiling on the MSEL. Psychometrics derived from the 
standardisation sample demonstrated correlation coefficients above .84 when 
compared to the full scale measure (Wechsler, 1999). 
Amended Challenging Behaviour Questionnaire (Amended CBQ. 
Appendix 3). Parents were asked to complete a measure which had been modified 
to combine the Challenging Behaviour Interview (CBI; Oliver et al., 2003) and the 
Challenging Behaviour Questionnaire (CBQ; Hyman, Oliver & Hall, 2002), referred 
to here as the Amended CBQ. Both measures have demonstrated adequate 
reliability and validity individually (Hyman et al., 2002; Oliver et al., 2003). This 
measure identified the presence of challenging behaviours across domains of self- 
injury,  aggression,  destruction  of  property  and  stereotypy,  as  well  as  other 
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behaviours. The behaviours within each domain were then given a subscale rating 
based on their pervasiveness, i.e. the duration and frequency of the behaviour, and 
how often the behaviour required intervention from the parent. 
Questionnaire about  Behavioural  Function (QABF;  Paclawskyj, 
Matson, Rush, Smalls & Vollmer, 2000; Richards, 2015).  The domain that 
received the highest subscale score on the amended CBQ was then the focus of 
the QABF. This questionnaire presents multiple scenarios and asks the parent to 
rate the likelihood of their child presenting with the chosen behaviour in each 
situation. From this, possible functions of the behaviour are identified. The QABF 
has been demonstrated as a valid alternative to experimental functional analysis, 
and has reportedly strong psychometric properties (Matson, Tureck & Rieske, 
2012). The version presented here, has been amended to include additional 
subscales focused on ASD-specific sensory-based and routine-based functions 
(Richards, 2015). 
Actigraphy. Families agreed to a week during which they were available to 
complete the main sleep assessment. During this week, the child’s sleep was 
measured using sleep diaries completed by the parent (Appendix 4), and an 
actiwatch that was worn on the child’s non-dominant wrist (Philips Respironics, 
2014). Actigraphy is a method used to estimate sleep duration and quality, based 
on the wearer’s movement and the presence of white light. The software uses this 
information to calculate sleep intervals, and generate statistics such as sleep 
efficiency, total sleep time, and sleep onset latency. Actigraphy has been used in 
several studies with children with ASD, and has shown acceptable consistency with 
parent-completed sleep diaries (Allik et al., 2006; Goodlin-Jones, Sitnick, Tang, Liu 
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& Anders, 2008; Wiggs & Stores, 2004). Here, the automatically generated data 
were checked against sleep diaries completed by parents, and cleaned according 
to an agreed protocol (Appendix 5). 
An additional sleep parameter was calculated based on the parent-reported 
bedtime, and the time at which the actigraphy estimated the child to have fallen 
asleep. This was due to the sleep onset latency parameter being defined by the 
actigraphy, as the time during which the individual is trying to fall asleep. This 
normally corresponds to the latency between the individual turning off the lights and 
them falling asleep, and is represented by a period of rest on the actigraphy output. 
However, it was considered that in our sample, the time at which the child goes to 
bed is determined primarily by the parent. It may be that, despite being in bed, the 
child is not necessarily trying to sleep at this time and is therefore active for a period 
before settling down to sleep, the latter of which would be detected by the actigraphy 
as sleep onset latency. However, the active time between bedtime and settling time, 
is also likely to be an important feature of sleep in children with ASD, and therefore 
this additional parameter of the latency between parent-intended bedtime and time 
falling asleep was included. 
In addition to measuring the child’s sleep, the sleep diaries included items 
asking parents to rate the severity of their child’s daytime irritability and challenging 
behaviour in the morning and afternoon, as well as listing any naps that the child 
took during the day. Once the data had been collected, the family was provided with 
a report which summarised their child’s sleep data, and their performance on the 
other measures. 
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2.2.3 Analysis 
 
Questionnaire packs were returned for fifteen of the seventeen participants. 
Data for the direct measures were available for the whole sample. Analyses were 
conducted using the Statistical Package for the Social Sciences: Version 19 (SPSS: 
IBM Corp., 2010), R (R Core Team, 2015), and the lme4 package (Bates, Mächler, 
Bolker & Walker, 2014). Where data were non-normally distributed, non-parametric 
statistical methods were used. An alpha level of p=.01 was employed to account for 
multiple comparisons. 
2.3 Results 
 
2.3.1 Challenging Behaviour 
 
All of the children displayed between one and seventeen forms of behaviour 
which parents considered to be challenging (mean= 5.6, SD= 4.3). Scores from the 
amended CBQ are summarised in Table 2.3. Stereotyped behaviour was the most 
prevalent topography, with 76.5% of children presenting with some form of 
stereotyped behaviour. 
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Table 2.3 - Mean score for each topography of challenging behaviour in the 
amended CBQ, and the proportion of the sample presenting with each behaviour 
(Summation of n may exceed N, as participants present with several behaviours). 
 
N % of sample (n) Mean (SD) 
 
SIB 17 52.9 (9) 3.8 (4.3) 
 
Hitting self                                                                                   23.5 (4) 
Hitting self with object                                                                 11.8 (2) 
Biting self                                                                                     23.5 (4) 
Pulling at hair/ skin                                                                       5.9 (1) 
Scratching self                                                                             11.8 (2) 
Inserting objects                                                                           5.9 (1) 
Other                                                                                            5.9 (1) 
Aggressive Behaviour 17 58.8 (10) 4.1 (4.2) 
 
Hitting                                                                                          41.2 (7) 
Hitting with object                                                                        11.8 (2) 
Pulling or grabbing                                                                      23.5 (4) 
Scratching or pinching                                                                 5.9 (1) 
Spitting                                                                                         5.9 (1) 
Verbally aggressive                                                                     41.2 (7) 
Other                                                                                            5.9 (1) 
Destructive Behaviour 17 47.1 (8) 3.4 (4.1) 
 
Tearing or ripping items                                                              17.6 (3) 
Throwing, kicking, smashing small items                                    17.6 (3) 
Slamming or kicking doors                                                          41.2 (7) 
Tipping, throwing, smashing large items                                     17.6 (3) 
Pulls items from shelves or walls                                                 5.9 (1) 
Other                                                                                            5.9 (1) 
Stereotypy 17 76.5 (13) 5.5 (4.0) 
 
Repetitive whole body movement                                               23.5 (4) 
Repetitive movement of an object                                               23.5 (4) 
Repetitive movement of body part                                              41.2 (7) 
Visual regard e.g. strobing                                                          17.6 (3) 
Mouthing                                                                                     35.3 (6) 
Other e.g. clearing throat, grunting, jumping                               23.5 (4) 
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Other 17 47 (8) 3.0 (3.9) 
Pica  5.9 (1)  
Vocalisations  29.4 (5)  
Smearing  5.9 (1)  
Stealing  17.6 (3)  
Other  11.8 (2)  
 
 
 
Sixteen of the participants had complete data for the QABF. These data 
demonstrated that the behaviours identified in the amended CBQ were maintained 
by numerous functions, and that some participants’ behaviour was maintained by 
more than one function. Mean scores for each of the subscales are presented in 
Table 2.4. 
Table 2.4 - Mean scores for each subscale of the QABF. 
 
 
Function of behaviour N Mean (SD) 
Attention 16 5.5 (5.1) 
Task Escape 16 7.6 (5.2) 
Self-stimulation 16 9.3 (3.6) 
Pain or Discomfort 16 5.6 (4.1) 
Tangibles 16 6.9 (5.1) 
Sensory 16 9.1 (4.3) 
Routine 16 9.7 (3.8) 
Social Escape 16 8.3 (4.3) 
 
 
 
2.3.2 Sleep Problems – Questionnaire Data 
 
Descriptive statistics for the MSPSQ data demonstrated that 87% of the 
sample scored above the recommended sleep disorder cut-off of 56 (Johnson et al., 
2012), suggesting that the majority of the sample met criteria for a sleep disorder 
worthy of clinical intervention. Analysis of the descriptive statistics of the subscale 
scores, where any individual item scoring four or above is suggestive of the frequent 
occurrence of a particular sleep problem (Wiggs & Stores, 2004), demonstrated that 
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the most prevalent sleep problems fell under the category of bedtime resistance. 
When applying the threshold of four to the median scores for each subscale, 
daytime sleepiness was observed to score most highly. The summary statistics for 
the MSPSQ are given in Table 2.5. 
Table 2.5 - Summary statistics for the MSPSQ. 
 
 
N Mean (SD) 
 
MSPSQ 15 73.3 (14.6) 
% over median cut- 
off (n) 
% over single item 
cut-off (n) 
 
Bedtime Resistance                           2.6 (0.9)                 26.7 (4)                      86.7 (13) 
Sleep Onset Delay                             3.2 (1.1)                 40.0 (6)                       40.0 (6) 
Sleep Anxiety                                     2.3 (0.7)                  6.7 (1)                       80.0 (12) 
Night-waking                                      2.7 (0.9)                  6.7 (1)                        53.3 (8) 
Parasomnia                                        1.8 (0.5)                    0 (0)                        80.0 (12) 
Sleep-disordered 
 
Breathing 
1.6 (0.9) 6.7 (1) 40.0 (6) 
 
Daytime Sleepiness 3.0 (1.3) 33.3 (5) 66.7 (10) 
 
 
 
No significant Spearman’s correlations were observed between the sleep 
variables, as measured on the MSPSQ, and adaptive functioning, as measured on 
the VABS. To investigate the association between sleep and challenging behaviour, 
a median split was carried out based on the MSPSQ total score. A significant 
difference was observed in the total scores of the amended CBQ when a t-test was 
conducted between the group with high MSPSQ scores (mean= 24.0, SD= 13.7) 
and those with low MSPSQ scores (mean= 11.7, SD= 5.4) (t(9.4)= -2.34, p= .04). 
Spearman’s correlations were then conducted between the MSPSQ sleep 
disorder subscales and the function subscales of the QABF. A significant correlation 
was observed between daytime sleepiness and the self-stimulatory scale (r= .70, 
p< .01). 
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Considering the Spearman’s correlations between the sleep disorder 
subscales on the MSPSQ and the challenging behaviour scores on the amended 
CBQ, night-wakings were observed to show a significant positive association with 
the overall score for the amended CBQ (r= .62, p= .01). 
2.3.3 Sleep Problems – Actigraphy Data 
 
Each child had valid actigraphy data for between four and eight nights. The 
sleep parameters included the times at which it was estimated that the child went to 
bed at night and got out of bed in the morning, the total time that the child spent in 
bed and the time spent asleep, the latency between getting into bed and falling 
asleep, the amount of time spent awake after sleep onset (WASO), and the number 
of wakings during the night. The additional parameter of the latency between parent- 
reported bedtime and falling asleep was also analysed. The actiware also provides 
an estimate of the child’s sleep efficiency as a percentage, based on a combination 
of the above variables. Summary statistics for the actigraphy data are presented in 
Table 2.6. 
 1
3
4
 
 
 
 
Table 2.6 - Summary statistics for the sleep parameters, as measured using actigraphy. 
 
 
 N Mean (SD) Minimum Maximum 
Bedtime (hh:mm:ss) 17 21:17:11 (01:06:30) 19:34:25 23:45:35 
Get-Up time (hh:mm:ss) 17 06:40:24 (00:52:46) 05:07:00 08:35:05 
Time in bed (hh:mm:ss) 17 09:23:12 (00:40:26) 08:26:21 10:41:30 
Time asleep (hh:mm:ss) 17 08:09:11 (00:34:27) 06:57:47 09:13:12 
Bedtime-sleep latency (hh:mm:ss) 15 00:50:33 (00:35:24) 00:07:26 01:49:21 
Sleep onset latency (mins) 17 9.51 (8.56) 0.71 35.33 
WASO (mins) 17 50.48 (16.26) 25.50 79.07 
Frequency of awakenings per night 17 38.81 (9.75) 25.57 64.50 
Sleep Efficiency (%) 17 86.93 (2.59) 82.35 91.40 
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As with the MSPSQ data, investigation of the Spearman’s correlations 
between sleep parameters, as measured using actigraphy, and adaptive 
functioning, as measured on the VABS, identified no significant associations. 
Spearman’s correlations were then carried out between the actigraphy parameters 
and the challenging behaviour subscales on the amended CBQ, with no significant 
associations identified. 
2.3.4 Temporal Associations between Sleep and Challenging Behaviour 
Linear mixed effects analyses were conducted to study the temporal relationships 
between the actigraphy sleep parameters and the daytime challenging behaviour 
and irritability data, as rated by parents in the sleep diaries. Estimates and standard 
errors for each parameter were calculated using maximum likelihood estimators (M 
estimators). This method of analysis is more robust than sum of squares indicators, 
as they are less reliant on the assumptions of parametric statistics. Furthermore, 
the method allows for the clustering of data across multiple levels, and in this 
manner accounts for autocorrelation occurring in longitudinal repeated measures 
designs. In the present study, challenging behaviour data were collected in both the 
morning and afternoon, for each day of the week, and for each participant. This 
resulted in three levels of measurement: time of day, day of week, and participant 
number, and therefore several potential sources of autocorrelation. The analysis 
accounted for differences at the level of intercept, to allow for differences in the 
sleep parameters between participants (Pinheiro & Bates, 2006). The intercept 
model was chosen, rather than slope, due to the sample size. This was because 
the number of terms required to model differences in slope would have greatly 
exceeded the number of data-points. 
136  
 
Does poor sleep predict daytime irritability? First, the extent to which the 
levels of the longitudinal study design and the individual differences between 
participants contributed to the variance in severity ratings of daytime irritability was 
analysed. To do this, variables coding for participant number, whether each time- 
point fell on a weekday or weekend, and whether data were collected in the morning 
or afternoon were each added into the null hypothesis model and removed in turn, 
to determine whether they should be included as random effects in the final model. 
A significant random effect was identified for the participant variable (X2= 162.6, p< 
.001), but not for day (X2= 0.0, p= 1.0), or time of day (X2= 0.4, p= 0.5). As a result, 
 
the variable denoting participant was included as a random effect in the null 
hypothesis model. 
The fixed effects of total sleep time, WASO and sleep efficiency were then 
added to the random effects model consisting of the participant variable, and this 
was compared to the null hypothesis model using a likelihood ratio test. None of the 
predictors offered significant improvement to the null hypothesis model (X2= 3.7, p= 
0.3), nor were the individual parameter estimates significant (Table 2.7), and so no 
fixed effects were added to the final model1. This implies that variance in daytime 
irritability is best explained by individual differences between participants, and was 
not further influenced by sleep time or quality. 
Table 2.7 - Fixed effects for the linear mixed effects model predicting irritability. 
 
 
 Estimate Standard Error t 
Intercept -0.86 1.83 -0.47 
Total Sleep Time -0.00 0.00 -0.62 
WASO 0.01 0.00 1.31 
Sleep Efficiency 0.04 0.02 1.89 
 
 
1 Model = lmer(Irritability ~ 1 + (1|Participant Number), REML=FALSE, data=d) 
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Does poor sleep predict daytime challenging behaviour?  As with the 
previous analysis, participant number, day and time of day were entered as random 
intercepts into the null hypothesis model, but only participant number was retained 
(X2= 104.2, p< 0.001), with the random effects of day (X2= 0.0, p= 1.0) and time of 
day (X2= 0.0, p= 1.0) being removed. 
The full model including predictor variables of total sleep time, WASO, sleep 
efficiency and irritability, was then compared to the null hypothesis model, in order 
to evaluate the fixed effects. Both the removal of WASO (X2= 6.4, p= 0.01) and 
irritability (X2= 62.6, p< 0.001) resulted in a significant change to the model, but total 
sleep time (X2= 2.1, p= 0.15) and sleep efficiency (X2= 3.2, p= 0.07) did not. WASO 
and irritability were therefore included as fixed effects in the final model1. This 
produced a final model for challenging behaviour, including participant number as a 
random effect, and WASO and irritability as fixed effects (Figures 2.1 and 2.2). This 
implies that daytime challenging behaviour is best predicted by WASO and 
irritability, when accounting for individual difference between participants. 
Covariance between WASO and irritability was r=-.02, suggesting that there was 
negligible shared variance between the variables. 
Table 2.8 - Fixed effects for the linear mixed effects model predicting challenging 
 
behaviour. 
 
 
 Estimate Standard Error t 
Intercept 0.26 0.26 1.02 
Irritability 0.48 0.05 8.75 
WASO 0.01 0.00 1.71 
 
 
 
 
 
 
1 Model = lmer(Challenging behaviour ~ 1 + WASO + Irritability + (1|Participant Number), REML=FALSE, 
data=d) 
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Figure 2.1 - Predicted values for the linear mixed effects model predicting severity 
of challenging behaviour, conditioned on random and fixed effects only. 
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Figure 2.2 – Marginal effects for the predictors of irritability and WASO on ratings of 
challenging behaviour. 
 
Does daytime irritability or challenging behaviour predict sleep 
efficiency? Random effects of participant and whether the day was a weekday or 
weekend were entered into the null hypothesis model. Time of day at which the data 
were collected was not entered in this analysis, as only data collected in the 
afternoon were thought to influence sleep efficiency that night, and therefore only 
afternoon data were included in the analysis. As in the previous analyses, a 
significant random effect was not observed for day (X2= 0.0, p= 1.00), and so only 
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participant number was retained as a random effect in the null hypothesis model 
 
(X2= 8.2, p< 0.01). 
 
Challenging behaviour and irritability ratings were added as fixed effects in 
the full model, and compared to the null hypothesis model consisting of the 
participant number. The addition of the fixed effects added no significant 
contribution to the null model (X2= 3.3, p= 0.19), and demonstrated no significant 
individual parameter estimates (Table 2.9). Therefore, no fixed effects were 
included to the final model1. This suggests that variance in sleep efficiency is best 
explained by individual differences between participants, and was not further 
influenced by daytime challenging behaviour or irritability. 
Table  2.9  -  Fixed  effects for  the  linear  mixed  effects model  predicting  sleep 
efficiency. 
 
Estimate Standard Error t 
 
Intercept 88.76 1.24 71.81 
 
Challenging Behaviour -0.70 0.57 -1.23 
 
Irritability -0.16 0.49 -0.33 
 
 
 
2.4 Discussion 
 
The aim of the present study was to delineate the nature of the relationship between 
sleep and daytime challenging behaviour in individuals with ASD. The study sought 
to improve upon previous work by including a temporal analysis of sleep and 
daytime challenging behaviour. The results support the hypothesis that poor sleep 
quality has a negative impact on ratings of daytime behaviour the following day. 
Specifically, the time spent awake after having fallen asleep (WASO), in interaction 
with parent-reported irritability, are significant predictors of the severity of daytime 
 
 
 
1 Model = lmer(Sleep Efficiency ~ 1 + (1|Participant Number), REML=FALSE, data=d) 
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challenging behaviour. Although numerous authors have hypothesised that 
observed associations between sleep problems and daytime challenging behaviour 
in cross-sectional datasets are indicative of a negative outcome of poor sleep on 
daytime functioning, this study provides the first findings based on longitudinal data 
to support this argument. Furthermore, the observation that daytime behaviour does 
not explain variance in sleep quality the subsequent night, further implies that the 
association between these two variables is unidirectional. 
Notably, it was specifically the time spent awake during the night, as 
measured using actigraphy, that was predictive of subsequent challenging 
behaviour, in contrast to other predictors, such as sleep duration. This suggests that 
it is disturbed or broken sleep rather than shortened sleep duration or sleep 
efficiency which is causally related to challenging behaviour for children with ASD. 
This assertion is supported by the correlations between sleep variables as 
measured by the MSPSQ, between reported night-wakings, and both overall score 
on the amended CBQ, and total frequency of challenging behaviours. 
Other observed associations, although not statistically significant, included 
the non-social operant functions for challenging behaviour of self-stimulation and 
pain, and scores for parasomnia. This implies that children whose behaviours are 
maintained by the non-social functions of self-stimulation or discomfort, also are 
more likely to show signs of parasomnia. It could be that an underlying factor 
mediates the relationship between these variables, such as the presence of health 
problems. The discomfort caused by a health problem may exacerbate behaviours 
maintained by underlying functions of pain and self-stimulation, in order to reduce 
or tolerate the distress. However, the discomfort may also increase the likelihood of 
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the child presenting with signs of parasomnia, such as bruxism or restlessness, and 
so, in this manner, an additional underlying factor may be influencing scores on both 
the QABF and MSPSQ. As Goldman et al. (2011) discuss, the parasomnia subscale 
consists of a wide range of different problems, which can frequently occur 
independently. In this sense, analysing parasomnias as a subscale of related sleep 
problems may not yield the most meaningful data, as a child may not score 
particularly high on the subscale average, yet may still present with behaviours 
significant enough to reach the threshold recommended by the ICSD. It can be 
observed that 80% of the sample frequently experienced at least one form of 
parasomnia, and yet this may not have been reflected in the use of the median data 
when correlating sleep subscales against challenging behaviour topography and 
function. Another observed association was between daytime sleepiness and 
behaviour maintained by a self-stimulatory function, suggesting that children who 
are tired in the daytime may also present with stereotyped behaviours, such as 
rocking or hand-flapping. This could imply that the stereotypy acts as a self-soothing 
behaviour to reduce the distress experienced when feeling tired, or the findings 
could also be related to the observation that some children become more overactive 
when tired, rather than more lethargic. It is not possible to test these hypotheses 
within the constraints of the data presented here, but is a possible avenue for future 
research. 
The potential existence of associations between specific sleep problems and 
the topographies of challenging behaviour partially support the findings of Tudor 
and colleagues (2012), who carried out similar correlational analyses. The authors 
suggested that specific sleep problems may show different relationships with certain 
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forms of daytime impairment, as they observed relationships between sleep onset 
delay and sleep duration and stereotypy, whereas social interaction was also 
related to night-wakings, parasomnias, and sleep-disordered breathing. Similarly, 
Patzold and colleagues (1998) found that difficult daytime behaviour was correlated 
with sleeping in the same bed as parents, past or present sleep problems, poor 
sleep quality and night-wakings, and that shorter sleep duration predicted severity 
of autistic symptomatology. Furthermore, Mazurek and Sohl (2016) observed 
multiple significant correlations between sleep disorders and challenging 
behaviours of aggression, hostility/ irritability, inattention and hyperactivity. 
However, they observed that sleep anxiety was the best predictor of hostility/ 
irritability, whereas night-wakings had the strongest association with the remaining 
three of the four behaviour variables. It would appear that quality of sleep, influenced 
by features such as night-wakings, restlessness or parasomnias, has a different 
impact on children’s daytime presentation in comparison to reduced sleep time, 
characterised by longer sleep latencies or early morning awakening. This implies 
that the nature of the relationship between sleep and daytime presentation may 
differ between specific sleep problems. 
As Wiggs and Stores (2004) identify, a number of research studies identify 
sleep problems in children with ASD, but do not link these data with underlying 
diagnostic sleep disorder classifications, which would better inform intervention for 
these children. As such, a sleep problem could be considered a manifestation of a 
number of underlying disorders, each of which would be best addressed by different 
approaches to treatment, and may therefore have different implications on wider 
functioning.  For  example,  night-waking  underpinned  by  anxiety,  may  have  a 
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different relationship to daytime behaviour than night-waking caused by an 
underlying sleep apnoea. Furthermore, the intervention for each of these sleep 
disorders would differ considerably. Although the present study alluded to the 
presence of sleep disorders within the sample, a diagnostic measure was not used, 
and the sleep disorder data taken from the subscales of the MSPSQ should 
therefore be interpreted with caution. However, it would be an interesting 
development to apply more stringent diagnostic criteria to the sleep problems 
observed in a sample of children with ASD, and to replicate the analysis conducted 
here, to identify whether the observed relationships between sleep disorders and 
the topographies and functions of challenging behaviour remain. 
In addition to advancing our understanding of the nature of the relationship 
between poor sleep and daytime challenging behaviour, the present study also 
replicated findings from a number of previous studies, in that children who were 
reported to have the most significant sleep problems, also scored highest on 
measures of challenging behaviour (Malow et al., 2006; Wiggs & Stores, 1996). 
Furthermore, sleep problems were not observed to be related to levels of adaptive 
functioning, which corresponds to the findings of authors, such as Patzold et al. 
(1998) who observed that children with ASD experienced more sleep problems then 
a typically-developing control group, despite being matched for age and IQ, 
Krakowiak and colleagues (2008) who reported that adaptive functioning was 
predictive of neither quality nor duration of sleep in their ASD sample, and Mayes 
and Calhoun (2009) who observed no relationship between intellectual or 
neuropsychological functioning and sleep disturbance. This would suggest that 
adaptive or intellectual ability levels are not related to sleep problems in this group, 
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yet, research in this area appears to be inconclusive, as other authors have reported 
findings to the contrary (Giannotti et al., 2008; Taylor, Schreck & Mulick, 2012). 
Despite there being a number of interesting findings in the present study, a 
key limitation was the wide range of individual differences within the group, resulting 
in a relatively non-homogenous sample. Because different types of underlying sleep 
disorder and topographies of challenging behaviour may be more prevalent in 
various subgroups within the sample, such as those with and without intellectual 
disability, or those with autism compared to ASD, it may be that different 
relationships exist between these variables for different children within the sample. 
As Cohen and colleagues (2014) discuss, the presentation of children with ASD 
differs significantly between those who are considered high-functioning and those 
who have an intellectual disability. Due to the size of our sample, and the difficulty 
with assessing IQ in a manner that was appropriate for both high- and low- 
functioning individuals, these two subgroups could not be analysed separately. 
Similarly, the sample consisted of children displaying a wide range of autistic 
symptomatology, and with diagnoses of autism and autism spectrum conditions. 
This limits the extent to which the findings can be generalised beyond this sample, 
as the association between autistic symptomatology and sleep problems cannot be 
ascertained and therefore accounted for. However, it should be noted that by 
analysing the data using a mixed effects linear regression, and including participant 
in the random effects element of the model, this will have largely accounted for the 
variance explained by individual differences between the participants. Future 
research should recruit a large enough sample, such that subgroups within the 
sample can be analysed separately and compared, such as ASD compared to 
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autism, or those with and without intellectual disability. Had a larger sample been 
obtained, it may have been possible to better disentangle the features of ASD that 
might mediate the relationship between sleep problems and challenging behaviour. 
Another limitation of the study is that the findings only provide information 
about the association between sleep and daytime challenging behaviour, in children 
whose parents consider them to have a sleep problem. This association may be 
different for children who display challenging behaviour but do not present with 
sleep problems. Future studies could assess sleep quality and duration in children 
with and without sleep problems, and examine temporal associations with daytime 
challenging behaviour, or other variables, such as attention, affect, or sociability. 
In summary, the findings presented here contribute to an improved 
understanding of the association between sleep and daytime challenging behaviour, 
in that the time spent awake after sleep onset, in combination with irritability, 
predicted the severity of challenging behaviour the following day. Although we 
cannot conclude that sleep problems cause daytime challenging behaviour, it is 
likely that disturbed sleep may exacerbate behaviour, and that by helping to improve 
a child’s sleep, we may also observe positive changes in their daytime behaviour. 
This finding therefore has implications for the way in which clinicians assess for the 
contributors to challenging behaviour, and the way in which interventions are 
developed. Future research should aim to replicate these findings with a larger, 
more homogenous sample. 
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CHAPTER THREE 
 
Public Dissemination Document 
 
 
 
3.1 Literature Review 
 
3.1.1 Background 
 
Insomnia is a sleep disorder characterised by difficulty initiating sleep (DIS), 
difficulty maintaining sleep (DMS) and early morning awakening (EMA), with 
evidence of associated distress or daytime impairment (Diagnostic and Statistical 
Manual: Fifth edition, American Psychiatric Association, 2013; International 
Classification for Sleep Disorders: Third edition; American Academy of Sleep 
Medicine, 2014). A wide range of prevalence estimates for insomnia in the child and 
adolescent population have been reported, from 4% to 41% (Archbold, Pituch, 
Panabi & Chervin, 2002; Camhi, Morgan, Pernisco & Quan, 1999). This varies 
dependent on the way in which insomnia has been defined, the methodology 
employed to identify the presence of insomnia, and the population from which the 
research sample was drawn. Consequently, it is difficult to gauge the extent to which 
insomnia is of clinical importance in this age-group. Furthermore, it has been 
questioned whether the diagnostic criteria can been meaningfully applied to this 
population, and whether insomnia should be considered in a more descriptive 
context with children and adolescents, rather than as a diagnostic term (Glaze, 
Rosen & Owens, 2002; Meltzer & Mindell, 2014; Mindell et al., 2006). 
Insomnia has been identified as being more common in physical and mental 
health disorders, yet the lack of synthesised prevalence data in the non-clinical 
population limits the extent to which the prevalence of insomnia in clinical groups 
can be accurately compared. This means that it is difficult to estimate the extent to 
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which clinical populations are at an increased risk of presenting with insomnia. The 
range of definitions and methods of assessment in the empirical literature also limits 
the extent to which the findings can be used to understand the components of 
insomnia, and therefore its value in developing effective interventions. The aims of 
the study were therefore to provide an overall estimate for the prevalence of 
insomnia in the non-clinical population of children and adolescents, adjusted for the 
quality of the research methodology. The study also looked to compare the 
prevalence figures identified for the non-clinical population, with those identified for 
populations of children and adolescents with physical and mental health conditions. 
3.1.2 Methodology 
 
A search of the research literature was conducted to identify articles that reported 
the prevalence of insomnia in children and adolescents aged 4-18 years. These 
articles were screened against a number of eligibility criteria (Table 3.1). Articles 
that did not meet these criteria were excluded. Additional criteria were developed to 
construct a quality framework, based on Munn, Moola, Lisy and Riitano (2014). This 
was used to test the quality of each article, with articles considered to be of better 
methodological quality receiving a higher weighting. The prevalence data from each 
article were then pooled to generate overall prevalence estimates, using a random- 
effects model, and then a quality-effects model based on the quality weightings. 
This was repeated for each definition of insomnia, and for different clinical 
populations. 
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Table 3.1 - Strategy for screening articles. 
 
Criteria  Articles to be excluded 
English language Non-English language  
 
Empirical study 
 
Reviews, guides, conference proceedings, case studies etc. 
 
Typically-developing 
sample 
 
Sample includes children with a neurodevelopmental disorder 
 
Sample of school-age 
 
Sample includes adult or infant populations 
 
Relevant 
 
Irrelevant articles, such as pharmacological trials 
 
Non-biased 
recruitment 
 
Sample recruited on basis of having a sleep, or related, disorder 
 
Prevalence statistics 
 
Frequency or prevalence data cannot be extracted 
 
 
 
3.1.3 Findings 
 
The findings are summarised in Figure 3.1. The pooled meta-analyses identified a 
prevalence estimate of 16-20% for the presence of insomnia in the child and 
adolescent population. The prevalence estimates for each of the three symptoms 
were 14% for DIS, 9% for DMS and 6% for EMA. More stringent variations of the 
insomnia criteria, such as the inclusion of distress or daytime impairment, or the 
exclusion of comorbid disorders, reduced the pooled prevalence estimates to 10% 
and 4% respectively. Fifty-four to 61% of children and adolescents who were 
considered to have anxiety disorders, depression or chronic pain also presented 
with insomnia. 
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Figure 3.1 - Pooled prevalence estimates and 95% confidence intervals for each definition of insomnia in the non-clinical sample, 
and for each clinical sample. R= Random-effects; Q= Quality-effects; = Random-effects; = Quality-effects. 
161  
 
3.1.4 Application 
 
This is the first meta-analysis of the prevalence of insomnia in the child and 
adolescent population, and provides not only a synthesised summary of the 
prevalence estimates in the empirical literature, but also an overview of the 
strengths and limitations of existing research. It was observed that the prevalence 
estimates reported by the articles in the meta-analyses were very discrepant, and it 
is suggested that this is due to the wide variety of definitions of insomnia, and the 
methodology used by authors. Future research should seek to define and assess 
the construct of insomnia carefully, or be clear about the limitations surrounding the 
generalisability of any findings, particularly with regards to epidemiology or 
development of intervention. The significant reduction in the prevalence estimates 
when only including cases of insomnia in the presence of daytime consequences 
also emphasises the question of which symptoms are clinically relevant for 
diagnostic purposes, and whether a child experiencing sleep problems in the 
absence of other symptomatology is any less in need of clinical input. 
3.2. Empirical Paper 
 
3.2.1 Background 
 
Autism Spectrum Disorder (ASD) is a pervasive developmental disorder 
characterised by impairments in social interaction and communication, and 
restricted or repetitive behaviours or interests (Diagnostic and Statistical Manual: 5th 
edition; American Psychiatric Association, 2013). Sleep problems have been 
reported frequently in children with ASD, with consistent evidence of an association 
between sleep problems and daytime challenging behaviour (Goldman et al., 2011; 
Malow et al., 2006; Matson, Ancona & Wilkins, 2008; Mazurek & Sohl, 2016; 
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Schreck, Mulick & Smith, 2004; Tudor, Hoffman & Sweeney (2012). However, the 
majority of studies employ a cross-sectional design, and compare behaviour 
between those above and below a sleep disorder cut-off, or explore associations 
between measures of sleep and behaviour. Thus, the findings could be interpreted 
as sleep affecting daytime behaviour, as well as daytime behaviour having an 
impact on sleep. Alternatively, it may be that an underlying factor exists which 
influences both of these variables. The lack of longitudinal data is a key limitation of 
existing literature, as the direction of any temporal association between sleep and 
daytime presentation cannot be identified. Therefore, the aim of this research was 
to explore the temporal association between sleep and daytime challenging 
behaviour. 
3.2.2 Methodology 
 
Seventeen children with ASD, aged 5-13 years (mean= 10.1, SD= 2.2), and their 
families completed questionnaire assessments of both sleep problems and 
challenging behaviour, as well as participating in a seven-day sleep study. During 
the sleep study, actigraphy data were collected alongside sleep diaries and twice- 
daily ratings of challenging behaviour and irritability. Actigraphy is a method used to 
estimate sleep duration and quality, based on the wearer’s movement and the 
presence of white light. The data is then entered into a software package, which 
uses this information to calculate the times during which the child is asleep, and to 
generate statistics such as sleep efficiency, total sleep time, and sleep onset 
latency1. 
 
 
 
 
1 Sleep efficiency is an estimate of sleep quality, based on the time a child has spent asleep, in 
relation to the time they have been in bed, and the period of awakenings during the night. Sleep 
onset latency refers to the time taken for a child to fall asleep after lights out. 
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3.2.3 Results 
 
Eighty-seven per-cent of the sample had scores indicative of a sleep problem. The 
study showed that the children who had the highest scores for sleep problems also 
had the highest scores on measures of challenging behaviour. An association was 
observed between sleep problems and daytime behaviours; specifically, the number 
of awakenings during the night and overall challenging behaviour score. 
Regression analyses using the actigraphy data identified that time spent 
awake after falling asleep the previous night, interacted with parental ratings of 
irritability to predict severity ratings of daytime challenging behaviour during the 
subsequent day. None of the sleep variables predicted subsequent daytime 
irritability, and neither irritability nor challenging behaviour predicted sleep the 
following night. This suggests that there is a direction of influence between sleep 
problems, specifically night-time waking, irritability and daytime challenging 
behaviour. 
3.2.4 Application 
 
The findings support the existing literature, which suggests children with sleep 
problems are more likely to also present with challenging behaviour. However, the 
present study is the first to provide evidence for a directional association between 
sleep problems and subsequent daytime behaviour. This finding therefore has 
implications for the way in which clinicians assess for the contributors to challenging 
behaviour, and the way in which interventions are developed. 
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